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A B S T R A C T
Background
Intramedullary nails may be used for the surgical fixation of extracapsular hip fractures in adults. This is an update of a Cochrane review
first published in 2005 and last updated in 2008.
Objectives
To assess the effects (benefits and harms) of different designs of intramedullary nails for treating extracapsular hip fractures in adults.
Search methods
We searched the Cochrane Bone, Joint andMuscle Trauma Group Specialised Register (6 January 2014), the Cochrane Central Register
of Controlled Trials (The Cochrane Library Issue 12, 2013), MEDLINE (1966 to November Week 3, 2013), MEDLINE In-Process
& Other Non-Indexed Citations (3 January 2014), EMBASE (1988 to 2014, Week 1) and the World Health Organization (WHO)
International Clinical Trials Registry Platform (accessed January 2014).
Selection criteria
All randomised or quasi-randomised trials comparing different types, or design modifications, of intramedullary nails in the treatment
of extracapsular hip fractures in adults.
Data collection and analysis
At least two review authors independently selected studies, assessed risk of bias and extracted data. We performed limited meta-analysis
using the fixed-effect model.
Main results
We included eight new trials, testing seven new comparisons in this update. Overall, we included 17 trials, testing 12 comparisons of
different cephalocondylic nail designs. The trials involved a total of 2130 adults (predominantly female and older people) with mainly
unstable trochanteric fractures.
All trials were at unclear risk of bias for most domains, with the majority at high risk of detection bias for subjective outcomes. The
three quasi-randomised trials were at high risk for selection bias.
1Intramedullary nails for extracapsular hip fractures in adults (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Four trials (910 participants) compared the proximal femoral nail (PFN) with the Gamma nail. There was no significant difference
between the two implants in functional outcome (the very low quality evidence being limited to results from single trials), mortality (low
quality evidence: 86/415 versus 80/415; risk ratio (RR) 1.08, 95% confidence interval (CI) 0.82 to 1.41), serious fixation complications
(operative fracture of the femur, cut-out, non-union and later fracture of the femur) nor re-operations (low quality evidence: 45/455
versus 36/455; RR 1.25, 95% CI 0.83 to 1.90).
Two trials (185 participants) provided very low quality evidence of a lack of clinically significant difference in outcome (functional
score, mortality, fracture fixation complications and re-operation) between the ACE trochanteric nail and the Gamma nail.
Two trials (200 participants) provided very low quality evidence of a lack of significant difference in outcome (mobility score, pain,
fracture fixation complications or re-operations) between the proximal femoral nail antirotation (PFNA) nail and the Gamma 3 nail.
Seven of the nine trials evaluating different comparisons provided very low quality evidence of a lack of significant between-group
differences in all of the reported main outcomes for the following comparisons: ACE trochanteric nail versus Gamma 3 nail (112
participants); gliding nail versus Gamma nail (80 participants); Russell-Taylor Recon nail versus long Gamma nail (34 participants, all
under 50 years); proximal femoral nail antirotation (PFNA) nail versus Targon PF nail (80 participants); dynamically versus statically
locked intramedullary hip screw (IMHS) nail (81 participants); sliding versus non-sliding Gamma 3 nail (80 participants, all under 60
years); and long versus standard PFNA nails (40 participants with reverse oblique fractures).
The other two single comparison trials also provided very low quality evidence of a lack of significant between-group differences in all
of the main outcomes with single exceptions. The trial (215 participants) comparing the ENDOVIS nail versus the IMHS nail found
low quality evidence of poorer mobility in the ENDOVIS nail group, where more participants in this group were bedridden after their
operation (29/105 versus 18/110; RR 1.69, 95% CI 1.00 to 2.85; P = 0.05). The trial (113 participants) comparing the InterTan nail
versus the PFNA II nail found very low quality evidence that more PFNA II group participants experienced thigh pain (3/47 versus
12/46; RR: 0.24, 95% CI 0.07 to 0.81).
Authors’ conclusions
The limited evidence from the randomised trials undertaken todate is insufficient to determinewhether there are important differences in
outcome between different designs of intramedullary nails used in treating extracapsular hip fractures. Given the evidence of superiority
of the sliding hip screw compared with intramedullary nails for extracapsular hip fractures, further studies comparing different designs
of intramedullary nails are not a priority. Any new design should be evaluated in a randomised comparison with the sliding hip screw.
P L A I N L A N G U A G E S U M M A R Y
Intramedullary nails for extracapsular hip fractures in adults
What is the medical problem?
Fractures of the upper part of the thigh bone (femur) are termed hip or proximal femoral fractures. These fractures are most common
in women aged over 65 years. Roughly two out of five hip fractures are ’extracapsular’ in that they lie outside the hip joint capsule.
What treatments are available?
The majority of these fractures are fixed surgically using metal implants. One increasingly used implant is the ’intramedullary nail’.
This consists of a metal rod, which is usually inserted from the upper end of the femur into the inner cavity (medulla) of the femur
bone and held in place with screws. There are several different types of nails, usually made by different manufacturers, in use.
Are some intramedullary nails better than others for these fractures?
This review set out to examine the evidence from trials that compared different designs of nails in clinical practice.
We searched medical databases and registers of new studies (until January 2014) and found 17 trials that compared different nail
designs. These involved a total of 2130 participants. Most participants were older women.
The quality of the evidence from these trials is low or very low, partly because most trials used flawed methods that mean their results
may not be reliable. In addition, several trials did not report on function or provide data that could be used. Of the 12 different
comparisons tested, nine were tested by one trial only.
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Four trials compared the proximal femoral nail (PFN) with the Gamma nail in 910 older adults. Two trials compared the ACE
intramedullary nail with the Gamma nail in 185 older adults. Two trials compared the proximal femoral nail antirotation (PFNA) with
the Gamma 3 nail in 200 older adults. The other nine trials were single comparisons of different types of nail designs.
Overall, the weak evidence available for all 12 comparisons showed no important differences in outcome (function, mobility, pain,
death, fracture fixation complications and revision surgery) between the two nails or two nail designs under test. There was one possible
exception. There was weak evidence from one trial of 215 older adults that the ENDOVIS nail resulted in poorer mobility (more
people could not walk after their operation) when compared with the intramedullary hip screw (IMHS). However, more evidence is
required to be confident of this result.
In conclusion, the available evidence is insufficient to determine whether there are important differences in outcome between different
designs of intramedullary nails used for fixing extracapsular hip fractures. In terms of future research, we propose that priority is given
to comparisons of intramedullary nails with another type of device in common use, the sliding hip screw.
B A C K G R O U N D
Description of the condition
Hip fracture is the general term for fracture of the proximal (up-
per) femur. These fractures can be subdivided into intracapsu-
lar fractures (those occurring within or proximal to the attach-
ment of the hip joint capsule to the femur) and extracapsular
(those occurring outside or distal to the hip joint capsule). Ex-
tracapsular hip fractures are defined as those fractures that occur
within the area of bone bounded by the attachment of the hip
joint capsule and extending down to a level which is five cen-
timetres below the distal (lower) border of the lesser trochanter.
Other terms used to describe these fractures include trochanteric,
subtrochanteric, pertrochanteric and intertrochanteric fractures.
These terms reflect the proximity of these fractures to the greater
and lesser trochanters, which are two bony protuberances (bulges)
at the upper end of the femur outside the joint capsule.
Hip fractures occur predominantly in older people (aged over 65
years), especially women. The incidence of hip fracture varies con-
siderably between different populations (Bjorgul 2007). An in-
cidence of 1024 per 100,000 for women over 50, and 452 per
100,000 for men over 50 was reported for Norway between 1998
and 2003 (Bjorgul 2007). The relative proportion of extracapsu-
lar fractures also varies: 39% of hip fractures were extracapsular
fractures in Bjorgul 2007 and 48% in Karagas 1996. A summary
of the casemix for 61,508 hip fractures occurring between 1 April
2012 and 31 March 2013 in 180 hospitals in England, Wales and
Northern Ireland is presented by an annual report of the National
Hip Fracture Database (NHFD 2013). This shows that around
three-quarters of hip fractures (73.2%) occurred in women, and
over 90% of cases were aged over 70 years. In each of four years
from 2009, around 40% of fractures were extracapsular.
Numerous subdivisions and classification methods exist for these
fractures (e.g. theAOclassification (Muller 1991)). Themost prac-
tical classification, and that used for this review, is the basic division
into four types: stable trochanteric fractures (AO classification type
A1); unstable trochanteric fractures (AO classification type A2);
fractures at the level of the lesser trochanter (transtrochanteric or
AO classification type A3); and subtrochanteric fractures. Stable
trochanteric fractures are two part fractures in which the fracture
line runs obliquely (at an angle) between the lesser and greater
trochanter of the femur.Unstable trochanteric fractures again have
an oblique fracture line running between the trochanters, but in
addition there is comminution (fragmentation) of the fracture site.
The comminution fragments may be the lesser trochanter, greater
trochanter or both trochanters. Transtrochanteric fractures, sited
at the level of the lesser trochanter, have a slightly more distally
located (lower) fracture line that either runs transversely (across
the bone) at the level of the lesser trochanter or in an oblique di-
rection that is opposite (or ’reverse’) to that of the stable and un-
stable trochanteric fractures. Transtrochanteric fractures may be
two part or comminuted. This fracture pattern is unstable as the
femur is displacedmedially (inwards) due to the pull of the adduc-
tor muscles. Subtrochanteric fractures are those fractures in which
the fracture crossing the femur is predominately found within the
five centimetres of bone immediately below the lesser trochanter.
These fractures may be two part or comminuted, and in some
instances the fracture may extend proximally into the trochanteric
region or distally into the shaft of the femur.
Description of the intervention
Operative treatment of hip fractures was introduced in the 1950s
using a variety of different implants. Implants may be either ex-
tramedullary or intramedullary in nature. The most commonly
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used extramedullary implant is the sliding hip screw (SHS), which
is synonymous with the term compression hip screw and equiva-
lent models such as the Dynamic, Richards or Ambi hip screws.
Intramedullary nails used for the internal fixation of extracapsular
fractures can either be inserted from proximal to distal (cephalo-
condylic nails) or from distal to proximal (condylocephalic nails).
Cephalocondylic nails are inserted through the greater trochanter
of the femur and secured by a cross pin or screw, which is passed
up the femoral neck into the femoral head. A number of different
designs have been developed and marketed by different manufac-
turers. Examples include the Gamma nail (Stryker-Howmedica),
the intramedullary hip screw (Smith and Nephew Richards), the
proximal femoral nail (Synthes) and the ACE trochanteric nail
(DePuy Orthopaedics). Table 1 presents further information of
the nails to date examined by the included trials in this review.
Condylocephalic nails are inserted into the distal femur and passed
up the intramedullary cavity across the fracture site and up into
the femoral head. The best known and tested type of such nails is
the Ender nail.
How the intervention might work
Successive updates of our Cochrane review (Parker 2010) compar-
ing the Gamma and other cephalocondylic intramedullary nails
with extramedullary implants for extracapsular hip fractures have
consistently found that cephalocondylic nails incur the compli-
cations of intra-operative fracture, and later fracture around the
implant. Based primarily on the higher rate of complications and
re-operations of these nails for trochanteric fractures, we suggested
that the SHS (an extramedullary implant) appears to be the better
device for these fractures. We also suggested that “Further stud-
ies are required to determine if different types of intramedullary
nail produce similar results, or if intramedullary nails have ad-
vantages for selected fracture types (for example, subtrochanteric
fractures).”
Our Cochrane review of randomised trials comparing condylo-
cephalic nails with extramedullary fixation (Parker 1998) con-
cluded that the use of condylocephalic nails could not be recom-
mended because of the markedly increased risk of fracture-heal-
ing complications and other problems associated with condylo-
cephalic nails (in particular Ender nails).
Why it is important to do this review
Despite the evidence of poor performance of intramedullary nails
in comparison with the SHS (an extramedullary implant), de-
velopments and modifications to intramedullary nails, especially
cephalocondylic nails, continue. Additionally, the use of these nails
is increasing (Anglen 2008). This systematic review of randomised
trials examines studies that have compared different types, ormod-
ifications to the design, of intramedullary nails for extracapsular
proximal femoral fractures. This is an update of a Cochrane review
first published in Parker 2005 and last updated in Parker 2008.
O B J E C T I V E S
To assess the effects (benefits and harms) of different designs of in-
tramedullary nails for treating extracapsular hip fractures in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised or quasi-randomised (for example, alternation)
controlled trials comparing different types of intramedullary nails.
Types of participants
Skeletally mature patients with an extracapsular proximal femoral
fracture. Given that one of the authors (MJP) has become aware of
the growing use of intramedullary nails in intracapsular fractures,
we note here that in a future update we will consider including
trials with a mixed population of intracapsular and extracapsular
proximal femoral fractures.Wewill, however, request separate data
for the two fracture types.
Types of interventions
Surgical fixation of the fracture with either a cephalocondylic
intramedullary nail (for example, the Gamma nail, the in-
tramedullary hip screw (IMHS) and the proximal femoral nail
(PFN)) or a condylocephalic nail (for example, the Ender nail).
In setting out our comparisons we generally selected the older,
more conventional, or static, or both, implant design as our con-
trol group. Before we undertake our next update, we will consider
setting up comparisons addressing more general design concepts,
such as long versus short nails.
Types of outcome measures
The primary focus is on long-term functional outcome, preferably
measured at one year or more.
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Primary outcomes
• Functional outcomes: preferably, validated patient-reported
measures of lower limb or hip function (e.g. Oxford hip score;
Western Ontario and McMaster Universities Arthritis Index
(WOMAC)) and activities of daily living and health related
quality of life scores (SF-36). Composite scores of subjectively
and objectively rated function and overall outcome (e.g. Harris
hip score, Merle D’Aubigne hip score).
• “Poor outcome”, defined as death or deterioration of
functional status leading to markedly increased dependency in
the community or admission to institutional care.
• Serious adverse events and technical complications of
fixation (e.g. deep infection, avascular necrosis, later fracture of
the femur, non-union, cut-out, implant breakage) for which
substantive treatment, such as revision surgery, is indicated or
performed.
Secondary outcomes
• Mobility, use of walking aids, presence of a limp.
• Hip, lower limb pain (chronic).
• Medical complications: pneumonia; thromboembolism
(symptomatic deep vein thrombosis or pulmonary embolism);
pressure sore; urinary tract infection; delirium.
• Less serious local complications: intra-operative
periprosthetic fracture; surgical site infection (superficial);
wound haematoma; minor operation for removal of hardware.
Other outcomes
Data for the following outcomes were collected for completeness,
but not presented as main results for this review.
• Operative details: length of surgery, operative blood loss,
number of patients transfused, radiographic screening time.
• Functional impairment: range of motion, muscle strength.
• Anatomical restoration: leg shortening (preferably > 2 cm),
varus deformity of the femoral neck, external rotation deformity
(preferably > 20 degrees).
Economic outcomes
Each trial report was reviewed for costs and resource data, such
as length of hospital stay and number of outpatient attendances,
that would enable economic evaluation.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
Specialised Register (6 January 2014), the Cochrane Central Reg-
ister of Controlled Trials (The Cochrane Library Issue 12, 2013),
MEDLINE (1966 to November Week 3, 2013), MEDLINE In-
Process & Other Non-Indexed Citations (3 January 2014) and
EMBASE (1988 to 2014, Week 1). We searched the WHO
International Clinical Trials Registry Platform (accessed January
2014) for ongoing and recently completed trials.We did not apply
any language restrictions.
Previously, we searched the UK National Research Register (ac-
cessed June 2007, now archived) and Current Controlled Trials
(accessed June 2007) for ongoing and recently completed trials.
Search strategies developed for The Cochrane Library (2007 on-
wards), MEDLINE (2007 onwards) and EMBASE (2007 on-
wards) are shown in Appendix 1. The subject specific MEDLINE
search was combined with the sensitivity-maximizing version of
the Cochrane Highly Sensitive Search Strategy for identifying ran-
domised trials (Lefebvre 2011). Previous search strategies can be
found in Appendix 2.
Searching other resources
We searched reference lists of articles and our own reference
databases.
In our previous update, we included the findings from hand-
searches of the British Volume of the Journal of Bone and
Joint Surgery supplements (1996 onwards) and abstracts of the
OTA (Orthopaedic Trauma Association) annual meetings (1996
to 2006) and AAOS (American Academy of Orthopaedic Sur-
geons) annual meetings (2004 to 2007). We also included hand-
search results from the final programmes of SICOT (Société In-
ternationale de Chirurgie Orthopédique et de Traumatologie)
(1996 and 1999) and SICOT/SIROT (Société Internationale de
Recherche enOrthopédie et Traumatologie) (2003), EFORT (Eu-
ropean Federation of National Associations of Orthopaedics and
Traumatology) (2007) and the BOA (British Orthopaedic Associ-
ation) Congress (2000, 2001, 2002, 2003, 2005 and 2006). We
scrutinised weekly downloads of “Fracture” articles in new issues
of 15 journals (Acta Orthopaedica Scandinavica; American Jour-
nal of Orthopedics; Archives of Orthopedic and Trauma Surgery;
Clinical Journal of Sport Medicine; Clinical Orthopaedics; Foot
andAnkle International; Injury; Journal of the AmericanAcademy
ofOrthopaedic Surgeons; Journal of Arthroplasty; Journal of Bone
and Joint Surgery American volume; Journal of Bone and Joint
SurgeryBritish volume; Journal of Foot andAnkle Surgery; Journal
of Orthopaedic Trauma; Journal of Trauma; Orthopedics) from
AMEDEO.
Data collection and analysis
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Selection of studies
Three review authors (JQ, EH and HH) independently screened
search results and, after obtaining full reports, assessed potentially
eligible trials for inclusion. The other review author (MJP) pro-
vided feedback on selection and notification of results from his
ongoing scrutiny of the hip fracture literature. We did not mask
the titles of journals, names of authors or supporting institutions
at any stage.
Data extraction and management
Using a data extraction form, two review authors (JQ and EH)
independently extracted data for the outcomes listed above and
resolved any differences by discussion. Data entry by these two
review authors was checked by a third author (HH).We contacted
all trialists for additional data and clarification when necessary.
Assessment of risk of bias in included studies
At least two review authors (always JQ and EH) independently
assessed risk of bias for all trials without masking of the source
and authorship of the trial reports, including those that had been
assessed in previous versions of the review. We piloted the assess-
ment form on one trial. JQ checked between rater consistency in
assessment at data entry, and this was subsequently checked by
HH. We resolved all differences by discussion. We used the tool
outlined in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011). This tool incorporates assessment of
randomisation (sequence generation and allocation concealment),
blinding (of participants and treatment providers, and outcome
assessment), completeness of outcome data, selection of outcomes
reported, and other sources of bias. We considered ’subjective’
outcomes (e.g. functional outcome scores, pain) and ’objective’
outcomes (mortality, complications) separately in our assessment
of blinding (outcome assessment) and short-term (in hospital; up
to four months) and longer-term (four months and above; post-
hospital discharge) outcomes for completeness of outcome data.
We assessed three additional sources of bias: bias resulting from
major imbalances in key baseline characteristics (e.g. age, gender,
type of fracture, prior mobility); performance bias, particularly
’differential expertise’ bias resulting from lack of comparability in
surgeon’s expertise with the devices under test; and bias relating to
a commercial conflict of interest.
Measures of treatment effect
For each study, we calculated risk ratios (RRs) with 95% confi-
dence intervals (CIs) for dichotomous outcomes, and mean dif-
ferences (MDs) with 95% CIs for continuous outcomes.
Unit of analysis issues
The unit of analysis was individual patients in these trials but we
remained alert to other potential unit of analyses issues, such as the
repeated observation frommore thanone time-point, andmultiple
observations for the same outcome (e.g. total adverse events).
Dealing with missing data
We contacted trial authors for missing data and information.
Where reported, we used the numbers of participants reported as
providing data for any particular outcome. In studies for which a
number of events were reported, but the denominator was unclear,
we used numbers randomised or alive at follow-up. We did not
impute missing standard deviations (SDs) but derived these from
standard errors, 95% CIs or exact P values, if these were presented
instead.
Assessment of heterogeneity
We used both the Chi² statistic and I² test (Higgins 2003), as
well as visual inspection, to determine whether heterogeneity was
present and whether data pooling was appropriate.
Assessment of reporting biases
Should data for meta-analyses be available for 10 or more trials in
a future update, we will consider the generation of funnel plots to
explore the potential for publication bias.
Data synthesis
Where appropriate, we pooled results of comparable groups of tri-
als using the fixed-effect model. We would have used the random-
effects model to compare the results where there was substantial
and unexplained heterogeneity.
Subgroup analysis and investigation of heterogeneity
No subgroup analyses were specified a priori in the protocol. For
this update, we prespecified two subgroups (type of fracture - ini-
tially, intertrochanteric versus subtrochanteric - and gender) and
indicated that we would test whether the subgroups were statis-
tically significantly different from one another by inspecting the
overlap of CIs and performing the test for subgroup differences
available in ReviewManager (RevMan 2014). However, we found
there were insufficient data to conduct either subgroup analysis.
Sensitivity analysis
There were insufficient data to conduct our planned exploratory
sensitivity analyses based on allocation concealment and on the re-
porting of surgical experience. Sensitivity analyses using numbers
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randomised were done for any outcome for which denominators
other than number randomised had been used, in order to assess
any impact of missing data on results.
Quality assessment
We used the GRADE approach to assess the quality of evidence
relating to the primary outcomes for the individual comparisons
(Schünemann 2011).
R E S U L T S
Description of studies
Results of the search
For this update (search completed January 2014), we screened
a total of 852 records from the following databases: Cochrane
Bone, Joint and Muscle Trauma Group Specialised Register (20
records), Cochrane Central Register of Controlled Trials (276),
MEDLINE (255) and EMBASE (301). We also screened further
records for 76 trials from a search of the WHO International
Clinical Trials Registry Platform conducted in January 2014, and
obtained references for two abstracts in Journal of Bone and Joint
Surgery (British Volume) supplements from one review author
(MJP). The results from the previous searches (up to June 2007) are
shown in Appendix 3. Upon assessment, we excluded Gahr 2003,
which had been in ’Studies awaiting classification’, because a full
trial report has not been forthcoming of the currently inadequately
reported quasi-randomised trial.
The search update resulted in the identification of 22 potentially
eligible studies, which consisted of 17 full reports, three trial re-
ports and two conference abstracts. Of the 17 fully reported tri-
als, we included eight new trials (De Grave 2012; Makridis 2010;
Okcu 2013; Vaquero 2012; Wild 2010; Xu 2010a; Zhang 2013;
Zhu 2012), excluded seven others (Cao 2009; Dall’Oca 2010;
Huang 2012; Ouyang 2010; Pan 2009; Xu 2010b; Yang 2011)
and left two in ’Studies awaiting classification’ pending further in-
formation (Park 2010; Stern 2011). Of the three potentially eligi-
ble studies identified from our search of the WHO International
Clinical Trials Registry Platform, one trial (NCT00736684) was
identified as having been published (Vaquero 2012), one is ex-
cluded (NTR1133) and one is ongoing (NCT01437176). One
conference abstract also awaits classification (Mora 2011). (The
other conference abstract was another report of Makridis 2010).
Figure 1 presents the study flow diagram for this review up-
date. Overall, there are now 17 included trials (De Grave 2012;
Efstathopoulos 2007; Fritz 1999; Hardy 2003; Herrera 2002;
Makridis 2010; Marques 2005; Okcu 2013; Papasimos 2005;
Schipper 2004; Starr 2006;Vaquero 2012;Vidyadhara 2007;Wild
2010; Xu 2010a; Zhang 2013; Zhu 2012), 12 excluded studies
(Cao 2009; Dall’Oca 2010; Gahr 2003; Huang 2012; Merenyi
1995; NTR1133; Ouyang 2010; Pan 2009; Suckel 2006; Wagner
1998; Xu 2010b; Yang 2011), one ongoing trial (NCT01437176)
and three studies awaiting classification (Mora 2011; Park 2010;
Stern 2011).
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Figure 1. Study flow diagram
Included studies
Sixteen included trials were reported in full in English lan-
guage journals; a full translation from Spanish being obtained
for Marques 2005. Thirteen were single centre trials based in
seven different countries (Belgium: De Grave 2012; Hardy 2003;
China: Xu 2010a; Zhu 2012; Germany: Fritz 1999; Wild 2010;
Greece: Efstathopoulos 2007; Makridis 2010; Papasimos 2005;
India: Vidyadhara 2007; Spain: Herrera 2002; Marques 2005;
USA: Starr 2006). Four were multi-centre trials: Okcu 2013 and
Zhang 2013 were two-centre trials based respectively in Turkey
and China; Schipper 2004 was a multi-centre trial based in The
Netherlands and Vaquero 2012 was a multi-centre trial carried
out in Spain. Papasimos 2005 tested three implants: those patients
allocated to the sliding hip screw (SHS) are included in a separate
Cochrane review (Parker 2010). Fifteen trials had predominantly
older populations, with mean ages ranging between 69 and 85
years. The two exceptions were Starr 2006, which only included
adults under 50 years of age with high-energy fractures and Zhu
2012 which included adults under 60 years of age. Ten trials (Fritz
1999; Hardy 2003; Marques 2005; Schipper 2004; Okcu 2013;
Papasimos 2005; Vaquero 2012; Vidyadhara 2007; Xu 2010a;
Zhang 2013) included only patients with unstable trochanteric
proximal femoral fractures, whereas a minority of patients in the
other seven trials (De Grave 2012; Efstathopoulos 2007; Herrera
2002;Makridis 2010; Starr 2006; Wild 2010; Zhu 2012) had sta-
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ble fractures. Further details of the 17 included studies are given
in the Characteristics of included studies. The trials tested 12 dif-
ferent comparisons between various cephalocondylic nail designs
(the nails are described in Table 1). There were no trials evaluating
condylocephalic nails.
Proximal femoral nail (PFN) versus Gamma nail
The PFNwas comparedwith the standardGammanail in 250 par-
ticipants in Herrera 2002, in 156 participants in Marques 2005,
in 80 participants in Papasimos 2005, and in 424 participants in
Schipper 2004.
ACE trochanteric nail versus Gamma nail
The ACE trochanteric nail was compared with the trochanteric
Gamma nail in 112 participants in Efstathopoulos 2007, and with
the Gamma AP nail in 73 participants in Vidyadhara 2007.
ACE trochanteric nail versus Gamma 3 nail
The ACE trochanteric nail was compared with the Gamma 3 nail
in 112 participants in De Grave 2012.
Gliding nail versus Gamma nail
One trial (Fritz 1999) involving 80 participants compared the
gliding nail (where the lag screw of a Gamma nail is replaced with
a double T-shaped blade) with the Gamma nail.
ENDOVIS nail versus intramedullary hip screw (IMHS)
One trial (Makridis 2010) involving 215 participants compared
the ENDOVIS nail (contains two holes for cephalic screw inser-
tion) and the IMHS nail.
Russell-Taylor recon nail versus long Gamma nail
One trial (Starr 2006) involving 34 participants compared the
Russell-Taylor Recon nail with the long Gamma nail.
Proximal femoral nail antirotation (PFNA) versus Targon PF
nail
One trial (Wild 2010) compared the PFNA (intramedullary device
with a helical blade instead of a screw) with the Targon PF nail (a
device that has an extra antirotation pin in the femoral neck) in
80 participants.
PFNA versus Gamma 3 nail
The PFNA nail was compared with the Gamma 3 nail in 136
participants in Xu 2010a and 64 participants in Vaquero 2012.
Dynamic versus static locked intramedullary hip screw
(IMHS)
One trial (Hardy 2003) involving 81 participants compared a
modified intramedullary hip screw (IMHS) featuring a single slot-
ted hole that allowed dynamic locking of the nail versus the stan-
dard IMHS, which is locked distally with two screws.
Sliding versus non-sliding lag screw Gamma 3 nail
One trial (Zhu 2012) compared a sliding versus a non-sliding lag
screw in 80 participants, all of whom were under 60 years of age,
who were treated with a Gamma 3 nail.
InterTan nail versus PFNA II
One trial (Zhang 2013) involving 113 participants compared the
InterTan nail with the PFNA II nail
Long versus standard PFNA nail
One trial (Okcu 2013) compared long versus standard (short)
PFNA nails in 40 participants with reverse oblique type proximal
femoral fractures.
Excluded studies
We excluded 12 studies for the reasons given in the Characteristics
of excluded studies. Eight trials were either not randomised or very
unlikely to be randomised trials. We excluded Xu 2010b because
the population overlapped to an unknown extent with that of Xu
2010a. We excluded Yang 2011 because of concerns raised from
similarities of this report with that of an earlier trial (Makridis
2010).We excludedNTR1133 because it seems very unlikely that
this trial, if started, will be published. We excluded Dall’Oca 2010
as it did not compare two different nails but the same nail (Gamma
nail), used with and without cement augmentation.
Risk of bias in included studies
The risk of bias assessments for the individual trials are shown in
Figure 2 and as a composite for all trials in Figure 3.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
All three quasi-randomised trials were deemed at high risk of se-
lection bias in terms of sequence generation (allocation was based
on odd and even record numbers in Herrera 2002 and Marques
2005; and on admission sequence in Wild 2010) and lack of allo-
cation concealment.
Eight trials (De Grave 2012; Efstathopoulos 2007; Fritz 1999;
Hardy 2003; Makridis 2010; Papasimos 2005; Starr 2006; Zhu
2012) did not specify their method of random sequence gener-
ation and were judged at unclear risk of bias for this domain.
The remaining five trials (Okcu 2013; Vaquero 2012; Vidyadhara
2007; Xu 2010a; Zhang 2013) used a computer-generated ran-
dom numbers table or list and were judged at low risk of bias.
Efstathopoulos 2007, Makridis 2010, Starr 2006, Vaquero 2012,
Xu 2010a, Zhang 2013 and Zhu 2012 used sealed envelopes.
These were reported to be numbered in Starr 2006, Xu 2010a
and Zhang 2013. We judged these seven studies and the six stud-
ies not providing details of their method of randomisation (De
Grave 2012; Fritz 1999; Hardy 2003; Okcu 2013; Papasimos
2005; Vidyadhara 2007) to be at unclear risk of bias for allocation
concealment.
We only considered Schipper 2004, which used computer-gener-
ated randomisation (stratified by participating centre and balanced
in blocks of four and six patients), and numbered and blinded
envelopes, to be at low risk of bias for both domains.
Blinding
Blinding of the participants did not appear to have occurred in
any of the trials. The surgeons could not be blinded. We judged all
trials to be at unclear risk of performance bias relating to blinding.
Complete assessor blinding does not appear to have occurred in
any of the trials. Okcu 2013 had a blinded assessor for themobility
and Harris hip scores and so we judged this as unclear risk of
bias for ’subjective’ outcomes. We also judged Efstathopoulos
2007 (which did not report subjective outcomes) and Hardy 2003
(which included some cross-checking of results) at unclear risk
of bias for subjective outcomes, whereas we judged the rest to
be at high risk of detection bias for these outcomes. The final
classification of complications was done using anonymised date
in Vaquero 2012. We judged all studies to be at unclear risk of
detection bias for objective outcomes.
Incomplete outcome data
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We judged 10 trials to be at low risk of attrition bias for short-term
outcome assessment; six were deemed to be at ’unclear risk’, either
because of lack of information on early losses (De Grave 2012;
Herrera 2002; Marques 2005; Papasimos 2005) or because data
were provided for survivors only (Okcu 2013) or people without
complications (Zhu 2012).We judged Vaquero 2012 to be at high
risk of short-term bias because of a 33% loss at three months, with
only a quarter of these attributable to mortality.
We judged four trials (Fritz 1999; Starr 2006; Zhang 2013;
Zhu 2012) to be at low risk of attrition bias for long-term out-
come assessment; and four trials (Papasimos 2005; Schipper 2004;
Vaquero 2012; Xu 2010a), at high risk. Of special note is that in
Schipper 2004, follow-up was discontinued at four months for
participants with complete radiological consolidation; this consid-
erably reduced the number of participants available at one year fol-
low-up. For Vaquero 2012, there was no explanation provided for
the high attrition rate of 61% at long-term follow-up. We deemed
the remaining nine trials to be at unclear risk of bias.
Selective reporting
Protocols were not available for any of these trials, which were
judged to be at unclear risk of bias with the exception of Herrera
2002 and Marques 2005. We judged these two trials to be at high
risk because several outcome measures mentioned in the methods
sections were not presented in their results. Zhu 2012 excluded
three cases with complications from the final analysis for unspec-
ified reasons.
Other potential sources of bias
Baseline characteristics
The baseline characteristics of the intervention groups were well
matched in the majority of studies. We judged three trials to be at
unclear risk of bias relating to this item: data for age and gender
were not presented in Herrera 2002; group allocation and baseline
data were missing for 21 participants not available at follow-up in
Papasimos 2005 and baseline mobility status was not documented
in Wild 2010.
Performance bias relating to surgeon expertise and care
programmes
Eight trials were judged at low risk of performance bias (De Grave
2012; Efstathopoulos 2007; Okcu 2013; Starr 2006; Vidyadhara
2007; Xu 2010a; Zhang 2013; Zhu 2012) as the surgeons were
reported as being experienced in the interventions under test and
care programmes were comparable in the two groups. The remain-
ing trials were all judged as being at unclear risk of bias. Of partic-
ular note is that both Marques 2005 and Hardy 2003 had a higher
number of junior surgeons performing the surgery in one group
and Papasimos 2005 reported that the four surgeons involved had
less experience with the PFN. There was a lack of information to
judge whether post-operative care was the same for both groups
in Fritz 1999 and Wild 2010.
Funding source or conflict of interest
We judged the nine trials that explicitly indicated there was no
conflict of interest to be at low risk of bias and that six provided no
information at unclear risk. Schipper 2004 andVaquero 2012were
judged to be at high risk reflecting the financial support received
from the manufacturer of one of the implants in their respective
trials.
Effects of interventions
In the following we have presented the outcomes in five categories,
starting with ’Final outcome measures’. Appendix 4 shows the
relationship between the outcomes listed in Types of outcome
measures and these categories.
Proximal femoral nail (PFN) versus Gamma nail
Four trials (Herrera 2002; Marques 2005; Papasimos 2005;
Schipper 2004) compared the PFNwith the standard Gamma nail
in a total of 910 participants. All participants had unstable frac-
tures other than 32 participants with stable fractures in Herrera
2002. Aside from Herrera 2002, which included 13 patients with
“neoplasia”, pathological fractures were excluded.
Final outcome measures
There was no statistically significant difference between the two
groups in mortality at 12 months for the three trials that provided
data (86/415 versus 80/415; risk ratio (RR) 1.08; 95% confidence
interval (CI) 0.82 to 1.41; see Analysis 1.1). Papasimos 2005 ex-
cluded from their analyses the data from the 10 people who had
died by one year follow up.
The few functional outcome data that could be presented are
shown in Analysis 1.2 and Analysis 1.3. Data from Herrera 2002
showed no statistically significant difference between the two
groups in the failure to recover pre-fracture walking ability (RR
1.03; 95% CI 0.80 to 1.33). Pain in the thigh at follow-up was
reported as being statistically significantly less in the PFN group
in Marques 2005 (4.7% versus 27.3%; reported P = 0.004) but
this difference was not apparent when the actual numbers of par-
ticipants with pain were obtained from the trialist (see Analysis
1.2). Marques 2005 reported there was no statistically significant
difference between the two groups in the final independent mo-
bility scores. Papasimos 2005 reported there was no significant
difference between the two groups in the return to pre-fracture
level of ambulation and independence. The Harris hip scores at
four weeks, six months and one year reported in Schipper 2004
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showed no statistically significant difference between groups (see
Analysis 1.3); however, this was for a subgroup of patients at each
time point and thus may not be representative of the outcome for
the population of survivors.
Fracture fixation complications
Operative details as presented by each study are summarised in
Analysis 1.4. None of the differences between the two groups in
the various aspects and intra-operative complications of fracture
fixation was statistically significant other than an increased risk
of greater trochanteric fractures, or intra-operative comminution
of the fracture around the trochanteric region, for those treated
with the Gamma nail (see Analysis 1.4.6, 6/165 versus 20/165;
RR 0.30, 95% CI 0.12 to 0.73). Herrera 2002 did not reveal the
surgical consequences of these fractures; both cases in Papasimos
2005 were treated conservatively. The difference between the two
groups in the more important outcome of operative fracture of
the femur was not statistically significant (see Analysis 1.4.7, 1/
455 versus 5/455; RR 0.33, 95% CI 0.07 to 1.63). Marques 2005
attributed all three intra-operative femoral fractures to bad surgical
technique. The operative fracture in the Gamma nail group of
Papasimos 2005 was managed conservatively. In Schipper 2004,
both operative fractures of the femur, featuring a subtrochanteric
extension, occurred in the Gamma nail group.
Analysis 1.5 presents the fracture healing complications as reported
by each study. None of the differences in outcomes between the
two implants in the pooled data from three or four studies was
statistically significant. The tendency to a higher rate of secondary
varus, reflecting a loss of reduction, in Herrera 2002 was stated
as not being linked with subsequent clinical problems. The most
common fracture healing complication was cut-out of the implant
(17/455 versus 24/455; RR 0.71, 95% CI 0.39 to 1.30). It should
be noted that in Schipper 2004, participants whose fractures were
judged to be healed at four months had no further radiological fol-
low-up. There was no significant difference in the incidence of lo-
cal complications, which included cut-out, infection, haematoma,
migration of hip screws, malrotation, shaft fracture and nail fa-
tigue, at four months in Schipper 2004 (45/211 versus 47/213);
and similarly at 12 months (51/211 versus 50/213).
Pooled data from all four trials for re-operation showed no statis-
tically significant difference between the two groups (see Analysis
1.6, 45/455 versus 36/455; RR 1.25, 95%CI 0.83 to 1.90). There
were no significant differences between the two implants in any
of the reported wound complications (see Analysis 1.7).
Post-operative complications and hospital stay
None of the differences between the two implant groups in spe-
cific post-operative complications were statistically significant in
Herrera 2002,Marques 2005 or Papasimos 2005 (seeAnalysis 1.8).
Schipper 2004 reported no difference between groups in medical
complications that had occurred by one year follow up.
Herrera 2002 reported that trial participants remained in hospital
for an average of 14.1 days. Themean length of stay in hospital was
nearly a week longer in Schipper 2004; there being no significant
difference between the two groups (see Analysis 1.9). Similarly, the
difference between the two groups in the mean hospital stays were
reported to be not statistically significant for both Marques 2005
(11.1 days for the PFN group versus 12.2 days for the Gamma
nail group) and Papasimos 2005 (8.6 days versus 8.8 days).
Anatomical restoration
These outcomes were not reported in any of the trials. However,
two participants of the PFN group and one of the Gamma nail
grouphad re-operations for “rotational defect of the leg” inHerrera
2002.
Operative details
The mean length of surgery of the PFN group reported as be-
ing significantly shorter in Herrera 2002 (49 versus 68 minutes),
whereas it was reported to be significantly longer in Papasimos
2005 (71 versus 51 minutes). The mean length of surgery was 60
minutes in both groups of Schipper 2004.Marques 2005 reported
the difference between the two groups in the median length of
surgery (45 versus 40 minutes) was not statistically significant.
Schipper 2004 found intra-operative blood loss was statistically
significantly lower in the PFN group (mean difference (MD) -
67.00 mL, 95% CI -111.40 to -22.60 mL: see Analysis 1.10).
Papasimos 2005 found the difference between the two groups
in mean operative blood loss (265 mL versus 250 mL) was not
statistically significant. Though significantly more participants in
the PFN group of Herrera 2002 received blood transfusion, the
converse was true for Marques 2005 (see Analysis 1.11). These
results were not pooled since visual inspection of the transfusion
results from the two trials shows substantial heterogeneity (I² =
88.9% when pooled).
Neither trial reporting radiographic screening time found a sta-
tistically significant difference in this outcome between the two
groups: for Marques 2005, the median times were 100 versus 120
seconds; for Papasimos 2005, the mean times were 0.26 minutes
in both groups.
ACE trochanteric nail versus Gamma nail
Two trials (Efstathopoulos 2007; Vidyadhara 2007) made this
comparison although with some variations in the intervention.
Efstathopoulos 2007 compared the ACE nail used with one prox-
imal screw versus the trochanteric Gamma nail in 112 people,
82% of whom had unstable fractures. In Vidyadhara 2007, the
ACE nail had two proximal screws and was compared with the AP
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(Asian/pacific) Gamma nail in 73 people with unstable fractures.
Neither study included subtrochanteric fractures.
Final outcome measures
There was no difference between the two groups in mortality (see
Analysis 2.1). Vidyadhara 2007 found no statistically significant
differences between the two groups in hip pain at one month af-
ter injury, or the presence of a limp or difficulty in squatting at
two years (see Analysis 2.2). Efstathopoulos 2007 found no differ-
ence between the two groups in mobility scores at follow-up (see
Analysis 2.3). Although the Harris hip scores at four months, one
year and two years were significantly different in the two groups
of Vidyadhara 2007, the very small differences were clinically in-
significant (see Analysis 2.4).
Fracture fixation complications
There were no fracture healing complications reported in
Efstathopoulos 2007 and only one in Vidyadhara 2007 (see
Analysis 2.5). This was a cut-out in the Gamma nail group that
was treated by removal of the implant followed by bed rest for three
months. Vidyadhara 2007 reported no wound infection whilst
Efstathopoulos 2007 reported four cases of superficial wound in-
fection in the ACE nail group versus three in the Gamma nail
group (see Analysis 2.6).
Post-operative complications and hospital stay
There were no significant differences between the two groups in
the limited data provided for post-operative complications (see
Analysis 2.7). Efstathopoulos 2007 reported similar mean lengths
of hospital stay for the two groups (7.2 versus 7.0 days; reported
as not significant).
Anatomical restoration
Three people had limb shortening in Vidyadhara 2007, with no
significant differences between the two groups (see Analysis 2.8).
Operative details
Efstathopoulos 2007 reported no difference in the mean length
of surgery between groups (see Analysis 2.9). Vidyadhara 2007
reported a higher median length of surgery for the ACE nail (43
versus 32minutes). The statistically significantly greater blood loss
found in Vidyadhara 2007 for the ACE nail is clinically minor
(see Analysis 2.9: mean difference 13 mL; 95% CI 6.78 to 19.22).
Efstathopoulos 2007 found no statistically significant differences
in the units of blood transfused, number of patients transfused
or the radiographic screening time (see Analysis 2.9 and Analysis
2.10).
ACE trochanteric nail versus Gamma 3 nail
One trial (De Grave 2012), with 112 participants with stable or
unstable trochanteric fractures, compared the ACE trochanteric
nail versus the Gamma 3 nail. The numbers of participants avail-
able at each follow-up was not provided.
Final outcome measures
De Grave 2012 reported no statistically significant differences be-
tween the two groups at fracture consolidation (between three and
12 months post-operatively) in the mean Merle d’Aubigne scores
for pain, walking function, mobility or overall (0 to 18: best out-
come) between the two groups (14.12 (SD 2.95) versus 14.19 (SD
2.86); reported P = 0.92). Walking ability was restored in 83%
of participants in the ACE group and in 80% of the Gamma 3
group. There was no significant difference between the two groups
in mortality at one year (12/51 versus 14/61; RR 1.03, 95% CI
0.52 to 2.01; see Analysis 3.1).
Fracture fixation complications
There were no statistically significant differences between the
two groups for these outcomes which included fixation failure,
non-union, wound infection and re-operation (see Analysis 3.2).
There were no intra-operative complications. Two people in each
group underwent another operative procedure, each receiving a
hip arthroplasty, because of either cut-out or secondary displace-
ment of their fracture. There was no wound infection or non-
union.
Post-operative complications and hospital stay
No trial participant had a deep vein thrombosis. The only recorded
complication was a peripheral nerve injury that resulted in foot
drop in one participant of the Gamma 3 nail group (see Analysis
3.3).
Anatomical restoration
These outcomes were not reported.
Operative details
De Grave 2012 reported that the mean operative time was 51
minutes in the ACE group and 41 minutes in the Gamma 3 nail
group.
Gliding nail versus Gamma nail
Fritz 1999 compared the gliding nail (a modification of the
Gamma nail) with a standard Gamma nail. There were 40 partic-
ipants, all with an unstable trochanteric fracture, in each group.
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Final outcome measures
No statistically significant difference was found between the two
groups for mortality (see Analysis 4.1), for residence of survivors
in a geriatric institution (see Analysis 4.2) or overall unfavourable
outcome, defined as residence in a geriatric institution or dead, at
six months. Fritz 1999 reported there were no statistically signif-
icant differences between the two groups in the Merle d’Aubigne
scores for pain, walking function, mobility or overall.
Fracture fixation complications
There were no statistically significant differences between the two
groups for these outcomes (see Analysis 4.3). There was one intra-
operative complication (a minor shaft fracture) in the gliding nail
group and seven intra-operative complications (six were due to
failed placement of the second locking screw) in the Gamma nail
group. One woman in the gliding nail group fell during mobilisa-
tion, fracturing her femur shaft. Cut-out of the implant occurred
in three cases in the standard nail group. Re-operations (three ver-
sus four) resulted from these two complications, as well as from
wound infection and a haematoma.
Post-operative complications and hospital stay
There were no statistically significant differences between the two
groups in those with any post-operative medical complication or
for specific complications as presented in Analysis 4.4. Fritz 1999
reported there was no statistically significant difference between
the two groups in the mean hospital stay (9.2 versus 10.4 days).
Anatomical restoration
There were no statistically significant differences between the two
groups in those with leg shortening or rotational deformity (see
Analysis 4.5).
Operative details
Fritz 1999 reported there were no statistically significant differ-
ences between the two groups for length of surgery (mean dura-
tion: 63 versus 62 minutes) or operative blood loss (mean loss:
338 mL versus 296 mL).
ENDOVIS nail versus intramedullary hip screw
(IMHS)
Makridis 2010 compared the Endovis nail versus the IMHS nail
in 215 participants with either stable or unstable pertrochanteric
fractures.
Final outcome measures
More participants in the ENDOVIS nail group were bedridden,
and thus unable to walk, after their operation (29/105 versus 18/
110; RR 1.69, 95% CI 1.00 to 2.85; see Analysis 5.1). The post-
operative Parker-Palmer mobility scores also reflected poorer mo-
bility after ENDOVIS nails (mean scores 4.7 versus 6.4; 9 = fully
mobile); the difference between the two groups was reported to
be statistically significant (P < 0.05). There was no difference be-
tween the two groups in mortality, either in hospital (3/105 versus
2/110; RR 1.57, 95% CI 0.27 to 9.22) or at one year (16/105
versus 15/110; RR 0.99; 95% CI 0.53 to 1.85); see Analysis 5.2.
Fracture fixation complications
The majority of these complications occurred in the EN-
DOVIS group. None of the differences between the two groups
for the more serious complications were statistically significant
(see Analysis 5.3); these include cut-out (3/105 versus 1/110),
later femoral shaft fracture (0/105 versus 1/110), intra-operative
femoral shaft fracture (0/105 versus 1/110); Z-phenomena (2/105
versus 0/110) and nail breakage (1/105 versus 1/110). The oper-
ative fracture was successfully treated with circular wires. Overall,
there were five re-operations in the ENDOVIS group (three for
cut-out, one for a Z-phenomenon and one for a reverse Z-phe-
nomenon) versus two re-operations in the IMHS group (one for
cut-out, one for periprosthetic femoral shaft fracture): RR 2.62,
95% CI 0.52 to 13.21. Similar rates (two in each group) of infec-
tion were seen in both groups; all were superficial wound infec-
tions successfully treated by intravenous antibiotics.
Post-operative complications and hospital stay
Post-operative medical complications were not assessed.
Anatomical restoration
Anatomical restoration outcomes were not assessed. However,
shortening was reported for five patients in the ENDOVIS nail
group who had medial displacement of the femur shaft.
Operative details
The mean operative times were similar in both groups (24.8 min-
utes versus 25.4 minutes). There were no significant differences
reported between the groups regarding blood loss, haemoglobin
levels or numbers of patients receiving transfusion (28/105 versus
29/105; (RR 1.01, 95% CI 0.65 to 1.58; see Analysis 5.4).
Russell-Taylor Recon nail versus long Gamma nail
Starr 2006 compared the Russell-Taylor Recon nail with the long
Gamma nail in 34 people, aged between 19 and 50 years, with
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high energy extracapsular hip fracture. Five trial participants had
stable and 21 unstable trochanteric fractures, and the other eight
had subtrochanteric fractures. Three patients had open fractures
and 17 had concurrent surgery for other injuries.
Final outcome measures
No deaths occurred within the one year follow-up period. Starr
2006 found no statistically significant differences between the two
groups in the numbers of participants who were unable to walk
independently or unable to return to the same work (see Analysis
6.1). The person who was unable to walk had sustained a spinal
cord injury at the time of her initial trauma. Similarly, there were
no statistically significant differences between the two groups in
the range of hip or knee movements. The Harris hip scores were
similar for the two groups (mean scores: 86 versus 84; reported P
= 0.60).
Fracture fixation complications
There were no fracture fixation complications reported (see
Analysis 6.2). One patient in the long Gamma nail group had
wound debridement for sepsis and a further 12 patients had elec-
tive removal of their implants for persistent pain (see Analysis 6.2).
Post-operative complications and hospital stay
These outcomes were not reported in Starr 2006.
Anatomical restoration
These outcomes were not reported in Starr 2006.
Operative details
Starr 2006 reported there were no statistically significant differ-
ences between the two groups for length of surgery (mean dura-
tion: 106 versus 88 minutes; reported P = 0.26) or operative blood
loss (mean loss: 328 versus 282 mL; reported P = 0.15).
PFNA versus Targon PF nail
Wild 2010 compared the PFNA with the Targon PF nail (a de-
vice that has an extra antirotation pin) in 80 patients with a
pertrochanteric femoral fracture.
Final outcome measures
There were no perioperative deaths. Overall, 18 patients died in
the first post-operative year but their group allocation was not
reported. Wild 2010 found no difference between the two groups
in the modified Harris hip score (0 to 100: best outcome) at one
year: mean 78.5 versus 78.1; reported P = 0.83). There were also
no significant differences in the range of motionmeasures between
the two groups.
Fracture fixation complications
There were no statistically significant differences between the two
groups for these outcomes, which included cut-out (three versus
two), periprosthetic fracture (one versus zero); fracture non-union
(zero versus one), implant breakage (zero versus zero) and superfi-
cial wound infection (four versus two): see Analysis 7.1. Two cut-
outs in the PFNA group required a re-operation as there was ir-
ritation of the iliotibial band/tract. Revision surgery was implied
for all six cases of wound infection but we suspect this was a typo-
graphical error in the report given the infections were all superfi-
cial. The sequelae of the periprosthetic fracture were not recorded.
Post-operative complications and hospital stay
These outcomes were not reported.
Anatomical restoration
These outcomes were not reported.
Operative details
Duration of operation (66.2 minutes versus 84.7 minutes; re-
ported P < 0.01) and fluoroscopy (103.6 sec versus 164.5 sec; re-
ported P < 0.01) were significantly shorter in the PFNA group.
PFNA versus Gamma 3 nail
Two trials (Vaquero 2012; Xu 2010a) compared the PFNA nail
with theGamma 3 nail in 200 participants with unstable proximal
femoral fractures.
Final outcome measures
Separate group data were not reported for the 43/136 participants
in Xu 2010a who were not available at final follow-up (17.68
months, range 12 to 27 months). Of these, three participants died
in the immediate post-operative period and a further 12 partic-
ipants died before the final follow-up. Twenty-one participants
were too ill to attend and seven were lost to follow-up in terms of
functional outcomes. Thirty-five participants (55%) were lost to
follow-up at 12months in Vaquero 2012. All four recorded deaths
that had occurred by 12 months in Vaquero 2012 were in the
PFNA group (4/31 versus 0/30; RR 8.72, 95%CI 0.49 to 155.27;
see Analysis 8.1). There were no significant differences found in
a variety of functional scores and return to mobility assessment.
Vaquero 2012 found no significant difference between the groups
in the Harris Hip Score at six and 12 months (65.1 versus 72.6;
MD 7.50, 95% CI -12.19 to 27.19; see Analysis 8.2). Similarly,
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Xu 2010a found no statistically significant differences between the
two groups in mobility scores (0 to 9: best score; 6.30 versus 6.10;
MD 0.20, 95%CI -0.51 to 0.91, seeAnalysis 8.3) and similar pro-
portions of participants in each group recovered their pre-opera-
tive weight bearing ability (29/46 versus 32/47, RR 0.93, 95% CI
0.69 to 1.24 see Analysis 8.4). Vaquero 2012 found no significant
difference between the two groups at six or 12months in the SF-36
Physical and Mental Health Scores (see Analysis 8.5 and Analysis
8.6), or the Katz ADL scores (0 to 6, higher score meaning best
function) (4 versus 3.6, see Analysis 8.7) at 12 months. Xu 2010a
found no difference between the two groups in mean hip flexion
(98.3 versus 94.9 degrees, see Analysis 8.8). Slightly more partici-
pants in the PFNA had hip and thigh pain in Xu 2010a but this
difference was not statistically significant (19/46 versus 11/47; RR
1.76, 95% CI 0.95 to 3.29, see Analysis 8.10). Vaquero 2012 used
a numeric pain score (0 to 10, higher score meaning worse pain)
to assess thigh pain and found no significant difference between
the groups at 12 months follow-up (mean score 1 versus 1.5, MD
-0.50, 95% CI -1.80, 0.80, see Analysis 8.9).
Fracture fixation complications
None of the differences between the two groups in specific fracture
fixation complications were statistically significant; see Analysis
8.11. Xu 2010a reported no significant difference in intra-opera-
tive femoral shaft fractures (2/66 versus 1/70), all of which were
treated with delayed weight bearing for six to eight weeks. One (1/
97) femoral shaft fracture occurred in the PFNA group onemonth
post-operatively and was treated with plate osteosynthesis; this was
the only reported re-operation in Xu 2010a. One post-operative
femoral (1/100) shaft fracture occurred in the Gamma 3 group
and was treated with a secondary procedure, the exact details of
which were not given. There were no significant differences be-
tween the groups in blade/screw cut-out (2/97 versus 0/100, RR
4.84, 95% CI 0.24 to 96.89, see Analysis 8.11) or non-union rates
(2/30 versus 3/31). The two cases of cut-out reported occurred
in the PFNA group and were treated with a secondary procedure.
There were no significant differences between the groups in su-
perficial wound infection (2/66 versus 1/70), wound haematoma
(5/66 versus 6/70) or deep wound infection (2/31 versus 0/30).
There was no significant difference in proximal screw migration
in Xu 2010a who reported nine cases of proximal screw migration
(6/66 versus 3/70), all of which were treated conservatively. The
mean time to fracture healing was similar in the two groups of this
trial (9.65 weeks versus 10.21 weeks; reported P = 0.183).
Post-operative complications and hospital stay
Vaquero 2012 reported that 16 participants in each group had
a “general” complication, which mainly related to the need for
transfusion. There were similar numbers in the two groups of pa-
tients with post-operative medical complications of chest infec-
tion, decubitus ulcers and urinary tract infection in Xu 2010a (see
Analysis 8.12). In Vaquero 2012, the mean Sangha scores (ques-
tionnaire based co-morbidity score; 1 to 6, higher score equals
more comorbidity) were not significantly different at 12 months
follow-up (mean 4.6 versus 4.5, see Analysis 8.13). There was no
significant difference between the two groups in length of hospital
stay (see Analysis 8.14).
Anatomical restoration
No significant difference in the amount of femoral shortening was
observed between the two groups at final follow-up in Xu 2010a
(5.30 mm versus 5.49mm;MD -0.19 mm, 95%CI -1.23 to 0.85;
see Analysis 8.15).
Operative details
There was no significant difference between the groups in oper-
ating time (two trials, MD -3.03 minutes, 95% CI -6.88 to 0.82
minutes; seeAnalysis 8.16); notably surgery took between 27 to 33
minutes longer in Xu 2010a. There was no significant difference
in fluoroscopy time (2.7 versus 3.2 minutes; MD -0.50 minutes,
95% CI -0.88 to -0.12; see Analysis 8.16). Intra-operative blood
loss was significantly lower in the PFNA group (217.4 mL versus
272.7 mL; MD -55.30, 95% CI -94.70 to -15.90; see Analysis
8.16) in Xu 2010a. However, there was no significant difference
between the two groups in the number of participants transfused
(24/66 versus 31/70; RR 0.82, 95% CI 0.54 to 1.24; see Analysis
8.17) nor in the mean number of units transfused (1.95 versus
2.03 units) in this trial.
Dynamic versus static locked intramedullary hip
screw
Hardy 2003 compared a dynamically locked intramedullary hip
screw (IMHS), which was allocated to 42 patients, with the usual
statically locked IMHS allocated to 39 patients.
Final outcome measures
No statistically significant difference was found between the two
groups for mortality (see Analysis 9.1). Pain in the mid-thigh re-
gion was reported at follow-up for two participants of the dy-
namic group and six in the static group (see Analysis 9.2). The
pain impaired walking in four of the latter group. All six partic-
ipants reporting mid-thigh pain in the static group had cortical
hypertrophy. The other instance of cortical hypertrophy occurred
in a participant of the dynamic group who did not report mid-
thigh pain. Hardy 2003 reported similar results in the two groups
for accommodation, mobility scores and independence rating of
survivors at one year.
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Fracture fixation complications
There were no statistically significant differences between the two
groups for these outcomes (see Analysis 9.3). Cut-out of the im-
plant occurred in one case in the dynamic group and a fracture
below the tip in one case in the static group. Re-operations (one
versus three) resulted from these two complications as well as from
two operations for hardware removal in the static group.
Post-operative complications and hospital stay
Medical complications and length of hospital stay were not re-
ported in Hardy 2003. Though there were some discrepancies be-
tween text and tables in the trial report for discharge destination
and in-hospital deaths, there was clearly no difference between the
two groups in these outcomes.
Anatomical restoration
Incomplete data for leg shortening (see Analysis 9.4) showed no
statistically significant difference between the two groups (subsi-
dence of the nail in the femoral shaft was seen in nine participants
of the dynamic group compared with none in the static group).
No information on deformity was presented in Hardy 2003.
Operative details
There were no statistically significant differences between the two
groups for length of surgery, operative blood loss, haemoglobin
levels or transfusion requirements (see Analysis 9.5).
Sliding versus non-sliding Gamma 3 nail
Zhu 2012 compared a sliding versus a non-sliding lag screw in
the Gamma 3 nail in 80 participants with intertrochanteric frac-
tures. Separate data for some outcomes were presented by sub-
groups based on the AO fracture classification with group A being
participants with the most stable fractures (AO 31A1.1, 1.2 and
1.3 fractures), group B being participants with less stable fractures
(AO 31A2.1) and group C being participants with the least stable
fractures (AO 31A2.2 and 2.3).
Final outcome measures
There was no statistical or clinically significant difference between
the sliding and non-sliding groups in their Harris hip scores (MD
-1.27, 95% CI -4.98 to 2.43; see Analysis 10.1).
Fracture fixation complications
Although all four reported complications occurred in the non-
sliding group, the differences between the two groups for these
outcomes, which were non-union (0/40 versus 1/40), cut-out (0/
40 versus 1/40) and femoral shaft fracture (0/40 versus 2/40), were
not statistically significant (see Analysis 10.2). There was also no
significant difference between the two intervention groups in time
to fracture healing (MD -0.06 months, 95% CI -0.55 to 0.43
months; see Analysis 10.3).
Post-operative complications and hospital stay
There was no between-group difference in the length of hospital
stay (see Analysis 10.5), which was four days in each group. Post-
operative complications other than fracture fixation complications
were not reported.
Anatomical restoration
Although in the 41 participants with unstable comminuted in-
tertrochanteric fractures (Group C, AO 31A2.2 and A2.3 frac-
tures) a significant difference in leg length was reported (see
Analysis 10.6, 0.573 mm versus 0.955 mm; MD 0.38 mm, 95%
CI 0.37 to 40 mm), this is not a clinically significant leg length
discrepancy. No other anatomical parameters were reported.
Operative details
Therewere no significant differences between the twogroups in the
operation time (46.73 min versus 48.35 min) or intra-operative
blood loss (141.1 mL versus 138.5 mL); see Analysis 10.4). No
participants received a blood transfusion.
InterTan nail versus PFNA II nail
Zhang 2013 compared the InterTan nail with the PFNA II nail in
113 participants with unstable intertrochanteric fractures.
Final outcome measures
Of the 113participants in the study, 15diedwithin 12months and
five were lost to follow-up due to illness.There was no difference
in mortality at 12 months after the procedure (8/57 versus 7/
56; RR 1.12, 95% CI 0.44 to 2.89, see Analysis 11.1). For the
93 participants followed-up for one year or longer, there were no
significant differences between the groups in theirHarris hip scores
(mean 80.2 versus 82.6, MD -2.40, 95% CI -7.50 to 2.70) or
walking ability scores (mean 5.8 versus 6.1; MD -0.30, 95% CI -
1.03 to 0.43; see Analysis 11.2). There was no difference between
the groups in the number of participants complaining of hip pain
at final follow-up (2/47 versus 2/46). However, significantly fewer
participants in the InterTan nail group had thigh pain (3/47 versus
12/46; RR: 0.24, 95% CI 0.07 to 0.81; see Analysis 11.3).
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Fracture fixation complications
There were no significant differences between the two groups
for outcomes such as cut-out (2/47 versus 0/46), intra-operative
femoral shaft fracture (1/57 versus 2/56) or later femoral shaft
fracture (0/47 versus 1/46), blade migration (0/47 versus 4/46),
problems with distal locking or prominence of the nail proximally
in the greater trochanter (see Analysis 11.4). A similar finding ap-
plied to re-operation, the reasons for the five re-operations were
not detailed in the report (2/47 versus 3/46). There was a signifi-
cant difference in time to fracture healing, with fractures healing
quicker in the InterTan group (14 versus 17 weeks;MD -3.0, 95%
CI -4.88 to -1.12 weeks; see Analysis 11.5).
Post-operative complications and hospital stay
There was no difference between the groups in the occurrence of
superficial (3/47 versus 2/46) or deep (2/47 versus 1/46) wound
infection, deep vein thrombosis, pulmonary embolism, pressure
sores or urinary tract infection (see Analysis 11.6). There was no
significant difference in the length of hospital stay (mean 8.33
versus 8.03 days; see Analysis 11.7).
Anatomical restoration
These outcomes were not reported. (While results for femoral
neck shortening were reported, the clinical significance of these is
unclear given that the results in both groups were less than the 5
mmof shortening required to affect abductor function (Zlowodzki
2008)).
Operative details
Zhang 2013 found that the length of surgery was longer in the
InterTan nail group (mean 66.5 versus 53.7 minutes; MD 12.80
min, 95% CI 7.87 to 17.73 minutes) as was the fluoroscopy time,
which took 1.5 minutes longer on average (see Analysis 11.8).
While the intra-operative blood losses were also greater in this
group, the between-group difference was not significant (mean
235.5 mL versus 197.5 mL; MD 37.80 mL, 95% CI -4.12 to
79.72 mL).
Long versus standard PFNA nail
Okcu 2013 compared long versus standard PFNA nails in 40
participants with reverse oblique fractures. Aside from mortality,
the results were presented for the 33 survivors at a minimum of
one year follow-up.
Final outcome measures
There was no significant difference in mortality at one year be-
tween the two groups (34/22 versus 4/22; RR 1.09, 95% CI 0.28
to 4.26; see Analysis 12.1). Similarly there was no significant dif-
ference at one year between the two groups in the reported func-
tional outcomes, namely the Harris hip score (0 to 100; top score
equals best outcome): 79 versus 74; MD 5.00, 95% CI -1.14 to
11.14; and the Parker and Palmer mobility score (0 to 9; top score
equals best outcome): 5.5 versus 5.2; MD 0.30, 95% CI -0.94 to
1.54); see Analysis 12.2.
Fracture fixation complications
There were no statistically significant differences between the two
groups for re-operation or other outcomes in this category (see
Analysis 12.3). Both re-operations were in the long nail group,
separately these were for blade cut-out and deep infection. There
were no cases of non-union in either group. There was one case of
superficial wound infection in the standard nail group.
Post-operative complications and hospital stay
There was no significant difference in the length of hospital stay
(5.4 days versus 4.9 days, reported P = 0.51). There was no report
of post-operative complications.
Anatomical restoration
There was no significant difference in the number of malunions,
defined as angulation or rotation deformity more than 10 degrees
or limb shortening more than one centimetre (6/18 versus 3/15;
RR 1.67, 95% CI 0.50 to 5.56; see Analysis 12.3).
Operative details
As would be expected given that reaming of the femoral canal
is required when placing a long nail, both duration of operation
(71.8 versus 52.6 minutes; reported P < 0.001) and fluoroscopy
(75.3 versus 58.6 seconds; reported P < 0.001) were significantly
longer in the long PFNA group.
D I S C U S S I O N
Summary of main results
The 17 trials included in this review, involving a total of predomi-
nantly female and older participants with predominantly unstable
trochanteric fractures, tested 12 comparisons of different cephalo-
condylic nail designs. There were no trials evaluating condylo-
cephalic nails. A summary of the risk of bias assessment and find-
ings for each of the comparisons are provided below.
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Proximal femoral nail (PFN) versus Gamma nail
All four trials contributing to this comparison were at high risk
of bias. Of note, is that two trials (Herrera 2002; Marques 2005)
were quasi-randomised and thus at high risk of selection bias; and
the other two trials (Papasimos 2005; Schipper 2004) were at high
risk of attrition bias.
There were no significant differences between groups in functional
outcome, these data being limited to results from single trials.
Pooled results from three trials showed no difference in mortality
between the two groups (86/415 versus 80/415; risk ratio (RR)
1.08; 95% confidence interval (CI) 0.82 to 1.41). There were no
statistically significant differences between the two implants in se-
rious fixation complications (operative fracture of the femur, cut-
out, non-union and later fracture of the femur) nor re-operations
(45/455 versus 36/455; RR 1.25, 95% CI 0.83 to 1.90). These
revision rates (9.8% versus 7.9%) are high, particularly in the con-
text of those found for short femoral nails (5.4%) or, indeed, the
sliding hip screw (3.4%) (Parker 2010). Schipper 2004 acknowl-
edged the high revision rates, for both implants in their study but
stressed their inclusion of exclusively unstable fractures.
ACE trochanteric nail versus Gamma nail
The two small trials (Efstathopoulos 2007; Vidyadhara 2007) ad-
dressing this comparisonuseddifferent implants or techniques and
had different populations. They were judged as being at unclear
risk of bias for most domains; Vidyadhara 2007 being at high risk
of detection bias for subjective outcomes.
The outcome of Vidyadhara 2007, which had no deaths or loss
to follow-up, was very favourable for both groups as shown by
the usually high Harris hip scores with very little variation within
each group. Supposing that the correct statistics were presented,
the clinical significance of the statistically significant differences
in the Harris hip scores at one year follow-up (MD 1.00, 95%
CI 0.28 to 1.72) is questionable. Two participants died in each
group of Efstathopoulos 2007. The only fracture fixation compli-
cation reported was a cut-out which resulted in a re-operation in
Vidyadhara 2007.
ACE trochanteric nail versus Gamma 3 nail
The single trial (DeGrave 2012) in this comparison was at unclear
risk of bias for most domains but at high risk of detection bias for
subjective outcomes.DeGrave 2012 foundnodifferences between
the two implants in any of the outcomes assessed (functional score,
mortality, fracture fixation complications and re-operation). Two
patients in each group underwent a revision procedure for either
cut-out or fracture displacement.
Gliding nail versus Gamma nail
The single trial (Fritz 1999) in this comparison was at unclear
risk of bias for most domains, but at high risk of detection bias
for subjective outcomes. Fritz 1999 found no differences between
the two implants in any of the outcomes assessed (mortality, poor
outcome, fracture fixation complications and re-operation).
ENDOVIS nail versus intramedullary hip screw
(IMHS)
The single trial (Makridis 2010) in this comparison was at unclear
risk of bias for most domains but at high risk of detection bias for
subjective outcomes.
Makridis 2010 reported poorer mobility scores in the ENDOVIS
nail group: this reflected that more participants in the ENDOVIS
nail group were bedridden, and thus unable to walk, after their
operation (29/105 versus 18/110; RR 1.69, 95%CI 1.00 to 2.85).
There were no significant differences between the two groups in
other outcomes (mortality, fracture fixation complications, re-op-
eration).
Russell-Taylor Recon nail versus long Gamma
nail
The single trial (Starr 2006) included people with high energy
fractures aged between 18 and 50 years; 17 of whom had concur-
rent surgery for other injuries. Thus, this was a very different pop-
ulation to the other trials in this review. Starr 2006 was at unclear
risk of bias for most domains but at high risk of detection bias for
subjective outcomes.
Starr 2006 found no notable differences in outcome between the
two groups. However, there was a very high rate of elective removal
of implants for pain (8/17 (47%) versus 5/17 (29%)) compared
with the other trials. Overall, Starr 2006 was too small to conclude
that the lack of differences between the twogroups is a true finding.
Proximal femoral nail antirotation (PFNA)
versus Targon PF nail
The quasi-randomised trial (Wild 2010) for this comparison was
at high risk of selection bias and at high risk of detection bias for
subjective outcomes. This was a poorly reported trial, including
the failure to provide separate group data formortality or complete
data for re-operations.
Wild 2010 found no difference between the two groups in func-
tional outcome; nor were there statistically significant between-
group differences in fracture fixation complications.
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PFNA versus Gamma 3 nail
Both trials (Vaquero 2012; Xu 2010a) for this comparison were at
high risk of detection bias for subjective outcomes and high risk
of attrition bias.
No statistically significant differences between implants were
found in a variety of functional scores including the Harris Hip
Score, SF-36 mental and physical health scores, a mobility score
or recovery of pre-operative weight bearing ability, hip range of
movement, in hip or thigh pain, in fracture fixation complica-
tions or re-operations (four re-operations occurred in the PFNA
group, two operations occurred in the Gamma 3 group). No sig-
nificant difference in mortality was observed between the groups
in Vaquero 2012. Separate group data for mortality were not pro-
vided in the other study (Xu 2010a). No significant difference was
seen in post-operative complications or length of stay. Intra-oper-
ative blood loss was lower in the PFNA group though this did not
translate to a significant difference in the amount of participants
transfused or the mean number of units transfused.
Dynamic versus static locked intramedullary nail
The single trial (Hardy 2003) making this comparison was at
unclear risk of bias for most domains. Though none of the dif-
ferences between the two groups reached statistical significance,
Hardy 2003 suggested that lower incidence of cortical hypertro-
phy of the bone at the level of the distal locking screws in the
dynamic group was linked with the lower number of participants
with mid-thigh pain in the dynamic group.
Sliding versus non-sliding Gamma 3 nail
The single trial (Zhu 2012) was at unclear risk of bias for most
domains. This trial, which aimed to avoid osteoporotic fractures,
includedparticipants aged less than60 yearswith intertrochanteric
fractures. This is a different population to all the other trials in
this review (except Starr 2006).
Zhu 2012 reported no significant differences in terms of theHarris
hip scores, fracture fixation complications, length of stay and op-
erative details such as operative time and blood loss. A significant
leg length discrepancy was reported in Group C (most unstable
fractures, AOA2.2, 2.3) with themean difference being 0.38 mm.
This is not a clinically significant leg length discrepancy.
InterTan nail versus PFNA II nail
The single trial (Zhang 2013) was at low risk of bias for most
domains, but at high risk of bias for reporting of subjective out-
comes. No significant differences were reported for themajority of
domains including mortality, functional scores (Harris hip score,
walking ability score), fracture fixation complications, post-oper-
ative complications and length of hospital stay. Although partici-
pants in the PFNA II group were four times more likely to expe-
rience thigh pain, the implications of this were not clear and not
apparent from the Harris hip score. Similarly, the implications of
the fracture healing occurring on average three weeks earlier in the
InterTan nail group were unclear as was the actual assessment of
this outcome. InterTan nailing surgery took longer, with greater
fluoroscopy exposure.
Long versus standard (short) PFNA nail
The single trial (Okcu 2013) was at low or unclear risk of bias
for individual domains. This small trial, which reported results for
33 participants with reverse oblique fractures, was described as a
“pilot” and no power analysis being conducted beforehand. No
significant differences were found for the majority of outcomes
including mortality, functional scores (Harris hip score, Parker
and Palmer mobility score), fracture fixation complications and
re-operation. There was no significant difference in the length of
hospital stay. As expected, overall operating and fluoroscopy times
were shorter in the standard PFNA group; reaming of the femoral
canal is rarely required with this implant.
Overall completeness and applicability of
evidence
Nine of the 12 comparisons in the review were made in single
trials, whose populations ranged from 34 participants to 215 par-
ticipants. The maximum number of participants available in any
pooled analysis for the two remaining comparisons was 910 and
197 respectively. There was no pooling of functional outcomes,
such asHarris hip scores, whichwere under-reported and recorded.
For each comparison, there were insufficient patient numbers to
rule out important differences, particularly in final outcomes, be-
tween the implants under test.
The trial populations were generally representative of the popu-
lations with these fractures. As indicated above, Starr 2006 and
Zhu 2012 were two exceptions to this with an upper age limit of
50 years being applied in Starr 2006 and 60 years being applied
in Zhu 2012. Starr 2006 was also exceptional in its inclusion of a
few subtrochanteric fractures. The other exception is Okcu 2013,
which included reverse oblique fractures only. Particular emphasis
was made in Zhang 2013 on the use of nails that reflect a differ-
ence in geometry between Asian and Caucasian femur geometry.
It is noteworthy that this review is predominantly a set of compar-
isons of intramedullary nails from different manufacturers. Newer
nails have different features aimed at enhancing stability and re-
ducing known complications (such as operative or later femoral
shaft fractures). But as well as testing for improved performance
of these different features in the clinical setting, it could be con-
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jectured that it is also the market place that has set the research
agenda and the associated aims of these generally underpowered
trials.
As stated above, functional outcomes were under-recorded and
reported. Several trials failed to report separate statistics for mor-
tality. We have already alerted the reader to the unusually high re-
operation rates in the PFN versus Gamma nail comparison and
also the very high rate of elective removal of implants for pain in
Starr 2006.
Quality of the evidence
As summarised above for the individual comparisons, all trials
were at unclear risk of bias for several domains and most trials
were at high risk of detection bias for subjective outcomes. Poor
reporting of methods of randomisation and participant flow were
commonplace and resulted in concerns regarding both selection
and attrition biases in several trials.
Proximal femoral nail (PFN) versus the Gamma nail
The quality of the evidence for this comparison was downgraded
three levels for function (one for limitations in design and imple-
mentation that related to potential risk of bias; one for impreci-
sion; and one because data were only available from one trial); two
levels for mortality (one for limitations in design and implemen-
tation that related to potential risk of bias; and one because data
were absent from one trial and a substantial number of partici-
pants for another trial) and two levels for fracture fixation compli-
cations and re-operation (one for limitations in design and imple-
mentation that related to potential risk of bias; and one for either
imprecision or that substantial amounts of data were absent).
ACE trochanteric nail versus the Gamma nail
The quality of the evidence for this comparison was downgraded
three levels for all primary outcomes (one for limitations in design
and implementation that related to potential risk of bias; one for
imprecision; and one because data were only available from one
trial or were highly unrepresentative of the general population).
PFNA versus the Gamma 3 nail
The quality of evidence for this comparison was downgraded three
levels for mortality and function (one for limitation in design and
implementation that related to potential risk of bias in multiple
areas including allocation, blinding, attritional and reporting bias;
one for imprecision of results due to small numbers of trial par-
ticipants; and one because data were only available from one trial
for the majority of these outcomes). The quality of evidence for
fracture fixation complications was downgraded two levels (one
for limitation in design that related to potential risk of bias; and
one for imprecision related to the small number of participants in
each trial or the substantial loss to follow-up).
Remaining comparisons
With one exception, the quality of the evidence for each com-
parison involving single trials was downgraded three levels for all
outcomes. This generally included the downgrading by one for
limitations in design and implementation that related to potential
risk of bias; one for imprecision; and one because data were from
one underpowered trial. The consistent finding of poorer mobil-
ity for the ENDOVIS nail when compared with the IMHS was
considered to merit an upgrading by one point.
This overall, reflected a triple downgrading; we judged the evi-
dence to be of very low quality, which indicates that we are very
uncertain about the estimates for all outcomes. For the first com-
parison, however, there was a double downgrading for mortality.
For the first (PFN versus the Gamma nail) and third (PFNA ver-
sus the Gamma 3 nail) comparisons there was a double down-
grading for fracture fixation complications. For these, we judged
the evidence to be low quality and thus we consider that further
research is very likely to change the estimated effect and affect our
confidence in this result.
Potential biases in the review process
While our search was comprehensive, it is possible that we have
failed to identify some trials, especially those reported in confer-
ence proceedings only. Changingmethodology and authorship be-
tween updates can be challenging and while we have taken a sys-
tematic approach, extra vigilance and checks have been required
to ensure a satisfactory transition and consistency. Inevitably, the
risk of bias judgements of similar aspects of trial quality do not
neatly correspond to the previous ratings for previous trials; this
difference is probably greater given that risk of bias assessment
was done by a different pair of reviewers. The restructuring of the
Types of outcome measures and reporting of the results presented
the greatest challenge. Rather than completely rewrite the previous
review, we took a pragmatic decision to reorder the categories of
outcomes and highlight the primary outcomes.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There was insufficient evidence from randomised trials to deter-
mine if there are important differences in patient outcomes be-
tween the different designs of proximal femoral intramedullary
nail produced by different manufacturers when used for the fixa-
tion of unstable, or stable, trochanteric fractures.
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Implications for research
Given the evidence indicating the current superiority of the sliding
hip screw (SHS) over intramedullary nails for trochanteric frac-
tures (Parker 2010), it is debatable whether studies comparing dif-
ferent types or aspects of intramedullary nail design should be un-
dertaken. Nonetheless, while we suggest that further development
and modification of cephalocondylic nails for these fractures is not
a priority, any new developments should be evaluated using robust
methodology with adequate patient numbers and the collection
of functional outcomes. We suggest the choice of comparator of
any such trial should be the SHS.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
De Grave 2012
Methods Randomised trial: method not stated
Length of follow-up: 1 year
Participants Orthopaedic Hospital, Ghent, Belgium
112 patients with pertrochanteric femoral fractures. 34% stable, 66% unstable fractures
Mean age 74.9 years
% male: 60
Number lost to follow-up: 6 (5%)
Assigned: 51/61 [ACE trochanteric nail/Gamma 3 nail]
Interventions ACE trochanteric nail versus Gamma 3 Nail
The ACE trochanteric nail as a 16 mm proximal diameter, 180 or 200 mm length, 5°
valgus curvature and a 10.5 mm diameter lag screw Additionally an optional antirotation
lag-screw is available. This was used when rotational instability was expected
The third generation Gamma Nail has 15.5 mm proximal diameter, 180 mm length and
4° valgus curvature with a single distal transverse locking screw and a 10.5 mm diameter
lag screw
Outcomes Mortality
Superfical or deep wound infections
Avascular necrosis
Deep vein thrombosis
Neurological injury
Severe general complications (cardiac/pulmonary/thromboembolic/cerebrovascular/
death)
Penetration of lag screw
Excessive displacement
- medialisation of femoral shaft
- breakage or loosening of the implant
- intra-operative or post-operative fracture of the femoral shaft
- non-union
Function: Merle d’Aubigne hip score (pain, mobility, walking)
Walking score
Study funding No benefits or funds were received
Notes 9 different surgeons
Risk of bias
Bias Authors’ judgement Support for judgement
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De Grave 2012 (Continued)
Random sequence generation (selection
bias)
Unclear risk Randomisation methodology not de-
scribed. “were on admission randomised
to” some stratification seems to have taken
place: in abstract “twogroupswerematched
for age, fracture type andMerle D’Aubigne
hip score
Allocation concealment (selection bias) Unclear risk No mention of concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind surgeons. No men-
tionof blinding otherwise (participants etc)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding. Outcomes in-
cluded Merle D’Aubigne scores
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding though uncertain
risk of bias for these outcomes
Incomplete outcome data (attrition bias)
Short-term outcome
Unclear risk 6patients lost to follow-up.Uncertain from
which groups. Overall a low attrition rate
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk 6patients lost to follow-up.Uncertain from
which groups. Mortality was balanced be-
tween groups but denominators not avail-
able
Selective reporting (reporting bias) Unclear risk No protocol though outcomes mentioned
in methods appear to be reported but in-
completely in terms of denominators
Other bias Low risk Minimal between-group differences in
baseline characteristics (age, sex, fracture
type, Merle D’Aubigne score)
Other performance bias (e.g. differential
expertise bias)
Low risk “A senior orthopaedic resident performed
the operations.”
Care programmes appear similar
Other sources of bias (funding) Low risk Clarification of funding (none) is provided
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Efstathopoulos 2007
Methods Randomised trial: sealed envelopes
Length of follow-up: mean 8 months (range 6 to 12 months)
Participants Orthopaedic hospital, Athens, Greece
112 people aged 65 or over with a trochanteric proximal femoral fracture (Jensen types
I and II : stable (18%), or III and IV: unstable (82%))
Age: mean 78 years (range 69 to 89 years)
% male: 29
Number lost to follow-up: 5 (4.5%)
Assigned: 56/56 [ACE trochanteric nail / trochanteric Gamma nail]
Interventions ACE trochanteric nail versus a trochanteric Gamma nail.
The ACE nail was 11 mm diameter, inserted without reaming and with one proximal
screw and one distally locking screw
The Gamma nail was 11 mm distal diameter, and inserted with reaming and had one
distal locking screw
Outcomes Length of surgery
Units of blood transfused
Number of patients transfused
Radiographic screening time
Cut-out of implant
Operative fracture of femur
Later fracture of the femur
Non-union
Re-operation
Wound infection
Deep wound infection
Deep vein thrombosis
All medical complications
Length of hospital stay
Mortality
Mobility
Study funding No mention of funding or a conflict of interest
Notes The trial report clearly states that there were no fracture healing complications: the
outcome of no re-operations was inferred from this
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “were randomised upon their admission
using a sealed envelope method.” Unclear
what the actual randomisation process was
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Efstathopoulos 2007 (Continued)
Allocation concealment (selection bias) Unclear risk “were randomised upon their admission us-
ing a sealed envelope method.” Not clear if
envelopes were opaque or not
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Surgeons not blinded but unclear risk of
bias
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk No subjective outcomes
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Nomentionof blindingbut uncertainwhat
is risk of bias
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk Data available for all patients
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk Few (5) patients lost to follow-up
Modest imbalance in groups (47 versus 41)
Selective reporting (reporting bias) Unclear risk No study protocol but it appears that all
outcomes discussed in the methods were
reported on
Other bias Low risk No ASA data available for one group, oth-
erwise comparable baseline characteristics
Other performance bias (e.g. differential
expertise bias)
Low risk “2 experienced surgeons” performed the
cases. Time to surgery and post-operative
protocols appear similar
Other sources of bias (funding) Unclear risk No mention of funding or conflict of in-
terest
Fritz 1999
Methods Randomised trial: method not stated except that it was “non-stratified”
Length of follow-up: 6 months
Participants Orthopaedic hospital, Heidelberg, Germany
80 people with an unstable trochanteric proximal femoral fracture
Age: mean 83 years
% male: 14
Number lost to follow-up: 1 (1.3%)
Assigned: 40/40 [Gliding nail / Gamma nail]
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Fritz 1999 (Continued)
Interventions Gliding nail (125 degree) versus a standard (130 degree) Gamma nail
For the gliding nail, the lag screw of the standard Gamma nail was replaced by a double
T profile blade
All nails were 220 mm long and 12 mm in diameter. A double distal locking was aimed
for in all cases
Outcomes Length of surgery
Operative blood loss
Operative fracture
Cut-out of implant
Later fracture of the femur
Re-operation
Medical complications
Pneumonia
Cerebrovascular accident
Decubitus ulcers
Length of hospital stay
Limb shortening
Rotational deformity
Mortality
Residence
Mobility
Pain
Function: Merle d’ Aubigne score
Study funding There was no mention of funding or a conflict of interest
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not clear what the exact methodology was
“according to a non-stratified randomisa-
tion”
Allocation concealment (selection bias) Unclear risk No details given
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No mention of blinding. Not possible to
blind surgeons
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding. Outcomes in-
cluded Merle D’Aubigne score
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Fritz 1999 (Continued)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding but uncertain risk
of bias
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk All short (perioperative) data available
Incomplete outcome data (attrition bias)
Longer-term outcome
Low risk 2% lost to follow-up. 12% died
Selective reporting (reporting bias) Unclear risk No protocol. No major concerns over out-
comes presented
Other bias Low risk Baseline characteristics similar between
groups
Other performance bias (e.g. differential
expertise bias)
Unclear risk No difference in surgeons’ expertise. An
experienced surgeon either performed the
procedure or assisted. Post-op programmes
though not described in detail seem to be
different “dependent on the preoperative
condition of the patient and not the fixa-
tion system”
Other sources of bias (funding) Unclear risk No mention of funding or conflict of in-
terest
Hardy 2003
Methods Randomised trial: method not stated
Length of follow-up: mean 37 months (range 12 to 49 months)
Participants Orthopaedic hospital, Brussels, Belgium
81 people with an unstable trochanteric proximal femoral fracture (fracture types fea-
turing loss of medial support: Jensen types IV and V; or reversed oblique fracture lines)
Age: mean 77 years
% male: 38
Number lost to follow-up: 1 (1.3%)
Assigned: 42/39 [Dynamic / Static locking]
Interventions Intramedullary hip screw (IMHS) with a slotted hole to allow for dynamic distal locking
of the nail with one screw versus a standard IMHS statically locked with two distal
locking screws
All nails were 12 mm in diameter, with a 135 degree angle between the nail and lag
screw, and 4 degree valgus angle
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Hardy 2003 (Continued)
Outcomes Length of surgery
Operative blood loss
Haemoglobin level
Volume of blood transfused
Cut-out of implant
Later fracture of the femur
Re-operation
Mortality
Pain
Mobility score
Independence (Jensen’s autonomy index)
Limb shortening
Subsidence of the nail
Cortical hypertrophy
Study funding No mention of conflict of interest or funding
Notes One patient allocated dynamic locking was excluded because the nail was erroneously
locked with two screws
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No mention of the blinding process “the
remaining 81 patients were allocated ran-
domly...”
Allocation concealment (selection bias) Unclear risk No mention of concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding. Not possible to blind sur-
geons. Uncertain risk of bias
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk No blinding. They do say however that for
pain, examinations were repeated and cross
matched with family members
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No blinding though is not required for ob-
jectives such as mortality
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk No lost data
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk 1 patient lost to follow-up. Mobility score
not provided (“similar ion both groups”).
No statistical analysis on many of the out-
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Hardy 2003 (Continued)
comes such as pain, leg length discrepancy
and mortality
Selective reporting (reporting bias) Unclear risk Noprotocol and somedata (mobility score)
not provided
Other bias Low risk Similar baseline characteristics in terms of
age, gender, mobility and fracture type
Other performance bias (e.g. differential
expertise bias)
Unclear risk Slightly more junior operators in group B.
Same care pathway
Other sources of bias (funding) Unclear risk No mention of funding or conflict of in-
terest
Herrera 2002
Methods Quasi-randomised trial: based on odd and even record numbers
Length of follow-up: 12 months minimum
Participants Orthopaedic hospital, Zaragoza, Spain
250 people with a trochanteric proximal femoral fracture: A1, A2 or A3 (stable and
unstable). Pathological fractures included
Age: mean 79 years
% male: 28
Number lost to follow-up: not stated
Assigned: 125/125 [PFN / Gamma nail]
Interventions Proximal femoral nail (PFN): usually 130 degree, 10 mm (inserted without reaming)
versus a Gamma nail (usually a 130 degree, 11 mm) inserted with reaming
With 3 exceptions (in the Gamma nail group) nails were locked distally using one or
two screws
Outcomes Length of surgery
Operative blood loss
Blood transfusion
Cut-out of implant
Operative fracture of femur (greater trochanter)
Later fracture of the femur
Secondary varus (> 10%)
Breakage of implant
Poor reduction of fracture
Migration of the proximal nail screw(s)
Non-union (and time to healing)
Re-operation
Seroma
Haematoma
Superficial wound infection
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Herrera 2002 (Continued)
Deep wound infection
Length of hospital stay
Pressure sores
Pulmonary embolism
Acute post-operative confusion
Digestive haemorrhage
Acute kidney failure
Muscle pain “due to point effect”
Mortality
Recovery of walking ability
Study funding No details given on funding or a conflict of interest
Notes Information on method of randomisation received from Dr Herrera (28/09/04)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Assignment based on add and even record
numbers - thus quasi-randomised
Allocation concealment (selection bias) High risk Quasi-randomised - no concealment re-
ported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind surgeons. No men-
tion of blinding of participants or assessors.
Uncertain risk of bias
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding. Outcomes in-
cluded time to fracture healing, fracture re-
duction and final walking ability
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding though may not
be relevant for these outcomes
Incomplete outcome data (attrition bias)
Short-term outcome
Unclear risk Short-term data appears complete though
for some outcomes, totals given rather than
individual group results: e.g. length of stay,
time to commence weight bearing
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk Unclear if any attrition from the study. 21%
mortality
Selective reporting (reporting bias) High risk No protocol though some outcomes men-
tioned in the methods are not reported on:
e.g.mental function, leg length discrepancy
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Herrera 2002 (Continued)
and axes of the affected limb
Other bias Unclear risk Baseline medical problems are similar but
data for age and gender not available for
each group
Other performance bias (e.g. differential
expertise bias)
Unclear risk No mention of number of surgeons or ex-
pertise. Care programmes appear similar
Other sources of bias (funding) Unclear risk No mention of funding or conflict of in-
terest
Makridis 2010
Methods Randomised trial: sealed envelopes containing cards
Length of follow-up: 12 months
Participants Orthopaedic Hospital, Polimeri, Greece
215 patients aged 60 or over with pertrochanteric fracture after a low energy fall. 35%
stable, 65% unstable
Age: mean age 83.7 years (range 69 to 99)
% male: 31
Number lost to follow-up: no mention of attrition from study
Assigned: 105/110 [ENDOVIS nail / Intramedullary hip screw]
Interventions ENDOVIS nail versus intramedullary hip screw (IMHS)
ENDOVIS: 13 mm proximal and 10 mm distal diameter, 195 mm in length. Inserted
without reaming. Two holes for cephalic screw and one for distal screw
IMHS: cannulated intramedullary nail inserted through greater trochanter. Used with
AMBI/CLASSIC lag screw, compression screw and 4.5 mm locking screws. Sleeve (to
prevent rotation while allowing lag screw to slide) passes through the nail and over the
lag screw. Two angles and four distal diameters available. Proximal diameter 17.5 mm,
210 mm in length
Distal locking was made preferably with 2 screws
Outcomes Length of surgery
Operative blood loss
Units of blood transfused
Intra-operative complications
- missing proximal hole
- misplaced proximal screws
- failure distal locking
- femoral shaft medialisation
- cut-out of implant
- Z-phenomenon
- reverse Z-phenomenon
- proximal screw back out
- joint penetration
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Makridis 2010 (Continued)
- periprosthetic fracture
- nail breakage
Wound infection
Post-operative haemoglobin level
Mobility score at discharge (Palmer-Parker mobility score)
Length of hospital stay (not reported)
Mortality
Study funding Authors declare no competing interests
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly dispersed “by the use of sealed
envelopes containing cards”
Allocation concealment (selection bias) Unclear risk No mention of opacity of the sealed en-
velopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Surgeons could not be blinded. Participants
not blinded
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding. Unclear risk of
bias
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk Short-term data appear complete
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk No mention of attrition from study; mor-
tality at 1 year reported
Selective reporting (reporting bias) Unclear risk No study protocol but outcomes discussed
in methods reported
Other bias Low risk Similar baseline characteristics in the two
groups. Similar pre- and post-op care pro-
grammes
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Makridis 2010 (Continued)
Other performance bias (e.g. differential
expertise bias)
Unclear risk No mention of surgeon number or exper-
tise
Other sources of bias (funding) Low risk Authors declare no competing interests
Marques 2005
Methods Quasi-randomised trial: based on odd and even record numbers
Length of follow-up: 12 months
Participants Orthopaedic hospital, Barcelona, Spain
156 people with an unstable trochanteric proximal femoral fracture (AO types 31 A2
and A3)
Age: mean 82 years
% male: 24
Number lost to follow-up: 25 (16%)
Assigned: 79/77 [PFN / Gamma nail]
Interventions Proximal femoral nail (PFN) versus a trochanteric Gamma nail
The PFN was 10 mm diameter, inserted without reaming, and had two distally locking
screws
The Gamma nail was 11 mm distal diameter, and inserted with reaming and had one
distal locking screw
With 3 exceptions (in the Gamma nail group) nails were locked distally using one or
two screws
Outcomes Length of surgery
Haemoglobin level
Number of patients transfused
Radiographic screening time
Cut-out of implant
Operative fracture of femur
Later fracture of the femur
Re-operation
Haematoma
Deep wound infection
Length of hospital stay
Pressure sores
Pulmonary embolism
Deep vein thrombosis
Pneumonia
Mortality
Pain in thigh
Study funding No funding was received for the study
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Marques 2005 (Continued)
Notes Additional information supplied by Dr Marques included exact numbers of people with
key outcomes. It should be noted, however, that the percentages given in the paper are
generally inconsistent with the data provided by Dr Marques
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomisation was performed “according
to their hospital number”
Allocation concealment (selection bias) High risk No details given; but quasi-randomised
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No mention of blinding of participants.
Surgeons could not be blinded
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding. One subjective
outcome: pain in thigh. Uncertain risk of
bias for this
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding. Unclear risk of
bias
Incomplete outcome data (attrition bias)
Short-term outcome
Unclear risk No mention of attrition from study
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk No mention of attrition from study. Un-
likely that all participants were followed up
Selective reporting (reporting bias) High risk No study protocol. Not all outcomes dis-
cussed in the methods were reported on: e.
g. fracture reduction
Other bias Low risk Baseline characteristics were similar in the
two groups
Other performance bias (e.g. differential
expertise bias)
Unclear risk Staff, senior and junior resident staff. More
junior residents in Gamma nail group. Ap-
pears similar post operative mobility plan
for both groups (weight bearing as toler-
ated) but no explicit description of other
pre-op, intra-op or post op care plans
Other sources of bias (funding) Low risk No funding was received for the study
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Okcu 2013
Methods Randomised trial: computer randomisation
Length of follow-up: mean 14 months (range 12 to 20 months)
Participants Orthopaedic Hospital, Manisa, Turkey
Orthopaedic Hospital, Izmir, Turkey
40 participants with reverse oblique type trochanteric fracture
Age: mean 79 years (range 67 to 95)
% male (of 33 survivors): 24
Number lost to follow-up: 7 (17.5%); all deaths
Assigned: 22/18 [Long PFNA/standard PFNA]
In analyses: 18/15
Interventions Long proximal femoral nail antirotation (PFNA) versus standard PFNA
Long PFNA: 34 to 42 cm length; diameter 9 and 10 mm and a neck shaft angle of 130
degrees; locked distally two 5 mm screws
Standard PFNA: 24 cm length; diameter 10, 11 and 12 mm and a neck shaft angle of
130 degrees; locked distally one 5 mm screw
Outcomes Length of surgery
Fluoroscopy time
Union (fracture consolidation)
Re-operation
Blade penetration
Superficial wound infection
Deep wound infection
Malunion
Length of hospital stay
Mortality
Harris hip score
Parker and Palmer mobility score
Study funding No funding was received for this study
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random allocation software used
Allocation concealment (selection bias) Unclear risk No mention of allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were not blinded. Surgeons
could not be blinded
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Okcu 2013 (Continued)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Outcome assessment of mobility and Har-
ris hip score blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding but independent
assessor
Incomplete outcome data (attrition bias)
Short-term outcome
Unclear risk Similar losses in both groups from mortal-
ity (4 versus 3) but results provided only
for survivors
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk Similar losses in both groups from mortal-
ity (4 versus 3) but results provided only
for survivors
Selective reporting (reporting bias) Unclear risk No protocol but outcomes reported in
methods appear to be reported
Other bias Low risk Similar baseline characteristics; although
data provided only for survivors the com-
mon fracture type, exclusion criteria, and
similarity of age characteristics in those ran-
domised and analysed indicate that this is
unlikely to be a source of bias
Other performance bias (e.g. differential
expertise bias)
Low risk Three ’experienced’ trauma surgeons. Same
pre- and post-operative care
Other sources of bias (funding) Low risk No funding bias as declared by authors
Papasimos 2005
Methods Randomised trial: method not stated
Length of follow-up: mean 12 months
Participants Orthopaedic hospital, Patras Hellas, Greece
80 of 141 people with an unstable trochanteric proximal femoral fracture (see Notes)
Age (of 80 participants): mean 81 years
% male (of 80): 41
Number lost to follow-up (of 141): 11 (7.8%)
Assigned: ?/? [PFN / Gamma nail]
In analyses: 40/40 [PFN / Gamma nail]
Interventions Proximal femoral nail (PFN) versus a trochanteric Gamma nail
11 or 12 mm diameter PFN with distal locking in 37 out of 40 participants
135 degree trochanteric Gamma nail with 17 mm proximal diameter and 11 mm distal
diameter and distal locking in all 40 participants
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Papasimos 2005 (Continued)
Outcomes Length of surgery
Operative blood loss
Radiographic screening time
Operative fracture (some of greater trochanter)
Cut-out of implant
Later fracture of the femur
Non-union
Re-operation
Superficial wound infection
Haematoma
Medical complications
Chest infection
Pneumonia
Mental disturbances
Deep vein thrombosis
Pulmonary embolism
Urinary infection
Length of hospital stay
Time to fracture consolidation
Function: Salvati and Wilson score
Study funding No mention of funding or a conflict of interest
Notes There were 141 people randomised into this trial but the intervention groups for the
10 participants who died before one year and the 11 who were lost to follow-up were
not identified. Forty of the 120 participants included in the trial analyses were treated
with a sliding hip screw. The results for this group are included in the Cochrane review
’Gamma and other cephalocondylic intramedullary nails versus extramedullary implants
for extracapsular hip fractures in adults’
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No indication of how randomisation was
performed “were strictly randomised”
Allocation concealment (selection bias) Unclear risk No details given
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No mention of blinding. Not possible to
blind surgeons
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No details given. Subjective outcomes in-
cluded mobility score, ease of reduction,
nature of procedure. Radigraphs were as-
sessed by the operating consultants and two
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Papasimos 2005 (Continued)
experienced residents
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Not blinded but unclear significance
Incomplete outcome data (attrition bias)
Short-term outcome
Unclear risk No details on which groups the 11 patients
who were lost to follow-up or 10 patients
who had died were in
Incomplete outcome data (attrition bias)
Longer-term outcome
High risk 11/141 lost to follow-up. No details on
which groups the 11 patients who were lost
to follow-up or of the 10 patients who had
died
Selective reporting (reporting bias) Unclear risk No protocol though all the outcomes men-
tioned in the methods are reported
Other bias Unclear risk Groups similar in baseline characteristics
but data not available for 21 participants
Other performance bias (e.g. differential
expertise bias)
Unclear risk Level of experience of 4 surgeons not stated
but less experience with PFN noted. Care
programmes are the same
Other sources of bias (funding) Unclear risk No mention of funding or a conflict of in-
terest
Schipper 2004
Methods Randomised trial: numbered and blinded envelopes with computer generated randomi-
sation code
Length of follow-up: 4 months for whole trial population; 12 months for those with
non-consolidated fractures at 4 months
Participants Multi-centre study conducted in 9 orthopaedic hospitals, The Netherlands
424 people with an unstable trochanteric proximal femoral fracture. Age 60 or above
Age: mean 82 years
% male: 18
Number lost to follow-up: 12 at 4 months (2.8%)
Assigned: 211/213 [PFN/Gamma nail]
Interventions Proximal femoral nail (PFN) versus a standard (130 degree,11 mm) mark 3 Gamma nail
The PFN was 130 degree, 10 or 11 mm, and inserted without reaming. The Gamma
nail was inserted with reaming
All nails were locked distally in a static mode
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Schipper 2004 (Continued)
Outcomes Length of surgery
Operative blood loss
Cut-out of implant
Operative fracture of femur
Later fracture of the femur
Technical difficulty during surgery
Breakage of implant
Suboptimal screw position
Malrotation
Need of open reduction
Poor reduction of fracture
Migration of the proximal nail screw(s)
Union (fracture consolidation)
Re-operation
Superficial wound infection
Deep wound infection
Time to full weight bearing
Length of hospital stay
Pressure sores
Pneumonia
Thromboembolic complications
Cardiovascular, urogenital, neurological, gastrointestinal and psychiatric complications
Mortality
Harris hip score
Study funding The study was supported by an implant company (Stryker) involved in the manufacture
of one of the nails (Gamma nail) used in the trial
Notes Follow-up of the full trial population was up to 4 months. As per protocol, only those
with incomplete radiological consolidation of their fractures at 4 months (85 versus 83)
were followed up until 12 months.
Additional clarification on results supplied by trialists
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The randomisation order was computer-
generated based on randomly permutated
blocks of four and six patients
Allocation concealment (selection bias) Low risk Numbered and blinded envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind surgeons.Unclear risk
of bias
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Schipper 2004 (Continued)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Subjective difficulty and quality of reduc-
tion as determined by surgeon not blinded.
Unclear significance. Radiologists and re-
search coordinator not blinded
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding though uncertain
risk of bias
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk Low number (6/424) lost to follow-up at 4
weeks. Otherwise, complete data
Incomplete outcome data (attrition bias)
Longer-term outcome
High risk 22 lost to follow-up in total. 342 followed
to 4 months. But only 140 (incorrect in
text) followed up to 1 year
Selective reporting (reporting bias) Unclear risk No protocol but all outcomes mentioned
in the methods are reported on
Other bias Low risk No differences in baseline characteristics
(age, sex, ASA and fracture type)
Other performance bias (e.g. differential
expertise bias)
Unclear risk Performed by surgeons with at experience
of at least five procedures (unclear if this
is enough experience). Not stated how
many surgeons: 74% operations by resi-
dents. Similar post-operative care described
Other sources of bias (funding) High risk Supported by Stryker Howmedica and
Mathys Medical Netherland. Authors re-
ceived benefits which were directed to re-
search fund etc. Stryker manufactures the
Gamma nail used in the trial
Starr 2006
Methods Randomised trial: numbered sealed envelopes (some attempt made to obscure allocation
but of uncertain effectiveness)
Length of follow-up: minimum 12 months (range 12 to 29 months)
Participants Orthopaedic hospital, Dallas, USA
34 people (aged 10 to 50 years) with an extracapsular proximal femoral fracture caused
by high energy trauma (15% stable trochanteric, 62% unstable trochanteric, 24% sub-
trochanteric fractures)
Age: mean 34 years (range 19 to 50 years)
% male: 35
Number lost to follow-up: 6 (18%)
Assigned: 17/17 [Russell Taylor/long Gamma nail]
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Starr 2006 (Continued)
Interventions Russell Taylor Recon or Delta Intramedullary nail versus a long Gamma intramedullary
nail
The Russell Taylor nails were 10 to 14 mm distal diameter and had two proximal screws
The Gamma nails were 11 mm distal diameter
All nails were statically locked
Outcomes Length of surgery
Operative blood loss
Cut-out of implant
Operative fracture of the femur
Later fracture of the femur
Non-union
Re-operation
Wound infection
Deep would infection
Mortality
Harris hip score
Mobility
Unable to do the same work
Hip and knee range of movement
Study funding Funding from a local research fund. No funding from industry
Notes Extra information including method of randomisation and fracture distribution was
supplied by trialists
Three patients had open fractures and 17 (9 versus 8) had concurrent surgery for other
injuries
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No clear details given. “Randomisationwas
carried out by use of envelopes opened”
Allocation concealment (selection bias) Unclear risk No details given: use of envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No mention of blinding. Surgeons not
blinded for operative difficulty. Partici-
pants not blinded for pain. Implication of
this is uncertain
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Not blinded
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Starr 2006 (Continued)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No blinding though uncertain risk of bias
for these outcomes
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk All data available
Incomplete outcome data (attrition bias)
Longer-term outcome
Low risk 6 patients (2 versus 4) lost to follow-up
(82% follow-up). 1 prisoner had incom-
plete follow-up
Selective reporting (reporting bias) Unclear risk No protocol though all outcomes discussed
in themethods appear to be reported in full
Other bias Low risk No difference between the two groups in
baseline characteristics
Other performance bias (e.g. differential
expertise bias)
Low risk 4 attending surgeons performed all cases.
Care programmes same in both groups
Other sources of bias (funding) Low risk Funding from a local research fund. No
funding from industry
Vaquero 2012
Methods Randomised trial: computer generated randomisation and sealed envelopes
Length of follow-up: 12 months
Participants Multi-centre study conducted in 6 orthopaedic hospitals in Spain: 2 in Madrid, 1 in
Barcelona, 1 in Palencia, 1 in San Sebastian, and 1 in Santander
64 patients with isolated, unstable, closed or type 1 open trochanteric fracture (AO 31-
A2 or 31-A3)
Age: mean 84 years (range 69 to 98 years).
% male: 13
Number lost to follow-up: 26 + 9 drop-outs (also 4 deaths)
Assigned: 33/31 [PFNA/Gamma Nail]
Interventions Proximal Femoral Nail Antirotation versus Gamma 3 Nail
PFNA were 200 mm length and 11 mm diameter
Gamma 3 nails were 180 mm length and 11 mm diameter. Both implants have neck
shaft angles of 125 or 130 degrees and were inserted percutaneously with reaming in the
majority of cases (>70%)
Outcomes Length of surgery
Technical problem at surgery/Surgical procedure change
Fluoroscopy time
Operative blood loss
Length of stay
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Vaquero 2012 (Continued)
Mobility
Return to previous living status
ADL independence (Katz index, EQ-5D index)
Pain at fracture site, middle thigh and knee
Implant loosening
Cut-out of implant
Implant breakage
Loss of reduction
Fracture impaction
Delayed healing
Non-union
Peri-prosthetic fracture
Superficial wound infection
Deep wound infection
Wound haematoma
Fracture fixation failure
Mortality
Harris hip score
SF-36 Physical Health
SF-36 Mental Health
Sangha Score
Anatomical reduction status/Rotational deformity
Study funding Financial Grant from Synthes. Authors state that there are no conflicts of interest that
could inappropriately influence their work
Notes Significant loss to follow-up of 39/64 patients (including 4 known deaths)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated randomisation se-
quence
Allocation concealment (selection bias) Unclear risk Sealed envelopes. No mention of opacity.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Surgeons could not be blinded.Unclear risk
of bias.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding of assessors assess-
ing functional scores such as SF-36, Haris
hip score etc)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding except for final
classification of complications at end of fol-
low-up. This was done using anonymised
data by the principal clinical investigator.
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Vaquero 2012 (Continued)
Uncertain risk of bias for other outcomes
such as operative time
Incomplete outcome data (attrition bias)
Short-term outcome
High risk Significant 21/64 (33%) short-term drop
out at 3 months; 3 of these were due
to deaths (5%). Some imbalance between
groups
Incomplete outcome data (attrition bias)
Longer-term outcome
High risk Significant attrition bias
22/33 lost PFNA (4 known to have died)
17/31 lost Gamma (0 deaths known about)
Selective reporting (reporting bias) Unclear risk All outcomes described in methods appear
to be reported on, though no specific pro-
tocol available
Other bias Low risk Groups similar in a wide variety of demo-
graphic variables
Pre and post op care similar
Other performance bias (e.g. differential
expertise bias)
Unclear risk No mention of surgeon number or expe-
rience (‘from six different hospitals’)
Other sources of bias (funding) High risk Funded by grant from Synthes which man-
ufactures the PFNA. Authors state there are
no conflicts of interest that could inappro-
priately influence their work
Vidyadhara 2007
Methods Randomised trial: computer generated random numbers table
Length of follow-up: 24 months
Participants Orthopaedic hospital, Karnataka, India
73 people with an unstable trochanteric proximal femoral fracture (AO types 31 A2.2,
A2.3, A3.1, A3.2 and A3.3)
Age: mean 69 years (range 61 to 89 years)
% male: 51
Number lost to follow-up: none
Assigned: 36/37 [ACE trochanteric nail / AP Gamma nail]
Interventions ACE trochanteric nail versus an AP (Asian/Pacific) Gamma nail
Nails of 130 degree angle and 200 mm length used in both groups. Both nails locked
distally with the upper screw. The proximal antirotation screw was used in all cases of
the ACE nail
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Vidyadhara 2007 (Continued)
Outcomes Length of surgery
Operative blood loss
Cut-out of implant
Later fracture of the femur
Non-union
Re-operation
All wound infection
Deep wound infection
Deep vein thrombosis
Shortening
Pain (at 1 month)
Mortality
Harris hip score
Mobility
Limp
Difficulty in squatting
Study funding No mention of funding or a conflict of interest
Notes Extra information, including no loss to follow up or deaths, supplied by trialists
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random number ta-
ble
Allocation concealment (selection bias) Unclear risk No mention of concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No mention of blinding. Surgeons could
not be blinded
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Nomention blinding. Subjective outcomes
included pain, limp and Harris hip score
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding but uncertain risk
of bias
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk All data available
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk No mortality or attrition data given.
Longer-term outcomes presented as aver-
ages
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Vidyadhara 2007 (Continued)
Selective reporting (reporting bias) Unclear risk No protocol but all outcomes discussed in
the methods are reported
Other bias Low risk Baseline characteristics similar in both
groups
Other performance bias (e.g. differential
expertise bias)
Low risk All performed by one surgeon. Same pro-
gramme of care
Other sources of bias (funding) Unclear risk No mention of funding or a conflict of in-
terest
Wild 2010
Methods Quasi-randomised trial: based on admission sequence
No mention of concealment
Length of follow-up: 12 months
Participants Heinrich Heine hospital, Dusseldorf, Germany
80 patients with a pertrochanteric fracture (AO type 31 A2)
Age: 82.5 years (range 51 to 101)
% male: 30
Number lost to follow-up: 4 (also 18 deaths)
Assigned: 40/40 [PFNA/Targon]
Interventions Proximal femoral nail antirotation (PFNA) nail versus a Targon PF nail
The PFNA is a monoaxial rotation-stabilising nail which has a neck blade designed to
improve fixation
The Targon PF nail is biaxial with an additional antirotation pin and a barrel aimed at
facilitating sliding of the femoral neck screw
No further details
Outcomes Operative time
Intra-operative fluoroscopy time
Perioperative mortality
Hip joint range of motion
Modified Harris hip score
Femoral neck component cut-out
Femoral neck component change (re-operation)
Post-operative wound infection
Periprosthetic fracture
Implant breakage
Radiographic union
Dynamisation as measured by sliding of the femoral neck components (not reported in
review)
Quality of reduction (not reported in review)
Study funding No conflict of interest noted
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Wild 2010 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Inappropriate randomisation based on ad-
mission sequence
Allocation concealment (selection bias) High risk Quasi-randomised. No mention of con-
cealment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind surgeons. No men-
tion of blinding otherwise. Uncertain risk
of bias
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding. Outcomes in-
cluded Harris hip score and radiographic
outcomes
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding though uncertain
risk of bias for these outcomes
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk All data available
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk 22 not available at 12 months: 4 lost to
follow-up and 18 deaths. Although 11 in
each groups, the group allocation of the 18
deaths was not given
Selective reporting (reporting bias) Unclear risk No protocol though outcomes mentioned
in methods are reported in full
Other bias Unclear risk Baseline characteristics similar but no base-
line mobility status documented. No de-
tails of exclusion criteria (22 patients)
Other performance bias (e.g. differential
expertise bias)
Unclear risk 2 experienced surgeons.Nomentionof care
programme for either group
Other sources of bias (funding) Low risk No relevant financial relationships to dis-
close
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Xu 2010a
Methods Randomised trial carried using consecutive numbered and sealed envelopes based on a
computer generated list
Length of follow-up: 17.68 months (12 to 27)
Participants First Affiliated Hospital of Soochow University, Suzhou, China
136 patients unstable trochanteric fractures (31 A2 (116) or 31 A3 (19))
Age: mean 76 years
% male: 40
Number lost to follow-up: 28 (21%)
Assigned: 66/70 [PFNA/Gamma Nail 3]
Interventions Proximal femoral nail antirotation (PFNA) versus a Gamma 3 nail
PFNA: solid titanium nail 170 or 240 mm in length, mediolateral curvature of 6 degrees,
diameter of 10 or 11 mm. Inserted without reaming of the canal. The helical blade
was inserted into the neck without drilling. The distal screw could be locked either
dynamically or statically. The neck shaft angle was 130 degrees
Gamma 3 nail: 170 mm in length, had a lower mediolateral curvature of 40 degrees
and a diameter of 11 mm. Reaming of the femur was performed prior to insertion. One
distal locking screw was placed
Outcomes Intra-operative blood loss
Blood transfusion
Operating time
Flouroscopy time
Fracture reduction
Length of hospital stay
Time to fracture healing
Femoral shaft fracture
Implant failure
Implant cutout
Medical complications
Wound complications
Femoral shaft shortening
Proximal screw migration
Hip and thigh pain
Mortality
Recovery of pre-operative weight bearing ability
Walking ability score
Range of hip flexion
Study funding No conflict of interest disclosed
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Xu 2010a (Continued)
Random sequence generation (selection
bias)
Low risk “use of consecutive numbered and sealed
envelopes based on a computer generated
list”
Allocation concealment (selection bias) Unclear risk Unclear if envelopes were opaque or not
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind surgeons. Uncertain
risk of bias
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No mention of blinding. Subjective out-
comes included mobility score and quality
of reduction
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding though uncertain
risk for these outcomes
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk All data available
Incomplete outcome data (attrition bias)
Longer-term outcome
High risk 28/136 unavailable for long-term follow-
up due to illness/moving. Together with 15
deaths (groups not specified), 43 unavail-
able in total (32%). Variable follow-up
Selective reporting (reporting bias) Unclear risk No protocol though outcomes in methods
appear to be reported completely
Other bias Low risk Similar baseline characteristics in the two
groups
Other performance bias (e.g. differential
expertise bias)
Low risk Similar care programmes. All surgeons had
experience with at least 5 procedures
Other sources of bias (funding) Low risk Disclosure of no conflict of interest at the
end of the references
Zhang 2013
Methods Randomised trial: computer generated randomisation list. Numbered and sealed en-
velopes
Length of follow-up: mean 18.6 months (range 12 to 30 months)
Participants Nanfang Hospital, Southern Medical University, Guangzhou, China
The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
113 people with unstable trochanteric femoral fractures caused by low energy trauma
(AO classification A2.1-3.3). Informed consent
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Zhang 2013 (Continued)
Age: mean 73 years
% male: 37
Number lost to follow-up: 5 (4%) (all were too ill)
Assigned: 57/56 [InterTan nail / PFNA-II]
Interventions InterTan nail versus Proximal Femoral Nail Antirotation (PFNA-II)
InterTan nail: 180 mm long; trapezoidal proximal end with diameter decreasing from
15.25 x 16.25 mm proximally to 11 mm distally; 2 cephalocervical screws proximally
(11 mm lag and 7 mm compression screw)
PFNA-II: solid titanium nail, 170 - 200 mm long and 9, 10 or 11mm diameter
Both nails were inserted percutaneously in the majority of participants. Open surgery
was done for 8 InterTan and 4 PFNA-II nails
Outcomes Intra-operative blood loss
Operating time
Flouroscopy time
Fracture reduction results (not reported in review)
Length of hospital stay
Implant position (optimal or suboptimal) (not reported in review)
Intra-operative complications
-Femoral shaft fracture
-Lateral greater trochanter fracture
-Distal interlocking problem
-Penetration trochanter by proximal nail
Post-operative complications
-Wound infection (superficial and deep)
-Haematoma
-Cutout
-Lateral migration of hip screw
-Femoral neck shortening
-Hip and thigh pain
-Delayed union
-Re-operation
-Medical complications: DVT, PE, cardiovascular disorder, pressure sore, UTI
Mortality
Walking ability score
Range of motion hip
Harris hip score
Study funding No relevant financial relationships to disclose
Notes The PFNA-II nail was designed to fit the different femur geometry in Asians
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation based on a computer gen-
erated list
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Zhang 2013 (Continued)
Allocation concealment (selection bias) Unclear risk “use of consecutive numbered and sealed
envelopes.” Unclear if envelopes were
opaque. The sealed envelopes were opened
by the surgeon pre-operatively (timing un-
clear)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind surgeons.Unclear risk
of bias
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Nomentionof blinding of assessors for out-
comes such as Haris hip score, hip pain,
walking ability score
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Nomention of blinding, though uncertain
risk of bias for outcomes such as mortality,
length of stay, operative time, blood loss,
implant position
Incomplete outcome data (attrition bias)
Short-term outcome
Low risk Short-term outcomes appear complete
Incomplete outcome data (attrition bias)
Longer-term outcome
Low risk Five (4.4%) lost to follow-up; 15 (13.3%)
died in the follow-up period. Losses bal-
anced in the two groups
Selective reporting (reporting bias) Unclear risk No protocol but all outcomes mentioned
in the methods appear reported on
Other bias Low risk No differences in baseline characteristics
(age, sex, weight, fracture type)
Other performance bias (e.g. differential
expertise bias)
Low risk Two surgeons with experience unclear, but
”At least 5 procedures independently with
either PFNA-II or InterTan nail”
Similar pre-operative and post-operative
care
Other sources of bias (funding) Low risk No conflict of interest identified at the be-
ginning of the paper
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Zhu 2012
Methods Randomised trial: sealed envelopes
Length of follow-up: mean 12 months
Participants Shanghai Sixth People’s Hospital, Shanghai, China
80 people with intertrochanteric fractures (AO classification A1 and A2)
Age: 46 (inclusion criteria: 18 to < 60 years)
% male: 67.5%
Number lost to follow-up: 0, but 3 complications
Assigned 40/40 [Sliding/Non-sliding Gamma 3 nail]
Interventions Gamma 3 nail: sliding versus non-sliding lag screw. Gamma 3 nail: 180 mm titanium
alloy with type II proximal anodization; distal diameter 15.5 mm and 11 mm. Reaming
of medullary canal ’generally performed’ before insertion. Distal locking screw used
Sliding lag screw: non-tightening of set screw
Non-sliding lag screw: tightening of set screw
Outcomes Operating time
Intra-operative blood loss
Transfusion
Fracture reduction results (not reported in review)
Length of hospital stay (days)
Bone union
Healing time (months)
Lag screw sliding distance (not reported in review)
Femoral shaft fracture (timing not clear)
Cutout
Leg length discrepancy
Harris Hip Score
Study funding No significant financial support confirmed by authors
Notes The trial aimed to exclude patients with osteoporosis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation was achieved by ’drawing
an unseen card from a sealed envelope’
Allocation concealment (selection bias) Unclear risk ’Unseen card from sealed envelope.’Un-
clear what unseen means; no mention of
opacity of envelope
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Surgeons could not be blinded.Unclear risk
of bias
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Zhu 2012 (Continued)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Nomentionof blinding of assessors for out-
comes such as Haris hip score, healing time
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk No mention of blinding though uncertain
risk
Incomplete outcome data (attrition bias)
Short-term outcome
Unclear risk Only thosewithout complications analysed
Incomplete outcome data (attrition bias)
Longer-term outcome
Unclear risk The flow diagram in the report indicates
that three non-sliding group participants
were excluded from the analysis because of
complications. The effect on the results for
Haris hip score are unclear but we judged
that these were unlikely to be important
Selective reporting (reporting bias) Unclear risk No protocol but all outcomes mentioned
inmethods and aims at end of introduction
reported on
Other bias Low risk Similar baseline characteristics
Other performance bias (e.g. differential
expertise bias)
Low risk All cases performed by the same surgeon.
No stated differences in the pre- and post-
operative care programmes
Other sources of bias (funding) Low risk No conflict of interest identified at the end
of the paper
DVT: deep vein thrombosis
IMHS: intramedullary hip screw
PE: pulmonary embolism
PFN: proximal femoral nail
UTI: urinary tract infection
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
Cao 2009 This was excluded in the Gamma nail review (Parker 2010) for the following reasons: “This was reported as a
randomised trial of 95 patients with trochanteric fractures treated with either a Gamma nail, proximal femoral nail
or a dynamic hip screw. The English abstract implied that the population was randomly divided according to the
Evans classification system. Overall, there was limited reporting of the study methodology within the paper such
that it was not possible to determine clearly if it was a randomised controlled trial or an observational study. The
study was excluded because it was uncertain that it was a randomised controlled trial”
Dall’Oca 2010 This is a trial comparing the Gamma nail with and without cement augmentation in the treatment of unstable
intertrochanteric fractures. It was excluded as it did not compare two different nails but rather the same nail with
and without cement augmentation
Gahr 2003 This quasi-randomised trial of 50 participants with a proximal femoral fracture treated alternatively with either the
long Gamma nail of 10 mm diameter or a long Gamma nail of 11 mm diameter. The trial report in German with
English abstract reported outcomes until hospital discharge (mean 19 days). The follow-up was incomplete but no
further report has been identified. There was no response from the contact author (latest: March 2006). The trial
was excluded on the basis of inadequacy of follow-up and limited reporting of outcomes
Huang 2012 This retrospective study compared the PFNA nail with the reconstruction nail. It was excluded as it was a not a
randomised trial
Merenyi 1995 This conference abstract suggested a randomised trial comparing three “different types of Gamma nail” versus
Ender nails versus angle plates. Previous correspondence with the authors indicated there was no randomisation of
patients only a ’random’ selection of patients which had been previously treated with one of the different types of
implant
NTR1133 The trial registration document reported a trial comparing the Fixion Proximal FemurNailing System versusGamma
3 nail that aimed to recruit 244 patients with proximal femur fractures with AO-classification 31 A1.1 - A3.3; age
>18 years
The contact author was contacted on 10/01/2013 and responded on 13/01/2013 that the trial was never published:
“The trial is as far as I know never published, because we do not work with that type of intramedullary nails
anymore.” There was no response to our subsequent request for further information (26/01/2013)
Ouyang 2010 This trial reported on 92 participants with an upper femoral shaft fracture where patients were divided into three
groups dependent on their preferences. The type of treatments used were an interlocking intramedullary nail,
compression plate or Plum nail. The study was excluded as there was inadequate information within the article to
determine if this was a randomised controlled trial. However, it seems more likely that it was based on preferences
Pan 2009 A related article by the same team was excluded in the Gamma nail review (Parker 2010).
This was reported as a randomised trial of 131 patients with a trochanteric fractures treated with either a Gamma
nail or a proximal femoral nail. There was limited reporting of the study methodology within the paper such that
it was not possible to determine clearly if it was a randomised controlled trial or an observational study. The study
was excluded because it was uncertain that it was a randomised controlled trial
Suckel 2006 This was a comparative study of 240 patients with extra-articular femur fractures: 124 were treated with a proximal
femoral nail and 116 with a gliding nail. The study was excluded as there was no randomisation of patients
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(Continued)
Wagner 1998 Translation fromGerman of themethods of this comparative study of the intramedullary hip screw with theGamma
nail established that it was not a randomised trial
Xu 2010b Overlapping recruitment period, same authors and implants as Xu 2010a but this included stable fractures as well.
Response to our request for clarification was “It is true that there is unstable fractures in both the Injury paper and
in the Orthopaedics paper and to be honest, some of the unstable patients reported in the Injury paper are also
included in the Orthopaedics paper.” This was excluded to avoid duplication of participant data
Yang 2011 This randomised trial, which compared the proximal femoral nail (PFN) versus the intramedullary hip screw in 215
patients (105 versus 110) with intertrochanteric fractures, was initially included upon receiving a translation. How-
ever, the extent of similarity betweenMakridis 2010, which compared the ENDOVIS nail versus the intramedullary
hip screw in 215 patients (105 versus 110), and Yang 2011 in the trial population and results (e.g. same statistics
for mobility and haemoglobin levels) and figures are very unusual. Additionally, those figures reported to be of the
PFN appeared more like the ENDOVIS nail. The trial report was excluded because of the serious doubts of its
authenticity engendered by these discoveries
Characteristics of studies awaiting assessment [ordered by study ID]
Mora 2011
Methods Randomised
Follow-up until fracture healed
Participants Unknown location
208 patients with an acute trochanteric femoral fracture (AO/ASIF A1, A2 and A3)
Interventions Proximal Femoral Nail Antirotation (PFNA) versus Proximal Femoral Nail (PFN)
Outcomes Intra- and post-operative complications: cut-out, cut-in
Notes Abstract available: http://www.bjjprocs.boneandjoint.org.uk/content/93-B/SUPP II/136.5
No publication found
Park 2010
Methods Randomised according to “admission sequence”. The exact details are unclear with the authors referencing another
trial rather than giving brief details of their methods. Furthermore, there is some concern regarding the imbalance in
the group numbers (17 versus 23). We sent a request to the trial investigators on 27/5/2014 for them to clarify the
exact randomisation methodology
Follow-up at 4 years (minimum 1.5 years)
Participants Ansan, Korea
40 patients with intertrochanteric fractures
Interventions Proximal femoral nail (PFN) versus PFNA (proximal femoral nail antirotation)
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Park 2010 (Continued)
Outcomes Operation time, blood loss, time to ambulation, time to union, complications, post-operative function and mobility
using social function scores and mobility scores
Notes There is no mention of randomisation/random allocation in the title or abstract of the report of this study, which
was not identified as an eligible study in the screening process. Prior to submission, one author (MJP) questioned
whether the full report should be checked. This refers to it being randomised in the Methods but the imbalance in
the numbers in the two groups (17 versus 23) raises questions about the trial methods. Our attempt to contact the
trial investigators for clarification was unsuccessful
Stern 2011
Methods Randomised: “computer-generated random numbers placed in sealed opaque envelopes”
Follow-up at one year
Participants Geneva, Switzerland
168 patients with trochanteric fractures
Interventions Gamma 3 Trochanteric Nail versus PFNA (proximal femoral nail antirotation)
Outcomes Re-operations, nonunion, superficial wound infection, cutout
Notes The study compared screw (dynamic hip screw and Gamma nail) versus helical blade implants (dynamic hip system
blade versus PFNA), but randomised separately by nail and hip system. The results were reported for the screw versus
blade comparison. Separate data for the nail comparison requested from the trial authors on 22/05/14
Characteristics of ongoing studies [ordered by study ID]
NCT01437176
Trial name or title Treatment of intertrochanteric fracture with new type of intramedullary nail
Methods Randomised
One year follow-up
Participants Patients 18 years of age or older with a stable intertrochanteric hip fracture, ambulatory prior to fracture. Plan
to enrol 36 patients
Interventions New type of intramedullary nail versus Proximal femoral nail antirotation (PFNA) nail
Outcomes Fracture healing
Complications (non-union. implant breakage/failure, infection, DVT)
Revision surgery
Quality of life score (SF-36; FIM)
Mortality
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NCT01437176 (Continued)
Starting date September 2011
Contact information Peifu Tang, Chinese PLA General Hospital, Beijing, China
pftang301@126.com
Notes Study was still recruiting in February 2013
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D A T A A N D A N A L Y S E S
Comparison 1. Proximal femoral nail (PFN) versus Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 At 4 months 1 424 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [0.82, 1.96]
1.2 At 12 months 3 830 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.82, 1.41]
2 Final functional outcomes 3 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Pain at follow up 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Symptoms or restriction
from the hip
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Incomplete recovery of
walking ability (including
death)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Harris hip scores (0 to 100: high
values = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 At 4 weeks 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 At 4 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 At 1 year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Intra-operative complications 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Changed method of
fixation
1 424 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.17, 3.34]
4.2 Open reduction 1 424 Risk Ratio (M-H, Fixed, 95% CI) 2.15 [0.95, 4.86]
4.3 Poor reduction 2 504 Risk Ratio (M-H, Fixed, 95% CI) 2.01 [0.62, 6.57]
4.4 Difficult surgery 2 504 Risk Ratio (M-H, Fixed, 95% CI) 1.46 [0.98, 2.19]
4.5 Difficult proximal or distal
screw insertion
1 424 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.36, 2.83]
4.6 Intra-operative
comminution of the fracture
around the trochanteric region
2 330 Risk Ratio (M-H, Fixed, 95% CI) 0.3 [0.12, 0.73]
4.7 Operative fracture of the
femur
4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.07, 1.63]
4.8 Suboptimal position of
fixation devices
1 424 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.77, 1.95]
5 Fracture healing complications 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Cut-out 4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.39, 1.30]
5.2 Later fracture of femur 4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.24, 2.84]
5.3 Implant breakage 3 754 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.21]
5.4
Non-union/pseudoarthrosis
3 754 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.14, 2.50]
5.5 Secondary varus (> 10%) 1 250 Risk Ratio (M-H, Fixed, 95% CI) 4.5 [0.99, 20.41]
5.6 Fracture site collapse due
to screw migration
1 250 Risk Ratio (M-H, Fixed, 95% CI) 2.5 [0.81, 7.76]
5.7 Medial or lateral hip screw
migration
1 424 Risk Ratio (M-H, Fixed, 95% CI) 6.06 [1.37, 26.74]
5.8 Muscle pain due to ’point
effect’
1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.17, 1.90]
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6 Re-operation 4 910 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [0.83, 1.90]
7 Wound complications 4 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Seroma 1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.51, 1.60]
7.2 Haematoma 4 910 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.62, 1.51]
7.3 Superficial infection 3 754 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.32, 1.29]
7.4 Deep infection 3 830 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.34, 2.95]
8 Post-operative complications 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8.1 Pneumonia 2 236 Risk Ratio (M-H, Fixed, 95% CI) 2.93 [0.12, 70.72]
8.2 Pressure sores 2 406 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.51, 2.30]
8.3 Deep vein thrombosis 2 236 Risk Ratio (M-H, Fixed, 95% CI) 1.65 [0.22, 12.29]
8.4 Pulmonary embolism 3 486 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.25, 8.85]
8.5 Acute post-operative
mental confusion
2 330 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.44, 1.39]
8.6 Urinary infection 2 330 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.44, 2.84]
8.7 Digestive haemorrhage 1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.10]
8.8 Acute kidney failure 1 250 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.05, 5.44]
9 Length of hospital stay (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10 Operative details: length of
surgery and blood loss
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10.2 Blood loss (mL) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Number of patients transfused 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. ACE trochanteric nail versus Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality 2 185 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.15, 6.85]
2 Final functional outcomes 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Hip pain at 1 month 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Limp 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Difficulty in squatting 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Mobility score (0: no difficulties
to 9: most difficulties)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Harris hip score (1 to 100: high
values = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 At 4 months 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 At 1 year 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 At 2 years 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Fracture healing complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Operative fracture of
femur
2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Later fracture of femur 2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Cut-out 2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.14]
5.4 Non-union 2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.5 All fracture healing
complications
2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.14]
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5.6 Re-operation 2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.34 [0.01, 8.14]
6 Wound complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 All wound infection 2 185 Risk Ratio (M-H, Fixed, 95% CI) 1.33 [0.31, 5.69]
6.2 Deep wound infection 2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Post-operative complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Deep vein thrombosis 2 185 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.01]
7.2 All medical complications 1 88 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [0.67, 2.27]
8 Anatomical restoration 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 Shortening (1 cm or more) 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Operative details: length
of surgery, blood loss and
radiographic screening time
2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Operative blood loss (mls) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 Units of blood transfused 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.4 Radiographic screening
time (minutes)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Number of patients transfused 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 3. ACE trochanteric nail versus the Gamma 3 nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Fracture healing complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Fixation failure (cut-out
or redisplacement)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Non-union 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Post-operative complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Deep vein thrombosis 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Peripheral nerve injury 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 4. Gliding nail versus Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality at 6 months 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Residence and unfavourable
outcome (geriatric institution
or death) at 6 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Living in a geriatric
institution
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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2.2 Unfavourable outcome
(institutionalised or dead)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Operative fracture of
femur
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Later fracture of femur 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Technical complications
of fixation
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.5 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Post-operative complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 Participants with a
complication
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Pressure sores (decubitus) 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Pneumonia 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 Cerebrovascular accident 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.5 Apoplexy 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.6 Forearm fracture 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Anatomical deformity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 Leg shortening > 2 cm 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 External rotation > 20
degrees
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Internal rotation > 20
degrees
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 5. ENDOVIS nail versus intramedullary hip screw (IMHS)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Unable to walk (bedridden)
post-operatively
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Mortality 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 During hospital stay 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 At 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Joint penetration 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Periprosthetic fracture 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Nail breakage 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.5 MIssed proximal hole 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.6 Misplaced proximal screws 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.7 Failure of distal locking 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.8 Z-phenomenon 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.9 Reverse Z-phenomenon 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.10 Proximal screw back-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.11 Femoral shaft
medialization
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.12 Femoral shaft fracture 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.13 Infection 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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3.14 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Number of patients transfused 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 6. Russell-Taylor Recon nail versus long Gamma nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Final outcome measures 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Mortality 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Non-independent
ambulator
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Unable to do the same
work
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Fracture healing and wound
healing complications
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Operative fracture of
femur
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Later fracture of femur 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 Non-union 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.5 All fracture healing
complications
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.6 Wound infection (any
type)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.7 Deep wound infection 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.8 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 7. PFNA versus Targon PF nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Femoral neck cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Re-operation to change
femoral neck components
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Periprosthetic fracture 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Implant breakage 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Fracture nonunion 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.6 Infection (superficial) 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
67Intramedullary nails for extracapsular hip fractures in adults (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 8. PFNA versus Gamma 3 nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality (12 months) 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Harris hip score (1 to 100;
higher values = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 6 months post-operative
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 12 months post-operative
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Mobility at 12+ months (Parker
and Palmer mobility score: 0 to
9: best)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Recovery of pre-operative
mobility (12+ months)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5 SF-36 Physical Health (0 to 100;
higher scores = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 6 months post-operative
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 12 months post-operative
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 SF-36 Mental Health (0 to 100;
higher scores = best function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 6 months post-operative
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 12 months post-operative
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Katz ADL score at 12 months
(0 to 6; higher score = best
function)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8 Range of hip flexion (degrees) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
9 Thigh pain at 12 months
(Numeric pain scale, 1 to 10,
higher scores = most pain)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
10 Hip or thigh pain (12+ months) 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11 Fracture fixation complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 Intra-operative femoral
shaft fracture
2 197 Risk Ratio (M-H, Fixed, 95% CI) 2.12 [0.20, 22.85]
11.2 Cut-out 2 197 Risk Ratio (M-H, Fixed, 95% CI) 4.84 [0.24, 96.89]
11.3 Later femoral shaft
fracture
2 197 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.15, 6.92]
11.4 Deep wound infection 1 61 Risk Ratio (M-H, Fixed, 95% CI) 4.84 [0.24, 96.89]
11.5 Superficial wound
infection
2 197 Risk Ratio (M-H, Fixed, 95% CI) 2.39 [0.36, 15.92]
11.6 Wound haematoma 2 197 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.27, 2.21]
11.7 Proximal screw/blade
migration
1 136 Risk Ratio (M-H, Fixed, 95% CI) 2.12 [0.55, 8.14]
11.8 Delayed healing 1 61 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.31, 3.01]
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11.9 Non-union 2 197 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.26, 8.09]
11.10 Implant breakage 1 61 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.01, 7.63]
11.11 Failure of fixation 1 61 Risk Ratio (M-H, Fixed, 95% CI) 2.26 [0.64, 7.93]
12 Post-operative complications 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
12.1 Number with “general”
complications (mainly need for
transfusion)
1 61 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.60, 1.56]
12.2 Chest infection 1 136 Risk Ratio (M-H, Fixed, 95% CI) 1.33 [0.37, 4.73]
12.3 Decubitus ulcer 1 136 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.15, 7.31]
12.4 Urinary tract infection 1 136 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.15, 7.31]
13 Sangha Score at 1 year (1
to 6; higher score = more
comorbidity)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
14 Length of stay (days) 2 197 Mean Difference (IV, Fixed, 95% CI) -0.17 [-0.63, 0.29]
15 Femoral shortening 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
16 Operative details 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
16.1 Operating time
(minutes)
2 197 Mean Difference (IV, Fixed, 95% CI) -3.03 [-6.88, 0.82]
16.2 Fluoroscopy time
(minutes)
1 136 Mean Difference (IV, Fixed, 95% CI) -0.5 [-0.88, -0.12]
16.3 Intra-operative blood
loss (mL)
1 136 Mean Difference (IV, Fixed, 95% CI) -55.30 [-94.70, -15.
90]
17 Number of patients transfused 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 9. Dynamic versus static locked intramedullary nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain and cortical hypertrophy 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Mid-thigh pain 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Cortical hypertrophy 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Later fracture of the femur 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Technical complications
of fixation
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Leg shortening (mm) in those
able to undergo a radiographic
assessment
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5 Operative details 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 Length of surgery
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Intra-operative blood loss
(minutes)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Haemoglobin level: 48
hours post-op (g/dL)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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5.4 Transfused packed blood
cells
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 10. Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Harris hip score (0 to 100: high
values = best function)
1 80 Mean Difference (IV, Fixed, 95% CI) -1.27 [-4.98, 2.43]
1.1 Group A (AO A1.1, 1.2,
1.3)
1 11 Mean Difference (IV, Fixed, 95% CI) -2.25 [-10.07, 5.57]
1.2 Group B (AO A2.1) 1 28 Mean Difference (IV, Fixed, 95% CI) -0.80 [-8.24, 6.64]
1.3 Group C (AO A2.2, 2.3) 1 41 Mean Difference (IV, Fixed, 95% CI) -1.08 [-6.19, 4.03]
2 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Femoral shaft fracture
(timing not known)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Non-union at 6 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 Non-union at 12 months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Average healing time (months) 1 80 Mean Difference (IV, Fixed, 95% CI) -0.06 [-0.55, 0.43]
3.1 Group A (AO
A1.1,1.2,1.3)
1 11 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.84, 0.84]
3.2 Group B (AO, A2.1) 1 28 Mean Difference (IV, Fixed, 95% CI) 0.0 [-0.65, 0.65]
3.3 Group C (AO, A2.2,2.3) 1 41 Mean Difference (IV, Fixed, 95% CI) -0.62 [-2.25, 1.01]
4 Operative details 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Operation time (mins) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Intra-operative blood loss
(mL)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Length of stay (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6 Leg length discrepancy (mm)
(’Group C’ - unstable fractures
- only)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 11. InterTan nail versus the PFNA II nail
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality (1 year) 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Final functional outcomes 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Harris hip score (1 to 100;
high values = best function)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Walking ability score (0 to
9; high value = best function)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Hip and thigh pain 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Hip pain 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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3.2 Thigh pain 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 Cutout 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Femoral shaft fracture
(post-operative)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Femoral shaft fracture
(intra-operative)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 Lateral greater trochanter
fracture
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.5 Proximal end of nail
penetrating trochanter
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.6 Distal interlocking
problem
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.7 Blade migration 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.8 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Time to fracture healing (weeks) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6 Post-operative complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 Superficial wound
infection
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Deep infection 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Deep venous thrombosis 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.4 Pulmonary embolism 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.5 Pressure sore 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.6 Urinary tract infection 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Length of stay (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8 Operative details 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 Operative time (min) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Blood loss (mL) 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Fluoroscopy time
(seconds)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 12. Long versus standard proximal femoral nail antirotation (PFNA nail)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Mortality (1 year) 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Final functional outcomes 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Harris hip score (1 to 100,
top score = best function)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Parker and Palmer
mobility score (0 to 9, top score
= best function)
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Fracture fixation complications 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Re-operation 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Blade cut-out 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Wound infection (deep) 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Wound infection
(superficial)
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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3.5 Non-union 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.6 Malunion 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 1 Mortality.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 1 Mortality
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 At 4 months
Schipper 2004 39/211 31/213 100.0 % 1.27 [ 0.82, 1.96 ]
Subtotal (95% CI) 211 213 100.0 % 1.27 [ 0.82, 1.96 ]
Total events: 39 (PFN), 31 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
2 At 12 months
Herrera 2002 29/125 24/125 30.0 % 1.21 [ 0.75, 1.95 ]
Marques 2005 11/79 14/77 17.7 % 0.77 [ 0.37, 1.58 ]
Schipper 2004 46/211 42/213 52.3 % 1.11 [ 0.76, 1.60 ]
Subtotal (95% CI) 415 415 100.0 % 1.08 [ 0.82, 1.41 ]
Total events: 86 (PFN), 80 (Gamma nail)
Heterogeneity: Chi2 = 1.09, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
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Analysis 1.2. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 2 Final functional
outcomes.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 2 Final functional outcomes
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pain at follow up
Marques 2005 6/79 14/77 0.42 [ 0.17, 1.03 ]
2 Symptoms or restriction from the hip
Schipper 2004 16/73 16/67 0.92 [ 0.50, 1.69 ]
3 Incomplete recovery of walking ability (including death)
Herrera 2002 63/125 61/125 1.03 [ 0.80, 1.33 ]
0.01 0.1 1 10 100
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Analysis 1.3. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 3 Harris hip scores
(0 to 100: high values = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 3 Harris hip scores (0 to 100: high values = best function)
Study or subgroup PFN Gamma nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At 4 weeks
Schipper 2004 140 52.6 (17.8) 139 53.9 (17.17) -1.30 [ -5.40, 2.80 ]
2 At 4 months
Schipper 2004 133 61.9 (18.45) 130 62 (19.38) -0.10 [ -4.67, 4.47 ]
3 At 1 year
Schipper 2004 73 66.8 (17.94) 64 69.5 (16) -2.70 [ -8.38, 2.98 ]
-10 -5 0 5 10
Favours Gamma Favours PFN
73Intramedullary nails for extracapsular hip fractures in adults (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.4. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 4 Intra-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 4 Intra-operative complications
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Changed method of fixation
Schipper 2004 3/211 4/213 100.0 % 0.76 [ 0.17, 3.34 ]
Subtotal (95% CI) 211 213 100.0 % 0.76 [ 0.17, 3.34 ]
Total events: 3 (PFN), 4 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
2 Open reduction
Schipper 2004 17/211 8/213 100.0 % 2.15 [ 0.95, 4.86 ]
Subtotal (95% CI) 211 213 100.0 % 2.15 [ 0.95, 4.86 ]
Total events: 17 (PFN), 8 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.068)
3 Poor reduction
Papasimos 2005 2/40 2/40 50.1 % 1.00 [ 0.15, 6.76 ]
Schipper 2004 6/211 2/213 49.9 % 3.03 [ 0.62, 14.83 ]
Subtotal (95% CI) 251 253 100.0 % 2.01 [ 0.62, 6.57 ]
Total events: 8 (PFN), 4 (Gamma nail)
Heterogeneity: Chi2 = 0.77, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
4 Difficult surgery
Papasimos 2005 14/40 9/40 27.4 % 1.56 [ 0.76, 3.18 ]
Schipper 2004 34/211 24/213 72.6 % 1.43 [ 0.88, 2.33 ]
Subtotal (95% CI) 251 253 100.0 % 1.46 [ 0.98, 2.19 ]
Total events: 48 (PFN), 33 (Gamma nail)
Heterogeneity: Chi2 = 0.04, df = 1 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 1.85 (P = 0.064)
5 Difficult proximal or distal screw insertion
0.005 0.1 1 10 200
Favours PFN Favours Gamma
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(. . . Continued)
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Schipper 2004 7/211 7/213 100.0 % 1.01 [ 0.36, 2.83 ]
Subtotal (95% CI) 211 213 100.0 % 1.01 [ 0.36, 2.83 ]
Total events: 7 (PFN), 7 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.99)
6 Intra-operative comminution of the fracture around the trochanteric region
Herrera 2002 5/125 19/125 95.0 % 0.26 [ 0.10, 0.68 ]
Papasimos 2005 1/40 1/40 5.0 % 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 165 165 100.0 % 0.30 [ 0.12, 0.73 ]
Total events: 6 (PFN), 20 (Gamma nail)
Heterogeneity: Chi2 = 0.82, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.67 (P = 0.0076)
7 Operative fracture of the femur
Herrera 2002 0/125 0/125 Not estimable
Marques 2005 1/79 2/77 33.7 % 0.49 [ 0.05, 5.26 ]
Papasimos 2005 0/40 1/40 24.9 % 0.33 [ 0.01, 7.95 ]
Schipper 2004 0/211 2/213 41.4 % 0.20 [ 0.01, 4.18 ]
Subtotal (95% CI) 455 455 100.0 % 0.33 [ 0.07, 1.63 ]
Total events: 1 (PFN), 5 (Gamma nail)
Heterogeneity: Chi2 = 0.20, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.36 (P = 0.17)
8 Suboptimal position of fixation devices
Schipper 2004 34/211 28/213 100.0 % 1.23 [ 0.77, 1.95 ]
Subtotal (95% CI) 211 213 100.0 % 1.23 [ 0.77, 1.95 ]
Total events: 34 (PFN), 28 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
0.005 0.1 1 10 200
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Analysis 1.5. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 5 Fracture healing
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 5 Fracture healing complications
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Cut-out
Herrera 2002 1/125 5/125 20.8 % 0.20 [ 0.02, 1.69 ]
Marques 2005 4/79 4/77 16.9 % 0.97 [ 0.25, 3.76 ]
Papasimos 2005 1/40 2/40 8.3 % 0.50 [ 0.05, 5.30 ]
Schipper 2004 11/211 13/213 53.9 % 0.85 [ 0.39, 1.86 ]
Subtotal (95% CI) 455 455 100.0 % 0.71 [ 0.39, 1.30 ]
Total events: 17 (PFN), 24 (Gamma nail)
Heterogeneity: Chi2 = 1.87, df = 3 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.11 (P = 0.27)
2 Later fracture of femur
Herrera 2002 0/125 4/125 81.9 % 0.11 [ 0.01, 2.04 ]
Marques 2005 0/79 0/77 Not estimable
Papasimos 2005 0/40 0/40 Not estimable
Schipper 2004 4/211 1/213 18.1 % 4.04 [ 0.46, 35.83 ]
Subtotal (95% CI) 455 455 100.0 % 0.82 [ 0.24, 2.84 ]
Total events: 4 (PFN), 5 (Gamma nail)
Heterogeneity: Chi2 = 3.86, df = 1 (P = 0.05); I2 =74%
Test for overall effect: Z = 0.31 (P = 0.76)
3 Implant breakage
Herrera 2002 0/125 0/125 Not estimable
Papasimos 2005 0/40 0/40 Not estimable
Schipper 2004 0/211 1/213 100.0 % 0.34 [ 0.01, 8.21 ]
Subtotal (95% CI) 376 378 100.0 % 0.34 [ 0.01, 8.21 ]
Total events: 0 (PFN), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
4 Non-union/pseudoarthrosis
Herrera 2002 2/125 1/125 20.0 % 2.00 [ 0.18, 21.78 ]
Papasimos 2005 0/40 1/40 30.1 % 0.33 [ 0.01, 7.95 ]
Schipper 2004 0/211 2/213 49.9 % 0.20 [ 0.01, 4.18 ]
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(. . . Continued)
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 376 378 100.0 % 0.60 [ 0.14, 2.50 ]
Total events: 2 (PFN), 4 (Gamma nail)
Heterogeneity: Chi2 = 1.60, df = 2 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.70 (P = 0.49)
5 Secondary varus (> 10%)
Herrera 2002 9/125 2/125 100.0 % 4.50 [ 0.99, 20.41 ]
Subtotal (95% CI) 125 125 100.0 % 4.50 [ 0.99, 20.41 ]
Total events: 9 (PFN), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.051)
6 Fracture site collapse due to screw migration
Herrera 2002 10/125 4/125 100.0 % 2.50 [ 0.81, 7.76 ]
Subtotal (95% CI) 125 125 100.0 % 2.50 [ 0.81, 7.76 ]
Total events: 10 (PFN), 4 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.59 (P = 0.11)
7 Medial or lateral hip screw migration
Schipper 2004 12/211 2/213 100.0 % 6.06 [ 1.37, 26.74 ]
Subtotal (95% CI) 211 213 100.0 % 6.06 [ 1.37, 26.74 ]
Total events: 12 (PFN), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 2.38 (P = 0.017)
8 Muscle pain due to ’point effect’
Herrera 2002 4/125 7/125 100.0 % 0.57 [ 0.17, 1.90 ]
Subtotal (95% CI) 125 125 100.0 % 0.57 [ 0.17, 1.90 ]
Total events: 4 (PFN), 7 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
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Analysis 1.6. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 6 Re-operation.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 6 Re-operation
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Herrera 2002 6/125 9/125 25.0 % 0.67 [ 0.24, 1.82 ]
Marques 2005 5/79 3/77 8.5 % 1.62 [ 0.40, 6.56 ]
Papasimos 2005 5/40 3/40 8.3 % 1.67 [ 0.43, 6.51 ]
Schipper 2004 29/211 21/213 58.2 % 1.39 [ 0.82, 2.36 ]
Total (95% CI) 455 455 100.0 % 1.25 [ 0.83, 1.90 ]
Total events: 45 (PFN), 36 (Gamma nail)
Heterogeneity: Chi2 = 1.98, df = 3 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 7 Wound
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 7 Wound complications
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Seroma
Herrera 2002 19/125 21/125 100.0 % 0.90 [ 0.51, 1.60 ]
Subtotal (95% CI) 125 125 100.0 % 0.90 [ 0.51, 1.60 ]
Total events: 19 (PFN), 21 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
2 Haematoma
Herrera 2002 17/125 13/125 36.0 % 1.31 [ 0.66, 2.58 ]
Marques 2005 8/79 11/77 30.9 % 0.71 [ 0.30, 1.67 ]
Papasimos 2005 3/40 2/40 5.5 % 1.50 [ 0.26, 8.50 ]
Schipper 2004 7/211 10/213 27.6 % 0.71 [ 0.27, 1.82 ]
Subtotal (95% CI) 455 455 100.0 % 0.97 [ 0.62, 1.51 ]
Total events: 35 (PFN), 36 (Gamma nail)
Heterogeneity: Chi2 = 1.94, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.15 (P = 0.88)
3 Superficial infection
Herrera 2002 3/125 4/125 20.6 % 0.75 [ 0.17, 3.28 ]
Papasimos 2005 1/40 0/40 2.6 % 3.00 [ 0.13, 71.51 ]
Schipper 2004 8/211 15/213 76.8 % 0.54 [ 0.23, 1.24 ]
Subtotal (95% CI) 376 378 100.0 % 0.65 [ 0.32, 1.29 ]
Total events: 12 (PFN), 19 (Gamma nail)
Heterogeneity: Chi2 = 1.12, df = 2 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.22)
4 Deep infection
Herrera 2002 1/125 0/125 7.7 % 3.00 [ 0.12, 72.94 ]
Marques 2005 0/79 0/77 Not estimable
Schipper 2004 5/211 6/213 92.3 % 0.84 [ 0.26, 2.71 ]
Subtotal (95% CI) 415 415 100.0 % 1.01 [ 0.34, 2.95 ]
Total events: 6 (PFN), 6 (Gamma nail)
Heterogeneity: Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
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Analysis 1.8. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 8 Post-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 8 Post-operative complications
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pneumonia
Marques 2005 1/79 0/77 100.0 % 2.93 [ 0.12, 70.72 ]
Papasimos 2005 0/40 0/40 Not estimable
Subtotal (95% CI) 119 117 100.0 % 2.93 [ 0.12, 70.72 ]
Total events: 1 (PFN), 0 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
2 Pressure sores
Herrera 2002 11/125 9/125 74.8 % 1.22 [ 0.52, 2.85 ]
Marques 2005 2/79 3/77 25.2 % 0.65 [ 0.11, 3.78 ]
Subtotal (95% CI) 204 202 100.0 % 1.08 [ 0.51, 2.30 ]
Total events: 13 (PFN), 12 (Gamma nail)
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
3 Deep vein thrombosis
Marques 2005 1/79 0/77 33.6 % 2.93 [ 0.12, 70.72 ]
Papasimos 2005 1/40 1/40 66.4 % 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 119 117 100.0 % 1.65 [ 0.22, 12.29 ]
Total events: 2 (PFN), 1 (Gamma nail)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.49 (P = 0.63)
4 Pulmonary embolism
Herrera 2002 2/125 1/125 50.0 % 2.00 [ 0.18, 21.78 ]
Marques 2005 0/79 0/77 Not estimable
Papasimos 2005 1/40 1/40 50.0 % 1.00 [ 0.06, 15.44 ]
Subtotal (95% CI) 244 242 100.0 % 1.50 [ 0.25, 8.85 ]
Total events: 3 (PFN), 2 (Gamma nail)
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
5 Acute post-operative mental confusion
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(. . . Continued)
Study or subgroup PFN Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Herrera 2002 15/125 20/125 87.0 % 0.75 [ 0.40, 1.40 ]
Papasimos 2005 3/40 3/40 13.0 % 1.00 [ 0.21, 4.66 ]
Subtotal (95% CI) 165 165 100.0 % 0.78 [ 0.44, 1.39 ]
Total events: 18 (PFN), 23 (Gamma nail)
Heterogeneity: Chi2 = 0.12, df = 1 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.40)
6 Urinary infection
Herrera 2002 8/125 6/125 75.0 % 1.33 [ 0.48, 3.73 ]
Papasimos 2005 1/40 2/40 25.0 % 0.50 [ 0.05, 5.30 ]
Subtotal (95% CI) 165 165 100.0 % 1.13 [ 0.44, 2.84 ]
Total events: 9 (PFN), 8 (Gamma nail)
Heterogeneity: Chi2 = 0.56, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.80)
7 Digestive haemorrhage
Herrera 2002 0/125 1/125 100.0 % 0.33 [ 0.01, 8.10 ]
Subtotal (95% CI) 125 125 100.0 % 0.33 [ 0.01, 8.10 ]
Total events: 0 (PFN), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
8 Acute kidney failure
Herrera 2002 1/125 2/125 100.0 % 0.50 [ 0.05, 5.44 ]
Subtotal (95% CI) 125 125 100.0 % 0.50 [ 0.05, 5.44 ]
Total events: 1 (PFN), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
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Analysis 1.9. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 9 Length of hospital
stay (days).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 9 Length of hospital stay (days)
Study or subgroup PFN Gamma
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Schipper 2004 211 21.7 (20.34) 213 19 (17.51) 2.70 [ -0.91, 6.31 ]
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Analysis 1.10. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 10 Operative
details: length of surgery and blood loss.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 10 Operative details: length of surgery and blood loss
Study or subgroup PFN Gamma nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Schipper 2004 211 60 (29.05) 213 60 (29.19) 0.0 [ -5.54, 5.54 ]
2 Blood loss (mL)
Schipper 2004 211 220 (199.84) 213 287 (262.7) -67.00 [ -111.40, -22.60 ]
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Analysis 1.11. Comparison 1 Proximal femoral nail (PFN) versus Gamma nail, Outcome 11 Number of
patients transfused.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 1 Proximal femoral nail (PFN) versus Gamma nail
Outcome: 11 Number of patients transfused
Study or subgroup PFN Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Herrera 2002 65/125 47/125 1.38 [ 1.04, 1.83 ]
Marques 2005 29/79 41/77 0.69 [ 0.48, 0.99 ]
0.2 0.5 1 2 5
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Analysis 2.1. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 1 Mortality.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 1 Mortality
Study or subgroup ACE nail Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Efstathopoulos 2007 2/56 2/56 100.0 % 1.00 [ 0.15, 6.85 ]
Vidyadhara 2007 0/36 0/37 Not estimable
Total (95% CI) 92 93 100.0 % 1.00 [ 0.15, 6.85 ]
Total events: 2 (ACE nail), 2 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 2.2. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 2 Final functional
outcomes.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 2 Final functional outcomes
Study or subgroup ACE nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Hip pain at 1 month
Vidyadhara 2007 2/36 4/37 0.51 [ 0.10, 2.63 ]
2 Limp
Vidyadhara 2007 2/36 3/37 0.69 [ 0.12, 3.86 ]
3 Difficulty in squatting
Vidyadhara 2007 11/36 10/37 1.13 [ 0.55, 2.33 ]
0.01 0.1 1 10 100
Favours ACE nail Favours Gamma nail
Analysis 2.3. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 3 Mobility score (0: no
difficulties to 9: most difficulties).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 3 Mobility score (0: no difficulties to 9: most difficulties)
Study or subgroup ACE nail Gamma nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Efstathopoulos 2007 47 7.1 (2.5) 41 7 (2.1) 0.10 [ -0.86, 1.06 ]
-10 -5 0 5 10
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Analysis 2.4. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 4 Harris hip score (1 to
100: high values = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 4 Harris hip score (1 to 100: high values = best function)
Study or subgroup ACE nail Gamma nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 At 4 months
Vidyadhara 2007 36 93 (3) 37 91 (2) 2.00 [ 0.83, 3.17 ]
2 At 1 year
Vidyadhara 2007 36 96 (1) 37 95 (2) 1.00 [ 0.28, 1.72 ]
3 At 2 years
Vidyadhara 2007 36 95 (1) 37 94 (2) 1.00 [ 0.28, 1.72 ]
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Analysis 2.5. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 5 Fracture healing
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 5 Fracture healing complications
Study or subgroup ACE nail Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 0/37 Not estimable
Subtotal (95% CI) 92 93 Not estimable
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Later fracture of femur
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 0/37 Not estimable
Subtotal (95% CI) 92 93 Not estimable
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Cut-out
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 1/37 100.0 % 0.34 [ 0.01, 8.14 ]
Subtotal (95% CI) 92 93 100.0 % 0.34 [ 0.01, 8.14 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
4 Non-union
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 0/37 Not estimable
Subtotal (95% CI) 92 93 Not estimable
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 All fracture healing complications
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 1/37 100.0 % 0.34 [ 0.01, 8.14 ]
0.01 0.1 1 10 100
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(. . . Continued)
Study or subgroup ACE nail Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 92 93 100.0 % 0.34 [ 0.01, 8.14 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
6 Re-operation
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 1/37 100.0 % 0.34 [ 0.01, 8.14 ]
Subtotal (95% CI) 92 93 100.0 % 0.34 [ 0.01, 8.14 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
0.01 0.1 1 10 100
Favours ACE nail Favours Gamma nail
Analysis 2.6. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 6 Wound complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 6 Wound complications
Study or subgroup ACE nail Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 All wound infection
Efstathopoulos 2007 4/56 3/56 100.0 % 1.33 [ 0.31, 5.69 ]
Vidyadhara 2007 0/36 0/37 Not estimable
Subtotal (95% CI) 92 93 100.0 % 1.33 [ 0.31, 5.69 ]
Total events: 4 (ACE nail), 3 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
2 Deep wound infection
Efstathopoulos 2007 0/56 0/56 Not estimable
Vidyadhara 2007 0/36 0/37 Not estimable
0.01 0.1 1 10 100
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Study or subgroup ACE nail Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 92 93 Not estimable
Total events: 0 (ACE nail), 0 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: not applicable
0.01 0.1 1 10 100
Favours ACE nail Favours Gamma nail
Analysis 2.7. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 7 Post-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 7 Post-operative complications
Study or subgroup ACE nail Gamma nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Deep vein thrombosis
Efstathopoulos 2007 0/56 1/56 100.0 % 0.33 [ 0.01, 8.01 ]
Vidyadhara 2007 0/36 0/37 Not estimable
Subtotal (95% CI) 92 93 100.0 % 0.33 [ 0.01, 8.01 ]
Total events: 0 (ACE nail), 1 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 All medical complications
Efstathopoulos 2007 17/47 12/41 100.0 % 1.24 [ 0.67, 2.27 ]
Subtotal (95% CI) 47 41 100.0 % 1.24 [ 0.67, 2.27 ]
Total events: 17 (ACE nail), 12 (Gamma nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
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Analysis 2.8. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 8 Anatomical restoration.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 8 Anatomical restoration
Study or subgroup ACE nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Shortening (1 cm or more)
Vidyadhara 2007 1/36 2/37 0.51 [ 0.05, 5.42 ]
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Analysis 2.9. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 9 Operative details: length
of surgery, blood loss and radiographic screening time.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 9 Operative details: length of surgery, blood loss and radiographic screening time
Study or subgroup ACE nail Gamma nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Efstathopoulos 2007 56 54 (15) 56 51 (11) 3.00 [ -1.87, 7.87 ]
2 Operative blood loss (mls)
Vidyadhara 2007 36 63 (12) 37 50 (15) 13.00 [ 6.78, 19.22 ]
3 Units of blood transfused
Efstathopoulos 2007 56 2 (1.7) 56 2.3 (1.6) -0.30 [ -0.91, 0.31 ]
4 Radiographic screening time (minutes)
Efstathopoulos 2007 56 2.5 (1.7) 56 2.2 (1.8) 0.30 [ -0.35, 0.95 ]
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Analysis 2.10. Comparison 2 ACE trochanteric nail versus Gamma nail, Outcome 10 Number of patients
transfused.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 2 ACE trochanteric nail versus Gamma nail
Outcome: 10 Number of patients transfused
Study or subgroup ACE nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Efstathopoulos 2007 49/56 42/56 1.17 [ 0.97, 1.40 ]
0.5 0.7 1 1.5 2
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Analysis 3.1. Comparison 3 ACE trochanteric nail versus the Gamma 3 nail, Outcome 1 Mortality at 1 year.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 ACE trochanteric nail versus the Gamma 3 nail
Outcome: 1 Mortality at 1 year
Study or subgroup ACE nail Gamma 3 nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
De Grave 2012 12/51 14/61 1.03 [ 0.52, 2.01 ]
0.05 0.2 1 5 20
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Analysis 3.2. Comparison 3 ACE trochanteric nail versus the Gamma 3 nail, Outcome 2 Fracture healing
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 ACE trochanteric nail versus the Gamma 3 nail
Outcome: 2 Fracture healing complications
Study or subgroup ACE nail Gamma 3 nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Fixation failure (cut-out or redisplacement)
De Grave 2012 2/51 2/61 1.20 [ 0.17, 8.19 ]
2 Non-union
De Grave 2012 0/51 0/61 Not estimable
3 Wound infection
De Grave 2012 0/51 0/61 Not estimable
4 Re-operation
De Grave 2012 (1) 2/51 2/61 1.20 [ 0.17, 8.19 ]
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(1) All reoperations involved hip arthroplasty
91Intramedullary nails for extracapsular hip fractures in adults (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.3. Comparison 3 ACE trochanteric nail versus the Gamma 3 nail, Outcome 3 Post-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 3 ACE trochanteric nail versus the Gamma 3 nail
Outcome: 3 Post-operative complications
Study or subgroup ACE nail Gamma 3 nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Deep vein thrombosis
De Grave 2012 0/51 0/61 Not estimable
2 Peripheral nerve injury
De Grave 2012 (1) 0/51 1/61 0.40 [ 0.02, 9.55 ]
0.001 0.01 0.1 1 10 100 1000
Favours ACE nail Favours Gamma 3 nail
(1) This resulted in ’foot drop’
Analysis 4.1. Comparison 4 Gliding nail versus Gamma nail, Outcome 1 Mortality at 6 months.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Gliding nail versus Gamma nail
Outcome: 1 Mortality at 6 months
Study or subgroup Favours gliding Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Fritz 1999 5/40 6/40 0.83 [ 0.28, 2.51 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 4.2. Comparison 4 Gliding nail versus Gamma nail, Outcome 2 Residence and unfavourable
outcome (geriatric institution or death) at 6 months.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Gliding nail versus Gamma nail
Outcome: 2 Residence and unfavourable outcome (geriatric institution or death) at 6 months
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Living in a geriatric institution
Fritz 1999 14/34 19/34 0.74 [ 0.45, 1.22 ]
2 Unfavourable outcome (institutionalised or dead)
Fritz 1999 20/40 24/40 0.83 [ 0.56, 1.24 ]
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Analysis 4.3. Comparison 4 Gliding nail versus Gamma nail, Outcome 3 Fracture fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Gliding nail versus Gamma nail
Outcome: 3 Fracture fixation complications
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
2 Later fracture of femur
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
3 Cut-out
Fritz 1999 0/40 3/40 0.14 [ 0.01, 2.68 ]
4 Technical complications of fixation
Fritz 1999 2/40 3/40 0.67 [ 0.12, 3.78 ]
5 Re-operation
Fritz 1999 3/40 4/40 0.75 [ 0.18, 3.14 ]
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Analysis 4.4. Comparison 4 Gliding nail versus Gamma nail, Outcome 4 Post-operative complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Gliding nail versus Gamma nail
Outcome: 4 Post-operative complications
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Participants with a complication
Fritz 1999 9/40 6/40 1.50 [ 0.59, 3.82 ]
2 Pressure sores (decubitus)
Fritz 1999 2/40 2/40 1.00 [ 0.15, 6.76 ]
3 Pneumonia
Fritz 1999 1/40 1/40 1.00 [ 0.06, 15.44 ]
4 Cerebrovascular accident
Fritz 1999 2/40 1/40 2.00 [ 0.19, 21.18 ]
5 Apoplexy
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
6 Forearm fracture
Fritz 1999 1/40 0/40 3.00 [ 0.13, 71.51 ]
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Analysis 4.5. Comparison 4 Gliding nail versus Gamma nail, Outcome 5 Anatomical deformity.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 4 Gliding nail versus Gamma nail
Outcome: 5 Anatomical deformity
Study or subgroup Gliding nail Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Leg shortening > 2 cm
Fritz 1999 1/34 3/34 0.33 [ 0.04, 3.05 ]
2 External rotation > 20 degrees
Fritz 1999 0/34 0/34 Not estimable
3 Internal rotation > 20 degrees
Fritz 1999 2/34 2/34 1.00 [ 0.15, 6.70 ]
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Analysis 5.1. Comparison 5 ENDOVIS nail versus intramedullary hip screw (IMHS), Outcome 1 Unable to
walk (bedridden) post-operatively.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 ENDOVIS nail versus intramedullary hip screw (IMHS)
Outcome: 1 Unable to walk (bedridden) post-operatively
Study or subgroup ENDOVIS IMHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Makridis 2010 29/105 18/110 1.69 [ 1.00, 2.85 ]
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Analysis 5.2. Comparison 5 ENDOVIS nail versus intramedullary hip screw (IMHS), Outcome 2 Mortality.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 ENDOVIS nail versus intramedullary hip screw (IMHS)
Outcome: 2 Mortality
Study or subgroup ENDOVIS IMHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 During hospital stay
Makridis 2010 3/105 2/110 1.57 [ 0.27, 9.22 ]
2 At 1 year
Makridis 2010 16/105 17/110 0.99 [ 0.53, 1.85 ]
0.01 0.1 1 10 100
Favours ENDOVIS Favours IMHS
Analysis 5.3. Comparison 5 ENDOVIS nail versus intramedullary hip screw (IMHS), Outcome 3 Fracture
fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 ENDOVIS nail versus intramedullary hip screw (IMHS)
Outcome: 3 Fracture fixation complications
Study or subgroup ENDOVIS IMHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Joint penetration
Makridis 2010 3/105 0/110 7.33 [ 0.38, 140.22 ]
2 Periprosthetic fracture
Makridis 2010 0/105 1/110 0.35 [ 0.01, 8.47 ]
3 Nail breakage
Makridis 2010 1/105 1/110 1.05 [ 0.07, 16.53 ]
4 Cut-out
Makridis 2010 3/105 1/110 3.14 [ 0.33, 29.74 ]
5 MIssed proximal hole
0.01 0.1 1 10 100
Favours ENDOVIS Favours IMHS
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Study or subgroup ENDOVIS IMHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Makridis 2010 2/105 0/110 5.24 [ 0.25, 107.79 ]
6 Misplaced proximal screws
Makridis 2010 8/105 1/110 8.38 [ 1.07, 65.86 ]
7 Failure of distal locking
Makridis 2010 4/105 1/110 4.19 [ 0.48, 36.88 ]
8 Z-phenomenon
Makridis 2010 1/105 0/110 3.14 [ 0.13, 76.27 ]
9 Reverse Z-phenomenon
Makridis 2010 1/105 0/110 3.14 [ 0.13, 76.27 ]
10 Proximal screw back-out
Makridis 2010 5/105 0/110 11.52 [ 0.64, 205.77 ]
11 Femoral shaft medialization
Makridis 2010 5/105 0/110 11.52 [ 0.64, 205.77 ]
12 Femoral shaft fracture
Makridis 2010 0/105 1/110 0.35 [ 0.01, 8.47 ]
13 Infection
Makridis 2010 2/105 2/110 1.05 [ 0.15, 7.30 ]
14 Re-operation
Makridis 2010 (1) 5/105 2/110 2.62 [ 0.52, 13.21 ]
0.01 0.1 1 10 100
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(1) ENDOVIS: cut-out (3); Z-phenomena (2); IMHS: cut-out (1); shaft fracture (1)
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Analysis 5.4. Comparison 5 ENDOVIS nail versus intramedullary hip screw (IMHS), Outcome 4 Number of
patients transfused.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 5 ENDOVIS nail versus intramedullary hip screw (IMHS)
Outcome: 4 Number of patients transfused
Study or subgroup ENDOVIS IMHS Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Makridis 2010 28/105 29/110 1.01 [ 0.65, 1.58 ]
0.2 0.5 1 2 5
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Analysis 6.1. Comparison 6 Russell-Taylor Recon nail versus long Gamma nail, Outcome 1 Final outcome
measures.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 6 Russell-Taylor Recon nail versus long Gamma nail
Outcome: 1 Final outcome measures
Study or subgroup Recon nail Long Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mortality
Starr 2006 0/17 0/17 Not estimable
2 Non-independent ambulator
Starr 2006 0/15 1/13 0.29 [ 0.01, 6.60 ]
3 Unable to do the same work
Starr 2006 2/15 2/13 0.87 [ 0.14, 5.32 ]
0.01 0.1 1 10 100
Favours Recon nai Favours Gamma nail
98Intramedullary nails for extracapsular hip fractures in adults (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 6.2. Comparison 6 Russell-Taylor Recon nail versus long Gamma nail, Outcome 2 Fracture healing
and wound healing complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 6 Russell-Taylor Recon nail versus long Gamma nail
Outcome: 2 Fracture healing and wound healing complications
Study or subgroup Recon nail Long Gamma nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Operative fracture of femur
Starr 2006 0/17 0/17 Not estimable
2 Later fracture of femur
Starr 2006 0/17 0/17 Not estimable
3 Cut-out
Starr 2006 0/17 0/17 Not estimable
4 Non-union
Starr 2006 0/17 0/17 Not estimable
5 All fracture healing complications
Starr 2006 0/17 0/17 Not estimable
6 Wound infection (any type)
Starr 2006 0/17 1/17 0.33 [ 0.01, 7.65 ]
7 Deep wound infection
Starr 2006 0/17 0/17 Not estimable
8 Re-operation
Starr 2006 8/17 5/17 1.60 [ 0.66, 3.91 ]
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Analysis 7.1. Comparison 7 PFNA versus Targon PF nail, Outcome 1 Fracture fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 7 PFNA versus Targon PF nail
Outcome: 1 Fracture fixation complications
Study or subgroup PFNA Targon Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Femoral neck cut-out
Wild 2010 3/40 2/40 1.50 [ 0.26, 8.50 ]
2 Re-operation to change femoral neck components
Wild 2010 2/40 0/40 5.00 [ 0.25, 100.97 ]
3 Periprosthetic fracture
Wild 2010 1/40 0/40 3.00 [ 0.13, 71.51 ]
4 Implant breakage
Wild 2010 0/40 0/40 Not estimable
5 Fracture nonunion
Wild 2010 0/40 1/40 0.33 [ 0.01, 7.95 ]
6 Infection (superficial)
Wild 2010 4/40 2/40 2.00 [ 0.39, 10.31 ]
0.01 0.1 1 10 100
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Analysis 8.1. Comparison 8 PFNA versus Gamma 3 nail, Outcome 1 Mortality (12 months).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 1 Mortality (12 months)
Study or subgroup PFNA Gamma 3 nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Vaquero 2012 4/31 0/30 8.72 [ 0.49, 155.27 ]
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Analysis 8.2. Comparison 8 PFNA versus Gamma 3 nail, Outcome 2 Harris hip score (1 to 100; higher
values = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 2 Harris hip score (1 to 100; higher values = best function)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months post-operative score
Vaquero 2012 15 68 (18.7) 11 56.5 (21.5) 11.50 [ -4.34, 27.34 ]
2 12 months post-operative score
Vaquero 2012 11 72.6 (20) 10 65.1 (25.4) 7.50 [ -12.19, 27.19 ]
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Analysis 8.3. Comparison 8 PFNA versus Gamma 3 nail, Outcome 3 Mobility at 12+ months (Parker and
Palmer mobility score: 0 to 9: best).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 3 Mobility at 12+ months (Parker and Palmer mobility score: 0 to 9: best)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Xu 2010a 46 6.3 (2.03) 47 6.1 (1.37) 0.20 [ -0.51, 0.91 ]
-2 -1 0 1 2
Favours PFNA Favours Gamma 3
Analysis 8.4. Comparison 8 PFNA versus Gamma 3 nail, Outcome 4 Recovery of pre-operative mobility
(12+ months).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 4 Recovery of pre-operative mobility (12+ months)
Study or subgroup PFNA Gamma 3 nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Xu 2010a 29/46 32/47 0.93 [ 0.69, 1.24 ]
0.01 0.1 1 10 100
Favours Gamma 3 Favours PFNA
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Analysis 8.5. Comparison 8 PFNA versus Gamma 3 nail, Outcome 5 SF-36 Physical Health (0 to 100; higher
scores = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 5 SF-36 Physical Health (0 to 100; higher scores = best function)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months post-operative score
Vaquero 2012 16 36.1 (8.6) 13 32.9 (8.6) 3.20 [ -3.09, 9.49 ]
2 12 months post-operative score
Vaquero 2012 10 36.6 (12.3) 11 35 (10.8) 1.60 [ -8.34, 11.54 ]
-100 -50 0 50 100
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Analysis 8.6. Comparison 8 PFNA versus Gamma 3 nail, Outcome 6 SF-36 Mental Health (0 to 100; higher
scores = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 6 SF-36 Mental Health (0 to 100; higher scores = best function)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months post-operative score
Vaquero 2012 16 41.5 (12) 13 41.3 (8.6) 0.20 [ -7.31, 7.71 ]
2 12 months post-operative score
Vaquero 2012 10 47.8 (11.3) 11 46.3 (12.8) 1.50 [ -8.81, 11.81 ]
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Analysis 8.7. Comparison 8 PFNA versus Gamma 3 nail, Outcome 7 Katz ADL score at 12 months (0 to 6;
higher score = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 7 Katz ADL score at 12 months (0 to 6; higher score = best function)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Vaquero 2012 10 4 (2.4) 12 3.6 (2.3) 0.40 [ -1.58, 2.38 ]
-10 -5 0 5 10
Favours Gamma 3 Favours PFNA
Analysis 8.8. Comparison 8 PFNA versus Gamma 3 nail, Outcome 8 Range of hip flexion (degrees).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 8 Range of hip flexion (degrees)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Xu 2010a 46 98.3 (14.2) 47 94.9 (15.1) 3.40 [ -2.56, 9.36 ]
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Analysis 8.9. Comparison 8 PFNA versus Gamma 3 nail, Outcome 9 Thigh pain at 12 months (Numeric
pain scale, 1 to 10, higher scores = most pain).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 9 Thigh pain at 12 months (Numeric pain scale, 1 to 10, higher scores = most pain)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Vaquero 2012 10 1 (1.3) 12 1.5 (1.8) -0.50 [ -1.80, 0.80 ]
-10 -5 0 5 10
Favours PFNA Favours Gamma 3
Analysis 8.10. Comparison 8 PFNA versus Gamma 3 nail, Outcome 10 Hip or thigh pain (12+ months).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 10 Hip or thigh pain (12+ months)
Study or subgroup PFNA Gamma 3 nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Xu 2010a 19/46 11/47 1.76 [ 0.95, 3.29 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 19 (PFNA), 11 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.01 0.1 1 10 100
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Analysis 8.11. Comparison 8 PFNA versus Gamma 3 nail, Outcome 11 Fracture fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 11 Fracture fixation complications
Study or subgroup PFNA Gamma 3 nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Intra-operative femoral shaft fracture
Vaquero 2012 0/31 0/30 Not estimable
Xu 2010a 2/66 1/70 100.0 % 2.12 [ 0.20, 22.85 ]
Subtotal (95% CI) 97 100 100.0 % 2.12 [ 0.20, 22.85 ]
Total events: 2 (PFNA), 1 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.54)
2 Cut-out
Vaquero 2012 (1) 2/31 0/30 100.0 % 4.84 [ 0.24, 96.89 ]
Xu 2010a 0/66 0/70 Not estimable
Subtotal (95% CI) 97 100 100.0 % 4.84 [ 0.24, 96.89 ]
Total events: 2 (PFNA), 0 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
3 Later femoral shaft fracture
Vaquero 2012 (2) 0/31 1/30 75.8 % 0.32 [ 0.01, 7.63 ]
Xu 2010a (3) 1/66 0/70 24.2 % 3.18 [ 0.13, 76.69 ]
Subtotal (95% CI) 97 100 100.0 % 1.01 [ 0.15, 6.92 ]
Total events: 1 (PFNA), 1 (Gamma 3 nail)
Heterogeneity: Chi2 = 1.00, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
4 Deep wound infection
Vaquero 2012 (4) 2/31 0/30 100.0 % 4.84 [ 0.24, 96.89 ]
Subtotal (95% CI) 31 30 100.0 % 4.84 [ 0.24, 96.89 ]
Total events: 2 (PFNA), 0 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
5 Superficial wound infection
Vaquero 2012 1/31 0/30 34.4 % 2.91 [ 0.12, 68.66 ]
Xu 2010a 2/66 1/70 65.6 % 2.12 [ 0.20, 22.85 ]
Subtotal (95% CI) 97 100 100.0 % 2.39 [ 0.36, 15.92 ]
Total events: 3 (PFNA), 1 (Gamma 3 nail)
0.01 0.1 1 10 100
Favours PFNA Favours Gamma 3
(Continued . . . )
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(. . . Continued)
Study or subgroup PFNA Gamma 3 nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.90 (P = 0.37)
6 Wound haematoma
Vaquero 2012 0/31 1/30 20.7 % 0.32 [ 0.01, 7.63 ]
Xu 2010a 5/66 6/70 79.3 % 0.88 [ 0.28, 2.76 ]
Subtotal (95% CI) 97 100 100.0 % 0.77 [ 0.27, 2.21 ]
Total events: 5 (PFNA), 7 (Gamma 3 nail)
Heterogeneity: Chi2 = 0.35, df = 1 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.49 (P = 0.62)
7 Proximal screw/blade migration
Xu 2010a 6/66 3/70 100.0 % 2.12 [ 0.55, 8.14 ]
Subtotal (95% CI) 66 70 100.0 % 2.12 [ 0.55, 8.14 ]
Total events: 6 (PFNA), 3 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
8 Delayed healing
Vaquero 2012 5/31 5/30 100.0 % 0.97 [ 0.31, 3.01 ]
Subtotal (95% CI) 31 30 100.0 % 0.97 [ 0.31, 3.01 ]
Total events: 5 (PFNA), 5 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
9 Non-union
Vaquero 2012 3/31 2/30 100.0 % 1.45 [ 0.26, 8.09 ]
Xu 2010a 0/66 0/70 Not estimable
Subtotal (95% CI) 97 100 100.0 % 1.45 [ 0.26, 8.09 ]
Total events: 3 (PFNA), 2 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
10 Implant breakage
Vaquero 2012 (5) 0/31 1/30 100.0 % 0.32 [ 0.01, 7.63 ]
Subtotal (95% CI) 31 30 100.0 % 0.32 [ 0.01, 7.63 ]
Total events: 0 (PFNA), 1 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.48)
11 Failure of fixation
Vaquero 2012 7/31 3/30 100.0 % 2.26 [ 0.64, 7.93 ]
Subtotal (95% CI) 31 30 100.0 % 2.26 [ 0.64, 7.93 ]
Total events: 7 (PFNA), 3 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
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(1) Both re-operated
(2) Re-operated
(3) This occurred at 1 month and was treated with a plate
(4) One patient died from sepsis
(5) Re-operated
Analysis 8.12. Comparison 8 PFNA versus Gamma 3 nail, Outcome 12 Post-operative complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 12 Post-operative complications
Study or subgroup PFNA Gamma 3 nail Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Number with ”general” complications (mainly need for transfusion)
Vaquero 2012 16/31 16/30 100.0 % 0.97 [ 0.60, 1.56 ]
Subtotal (95% CI) 31 30 100.0 % 0.97 [ 0.60, 1.56 ]
Total events: 16 (PFNA), 16 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.89)
2 Chest infection
Xu 2010a 5/66 4/70 100.0 % 1.33 [ 0.37, 4.73 ]
Subtotal (95% CI) 66 70 100.0 % 1.33 [ 0.37, 4.73 ]
Total events: 5 (PFNA), 4 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.66)
3 Decubitus ulcer
Xu 2010a 2/66 2/70 100.0 % 1.06 [ 0.15, 7.31 ]
Subtotal (95% CI) 66 70 100.0 % 1.06 [ 0.15, 7.31 ]
Total events: 2 (PFNA), 2 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
4 Urinary tract infection
Xu 2010a 2/66 2/70 100.0 % 1.06 [ 0.15, 7.31 ]
Subtotal (95% CI) 66 70 100.0 % 1.06 [ 0.15, 7.31 ]
Total events: 2 (PFNA), 2 (Gamma 3 nail)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
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Analysis 8.13. Comparison 8 PFNA versus Gamma 3 nail, Outcome 13 Sangha Score at 1 year (1 to 6;
higher score = more comorbidity).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 13 Sangha Score at 1 year (1 to 6; higher score = more comorbidity)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Vaquero 2012 11 4.6 (2.8) 12 4.5 (3.2) 0.10 [ -2.35, 2.55 ]
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Analysis 8.14. Comparison 8 PFNA versus Gamma 3 nail, Outcome 14 Length of stay (days).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 14 Length of stay (days)
Study or subgroup PFNA Gamma 3 nail
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Vaquero 2012 31 11 (7) 30 10 (4) 2.6 % 1.00 [ -1.85, 3.85 ]
Xu 2010a 66 7.2 (1.62) 70 7.4 (1.07) 97.4 % -0.20 [ -0.66, 0.26 ]
Total (95% CI) 97 100 100.0 % -0.17 [ -0.63, 0.29 ]
Heterogeneity: Chi2 = 0.66, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
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Analysis 8.15. Comparison 8 PFNA versus Gamma 3 nail, Outcome 15 Femoral shortening.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 15 Femoral shortening
Study or subgroup PFNA Gamma 3 nail
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Xu 2010a 46 5.3 (2.44) 47 5.49 (2.67) -0.19 [ -1.23, 0.85 ]
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Analysis 8.16. Comparison 8 PFNA versus Gamma 3 nail, Outcome 16 Operative details.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 16 Operative details
Study or subgroup PFNA Gamma 3 nail
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Operating time (minutes)
Vaquero 2012 31 35 (10) 30 37 (10) 58.8 % -2.00 [ -7.02, 3.02 ]
Xu 2010a 66 64.1 (15.44) 70 68.6 (20.08) 41.2 % -4.50 [ -10.50, 1.50 ]
Subtotal (95% CI) 97 100 100.0 % -3.03 [ -6.88, 0.82 ]
Heterogeneity: Chi2 = 0.39, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.54 (P = 0.12)
2 Fluoroscopy time (minutes)
Xu 2010a 66 2.7 (1.14) 70 3.2 (1.09) 100.0 % -0.50 [ -0.88, -0.12 ]
Subtotal (95% CI) 66 70 100.0 % -0.50 [ -0.88, -0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.61 (P = 0.0090)
3 Intra-operative blood loss (mL)
Xu 2010a 66 217.4 (110.49) 70 272.7 (123.83) 100.0 % -55.30 [ -94.70, -15.90 ]
Subtotal (95% CI) 66 70 100.0 % -55.30 [ -94.70, -15.90 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.75 (P = 0.0059)
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Analysis 8.17. Comparison 8 PFNA versus Gamma 3 nail, Outcome 17 Number of patients transfused.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 8 PFNA versus Gamma 3 nail
Outcome: 17 Number of patients transfused
Study or subgroup PFNA Gamma 3 nail Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Xu 2010a 24/66 31/70 0.82 [ 0.54, 1.24 ]
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Analysis 9.1. Comparison 9 Dynamic versus static locked intramedullary nail, Outcome 1 Mortality at 1
year.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 9 Dynamic versus static locked intramedullary nail
Outcome: 1 Mortality at 1 year
Study or subgroup Dynamic locking Static locking Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hardy 2003 7/41 9/39 0.74 [ 0.31, 1.79 ]
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Analysis 9.2. Comparison 9 Dynamic versus static locked intramedullary nail, Outcome 2 Pain and cortical
hypertrophy.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 9 Dynamic versus static locked intramedullary nail
Outcome: 2 Pain and cortical hypertrophy
Study or subgroup Dynamic locking Static locking Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Mid-thigh pain
Hardy 2003 2/33 6/30 0.30 [ 0.07, 1.39 ]
2 Cortical hypertrophy
Hardy 2003 1/34 6/30 0.15 [ 0.02, 1.15 ]
0.01 0.1 1 10 100
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Analysis 9.3. Comparison 9 Dynamic versus static locked intramedullary nail, Outcome 3 Fracture fixation
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 9 Dynamic versus static locked intramedullary nail
Outcome: 3 Fracture fixation complications
Study or subgroup Dynamic locking Static locking Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Later fracture of the femur
Hardy 2003 0/41 1/39 0.32 [ 0.01, 7.57 ]
2 Cut-out
Hardy 2003 1/41 0/39 2.86 [ 0.12, 68.10 ]
3 Technical complications of fixation
Hardy 2003 1/41 1/39 0.95 [ 0.06, 14.69 ]
4 Re-operation
Hardy 2003 1/41 3/39 0.32 [ 0.03, 2.92 ]
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Analysis 9.4. Comparison 9 Dynamic versus static locked intramedullary nail, Outcome 4 Leg shortening
(mm) in those able to undergo a radiographic assessment.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 9 Dynamic versus static locked intramedullary nail
Outcome: 4 Leg shortening (mm) in those able to undergo a radiographic assessment
Study or subgroup Dynamic locking Static locking
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Hardy 2003 21 7.6 (5.37) 26 6.3 (5.07) 1.30 [ -1.71, 4.31 ]
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Analysis 9.5. Comparison 9 Dynamic versus static locked intramedullary nail, Outcome 5 Operative details.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 9 Dynamic versus static locked intramedullary nail
Outcome: 5 Operative details
Study or subgroup Dynamic locking Static locking
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Length of surgery (minutes)
Hardy 2003 41 58.4 (17.9) 39 58.2 (14.8) 0.20 [ -6.98, 7.38 ]
2 Intra-operative blood loss (minutes)
Hardy 2003 41 142.4 (82.42) 39 133.6 (88.54) 8.80 [ -28.73, 46.33 ]
3 Haemoglobin level: 48 hours post-op (g/dL)
Hardy 2003 41 9.1 (1.05) 39 9.2 (1.32) -0.10 [ -0.62, 0.42 ]
4 Transfused packed blood cells
Hardy 2003 41 0.9 (1.03) 39 1.1 (1.06) -0.20 [ -0.66, 0.26 ]
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Analysis 10.1. Comparison 10 Sliding versus non-sliding lag screw for Gamma 3 nail, Outcome 1 Harris hip
score (0 to 100: high values = best function).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 10 Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome: 1 Harris hip score (0 to 100: high values = best function)
Study or subgroup Sliding Non sliding
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Group A (AO A1.1, 1.2, 1.3)
Zhu 2012 7 88 (8.1) 4 90.25 (5.12) 22.5 % -2.25 [ -10.07, 5.57 ]
Subtotal (95% CI) 7 4 22.5 % -2.25 [ -10.07, 5.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.56 (P = 0.57)
2 Group B (AO A2.1)
Zhu 2012 12 86.33 (11.85) 16 87.13 (6.6) 24.8 % -0.80 [ -8.24, 6.64 ]
Subtotal (95% CI) 12 16 24.8 % -0.80 [ -8.24, 6.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
3 Group C (AO A2.2, 2.3)
Zhu 2012 21 84.52 (5.51) 20 85.6 (10.34) 52.7 % -1.08 [ -6.19, 4.03 ]
Subtotal (95% CI) 21 20 52.7 % -1.08 [ -6.19, 4.03 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 40 40 100.0 % -1.27 [ -4.98, 2.43 ]
Heterogeneity: Chi2 = 0.08, df = 2 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Chi2 = 0.08, df = 2 (P = 0.96), I2 =0.0%
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Analysis 10.2. Comparison 10 Sliding versus non-sliding lag screw for Gamma 3 nail, Outcome 2 Fracture
fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 10 Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome: 2 Fracture fixation complications
Study or subgroup Sliding Non sliding Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Femoral shaft fracture (timing not known)
Zhu 2012 (1) 0/40 2/40 0.20 [ 0.01, 4.04 ]
2 Cut-out
Zhu 2012 (2) 0/40 1/40 0.33 [ 0.01, 7.95 ]
3 Non-union at 6 months
Zhu 2012 1/40 2/40 0.50 [ 0.05, 5.30 ]
4 Non-union at 12 months
Zhu 2012 0/40 1/40 0.33 [ 0.01, 7.95 ]
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(1) Both resolved with additional fixation
(2) Resolved with additional fixation
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Analysis 10.3. Comparison 10 Sliding versus non-sliding lag screw for Gamma 3 nail, Outcome 3 Average
healing time (months).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 10 Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome: 3 Average healing time (months)
Study or subgroup Sliding Non sliding
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Group A (AO A1.1,1.2,1.3)
Zhu 2012 (1) 7 3 (1.13) 4 3 (0.01) 34.3 % 0.0 [ -0.84, 0.84 ]
Subtotal (95% CI) 7 4 34.3 % 0.0 [ -0.84, 0.84 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Group B (AO, A2.1)
Zhu 2012 12 3.25 (0.87) 16 3.25 (0.87) 56.7 % 0.0 [ -0.65, 0.65 ]
Subtotal (95% CI) 12 16 56.7 % 0.0 [ -0.65, 0.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
3 Group C (AO, A2.2,2.3)
Zhu 2012 21 3.23 (0.81) 20 3.85 (3.64) 9.0 % -0.62 [ -2.25, 1.01 ]
Subtotal (95% CI) 21 20 9.0 % -0.62 [ -2.25, 1.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
Total (95% CI) 40 40 100.0 % -0.06 [ -0.55, 0.43 ]
Heterogeneity: Chi2 = 0.50, df = 2 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.82)
Test for subgroup differences: Chi2 = 0.50, df = 2 (P = 0.78), I2 =0.0%
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(1) SD in the non sliding group changed from 0 to 0.01
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Analysis 10.4. Comparison 10 Sliding versus non-sliding lag screw for Gamma 3 nail, Outcome 4 Operative
details.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 10 Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome: 4 Operative details
Study or subgroup Sliding Non sliding
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Operation time (mins)
Zhu 2012 40 46.73 (10.37) 40 48.35 (9.23) -1.62 [ -5.92, 2.68 ]
2 Intra-operative blood loss (mL)
Zhu 2012 40 141.1 (18.12) 40 138.5 (19.42) 2.60 [ -5.63, 10.83 ]
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Favours sliding Favours non sliding
Analysis 10.5. Comparison 10 Sliding versus non-sliding lag screw for Gamma 3 nail, Outcome 5 Length of
stay (days).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 10 Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome: 5 Length of stay (days)
Study or subgroup Sliding Non sliding
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Zhu 2012 40 4 (1) 40 4 (1) 0.0 [ -0.44, 0.44 ]
-1 -0.5 0 0.5 1
Favours sliding Favours non sliding
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Analysis 10.6. Comparison 10 Sliding versus non-sliding lag screw for Gamma 3 nail, Outcome 6 Leg length
discrepancy (mm) (’Group C’ - unstable fractures - only).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 10 Sliding versus non-sliding lag screw for Gamma 3 nail
Outcome: 6 Leg length discrepancy (mm) (’Group C’ - unstable fractures - only)
Study or subgroup Sliding Non sliding
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Zhu 2012 21 0.955 (0.024) 20 0.57 (0.019) 0.38 [ 0.37, 0.40 ]
-0.5 -0.25 0 0.25 0.5
Favours sliding Favours non sliding
Analysis 11.1. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 1 Mortality (1 year).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 1 Mortality (1 year)
Study or subgroup InterTan nail PFNA II Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Zhang 2013 8/57 7/56 1.12 [ 0.44, 2.89 ]
0.01 0.1 1 10 100
Favours InterTan Favours PFNA II
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Analysis 11.2. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 2 Final functional outcomes.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 2 Final functional outcomes
Study or subgroup InterTan nail PFNA II
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Harris hip score (1 to 100; high values = best function)
Zhang 2013 47 80.2 (13.7) 46 82.6 (11.3) -2.40 [ -7.50, 2.70 ]
2 Walking ability score (0 to 9; high value = best function)
Zhang 2013 47 5.8 (1.9) 46 6.1 (1.7) -0.30 [ -1.03, 0.43 ]
-10 -5 0 5 10
Favours PFNA II Favours InterTan
Analysis 11.3. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 3 Hip and thigh pain.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 3 Hip and thigh pain
Study or subgroup InterTan nail PFNA II Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Hip pain
Zhang 2013 2/47 2/46 0.98 [ 0.14, 6.66 ]
2 Thigh pain
Zhang 2013 3/47 12/46 0.24 [ 0.07, 0.81 ]
0.01 0.1 1 10 100
Favours InterTan Favours PFNA II
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Analysis 11.4. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 4 Fracture fixation
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 4 Fracture fixation complications
Study or subgroup InterTan nail PFNA II Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Cutout
Zhang 2013 0/47 2/46 0.20 [ 0.01, 3.97 ]
2 Femoral shaft fracture (post-operative)
Zhang 2013 0/47 1/46 0.33 [ 0.01, 7.81 ]
3 Femoral shaft fracture (intra-operative)
Zhang 2013 1/57 2/56 0.49 [ 0.05, 5.27 ]
4 Lateral greater trochanter fracture
Zhang 2013 6/57 1/56 5.89 [ 0.73, 47.40 ]
5 Proximal end of nail penetrating trochanter
Zhang 2013 1/57 4/56 0.25 [ 0.03, 2.13 ]
6 Distal interlocking problem
Zhang 2013 2/57 2/56 0.98 [ 0.14, 6.73 ]
7 Blade migration
Zhang 2013 0/47 4/46 0.11 [ 0.01, 1.97 ]
8 Re-operation
Zhang 2013 2/47 3/46 0.65 [ 0.11, 3.73 ]
0.002 0.1 1 10 500
Favours InerTan Favours PFNA II
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Analysis 11.5. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 5 Time to fracture healing
(weeks).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 5 Time to fracture healing (weeks)
Study or subgroup InterTan nail PFNA II
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Zhang 2013 47 14 (4.86) 46 17 (4.37) -3.00 [ -4.88, -1.12 ]
-10 -5 0 5 10
Favours InterTan Favours PFNA II
Analysis 11.6. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 6 Post-operative
complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 6 Post-operative complications
Study or subgroup InterTan nail PFNA II Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Superficial wound infection
Zhang 2013 3/47 2/46 1.47 [ 0.26, 8.38 ]
2 Deep infection
Zhang 2013 2/47 1/46 1.96 [ 0.18, 20.85 ]
3 Deep venous thrombosis
Zhang 2013 7/47 6/46 1.14 [ 0.42, 3.14 ]
4 Pulmonary embolism
Zhang 2013 1/47 0/46 2.94 [ 0.12, 70.30 ]
5 Pressure sore
Zhang 2013 3/47 4/46 0.73 [ 0.17, 3.10 ]
6 Urinary tract infection
Zhang 2013 4/47 6/46 0.65 [ 0.20, 2.16 ]
0.01 0.1 1 10 100
Favours InterTan Favours PFNA II
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Analysis 11.7. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 7 Length of stay (days).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 7 Length of stay (days)
Study or subgroup InterTan nail PFNA II
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Zhang 2013 57 8.33 (1.65) 56 8.03 (1.21) 0.30 [ -0.23, 0.83 ]
-10 -5 0 5 10
Favours InterTan Favours PFNA II
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Analysis 11.8. Comparison 11 InterTan nail versus the PFNA II nail, Outcome 8 Operative details.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 11 InterTan nail versus the PFNA II nail
Outcome: 8 Operative details
Study or subgroup InterTan nail PFNA II
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Operative time (min)
Zhang 2013 57 66.5 (15.2) 56 53.7 (11.3) 12.80 [ 7.87, 17.73 ]
2 Blood loss (mL)
Zhang 2013 57 235.3 (124.6) 56 197.5 (101.8) 37.80 [ -4.12, 79.72 ]
3 Fluoroscopy time (seconds)
Zhang 2013 57 216 (10.8) 56 126 (9.6) 90.00 [ 86.23, 93.77 ]
-100 -50 0 50 100
Favours InterTan Favours PFNA II
Analysis 12.1. Comparison 12 Long versus standard proximal femoral nail antirotation (PFNA nail),
Outcome 1 Mortality (1 year).
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 12 Long versus standard proximal femoral nail antirotation (PFNA nail)
Outcome: 1 Mortality (1 year)
Study or subgroup Long PFNA Standard PFNA Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Okcu 2013 4/22 3/18 1.09 [ 0.28, 4.26 ]
0.01 0.1 1 10 100
Favours long Favours standard
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Analysis 12.2. Comparison 12 Long versus standard proximal femoral nail antirotation (PFNA nail),
Outcome 2 Final functional outcomes.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 12 Long versus standard proximal femoral nail antirotation (PFNA nail)
Outcome: 2 Final functional outcomes
Study or subgroup Long PFNA Standard PFNA
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Harris hip score (1 to 100, top score = best function)
Okcu 2013 18 79 (10) 15 74 (8) 5.00 [ -1.14, 11.14 ]
2 Parker and Palmer mobility score (0 to 9, top score = best function)
Okcu 2013 18 5.5 (1.7) 15 5.2 (1.9) 0.30 [ -0.94, 1.54 ]
-10 -5 0 5 10
Favours standard Favours long
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Analysis 12.3. Comparison 12 Long versus standard proximal femoral nail antirotation (PFNA nail),
Outcome 3 Fracture fixation complications.
Review: Intramedullary nails for extracapsular hip fractures in adults
Comparison: 12 Long versus standard proximal femoral nail antirotation (PFNA nail)
Outcome: 3 Fracture fixation complications
Study or subgroup Long PFNA Standard PFNA Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Re-operation
Okcu 2013 (1) 2/18 0/15 4.21 [ 0.22, 81.47 ]
2 Blade cut-out
Okcu 2013 1/18 0/15 2.53 [ 0.11, 57.83 ]
3 Wound infection (deep)
Okcu 2013 1/18 0/15 2.53 [ 0.11, 57.83 ]
4 Wound infection (superficial)
Okcu 2013 0/18 1/15 0.28 [ 0.01, 6.43 ]
5 Non-union
Okcu 2013 0/18 0/15 Not estimable
6 Malunion
Okcu 2013 6/18 3/15 1.67 [ 0.50, 5.56 ]
0.002 0.1 1 10 500
Favours long Favours standard
(1) Re-operation required for 1 deep infection and 1 blade cut-out
A D D I T I O N A L T A B L E S
Table 1. Intramedullary nails evaluated by the included trials
Name Description
Endovis nail The Endovis nail (Citieffe Ltd) is available in 3 sizes (195 to 400 mm) and has
a neck shaft angle of 130°. It has two cephalic screws for the femoral head to
facilitate fracture compression. The distal section is slotted to produce a graduated
variation of stiffness
Gamma nail The Gamma nail (Stryker Ltd) was introduced in the late 1980s for the treatment
of extracapsular hip fractures. The implant consists of a sliding lag screw which
passes through a short intramedullary nail placed via the trochanteric entry point.
One or two screws may be passed through the nail tip to secure it to the femoral
shaft (distal locking). Theoretical advantages of this implant are due to a percu-
taneous insertion technique and include reduced blood loss, minimal soft tissue
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Table 1. Intramedullary nails evaluated by the included trials (Continued)
trauma and short operating time. Modifications to the design of the Gamma nail
and its instrumentation have occurred since its introduction. The long Gamma
nail has a range of different lengths from 280 to 460 mm with two distal locking
screw options. An Asian-Pacific version of the nail is available for use in the Asian
population and has reduced length, diameter and mediolateral angle to accommo-
date small femurs typically seen in this group
Gamma 3 nail The Gamma 3 nail (Stryker Ltd) is the third generation of the gamma nail fixation
system for proximal femoral fractures. It is a trochanteric entry nail with a reduced
proximal nail diameter (15.5 mm versus 17 mm) to facilitate a shorter incision.
Its length options range from 280 mm to 460 mm. Its neck shaft angle options
include 120°, 125° and 130°. The lag screw shape has also been modified to
provide superior cutting behaviour and greater resistance to cut-out. One trial
in this review compared a sliding and a non-sliding lag screw mechanism in the
Gamma 3 nail
Gliding nail The gliding nail (Smith-Nephew) is a trochanteric entry nail designed to avoid the
complications of implants such as the Gamma nail. It utilises a T-shaped femoral
neck blade that has an extensive surface area relative to other intramedullary devices
which provides good rotational stability and a high resistance to fatigue fracture.
The T-shaped blade can slide through the nail, facilitating fracture compression
and healing. The standard length is 220 mm with long nail options ranging from
340 mm to 440 mm. Blade shaft angles include 125° and 135°
Intramedullary hip screw (IMHS) The IMHS (Smith and Nephew), length 210 mm, was introduced in 1991 for
the treatment of extracapsular femoral fractures. Like the Gamma nail, it consists
of a nail inserted via the greater trochanter into the medullary cavity. It utilises a
single screw in the femoral head that can slide through a barrel in the nail allowing
fracture compression. Three different neck angles are available, 125°, 130° and
135°. Nail lengths are available from 195 mm to 440 mm
Proximal femoral nail (PFN) The PFN (Synthes Ltd), length 240mm, was introduced in 1998 for the treatment
of extracapsular fractures. Like the Gamma and IMHS, it consists of a nail inserted
via the greater trochanter into the medullary cavity. Two lengths are available, 200
mm and 240 mm. Two proximal lag screws are passed up the femoral neck to the
head. Distal locking can be performed in static or dynamic mode via two distal
locking screws
Proximal femoral nail antirotation (PFNA) The PFNA (Synthes Ltd), length 170 mm, 200 mm or 240 mm, is a modification
of the PFN nail. It is similar to the PFN nail apart from not having two proximal
lag screws, but instead a single helically-shaped blade which is designed to provide
increased angular and rotational stability. The helical blade is designed to avoid
bone loss that occurs during drilling and insertion of a standard hip screw. It has 2
distal locking screw options for either dynamic or static locking. Blade shaft angle
options include 125°, 130° and 135°
Proximal femoral nail antirotation II (PFNA II) The PFNA II (Synthes Ltd) is a modification of the PFNA nail to address the
different proximal femoral anatomy of Asian patients. The PFNA has a large
proximal diameter (17 mm) which was thought to account for the increase in
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Table 1. Intramedullary nails evaluated by the included trials (Continued)
femoral shaft fracture, lateral cortex splitting and thigh pain reported in Asian
patients. The PFNA II has a smaller proximal diameter (16.5 mm versus 17 mm)
and a flatter lateral shape (5° versus 6°)
Targon PF (proximal femoral) nail The Targon PF nail (B Braun Ltd), length 220 mm, is inserted into the in-
tramedullary cavity via a trochanteric entry point. Proximally, this nail has a sliding
lag screw and an antirotation pin. The Targon PF nail facilitates fracture dynami-
sation via a gliding screw that glides through a sleeve that is attached to the nail,
thereby avoiding protrusion of the screw into peritrochanteric tissues
ACE trochanteric nail The ACE nail (Depuy) has a 10.5 mm lag screw and an optional antirotation lag
screw. It has 2 distal holes for static or dynamic locking. Its proximal diameter is
16 mm and length is 180 mm or 200 mm
Russell-Taylor Recon nail The Russel-Taylor Recon nail (Smith-Nephew) is an intramedullary nail that
utilises a piriformis entry point. 2 screws are available for fixation in the femoral
head. It is a full length femoral nail with no short versions available for proximal
femoral fixation only
InterTan nail The InterTan nail (Smith-Nephew) uses 2 cephalocervical screws in an integrated
mechanism allowing intra-operative compression and rotational stability of the
head-neck fragments. It has a cannulated set screw mechanism that allows for the
device to be used in fixed angle mode or in sliding/compression mode. Its length
ranges from 180 mm to 460 mm (long nail option)
A P P E N D I C E S
Appendix 1. Search strategies (2007 to present)
The Cochrane Library (Wiley Online Library)
#1 MeSH descriptor: [Hip Fractures] explode all trees (1048)
#2 ((hip* or femur* or femoral* or trochant* or pertrochant* or intertrochant* or subtrochant* or extracapsular*) near/4 fracture*):
ti,ab,kw (Word variations have been searched) (2521)
#3 #1 or #2 (2521)
#4 (nail* or screw* or fix* or implant* or rod or rods):ti,ab,kw (Word variations have been searched) (25458)
#5 MeSH descriptor: [Internal Fixators] this term only (131)
#6 MeSH descriptor: [Bone Screws] this term only (513)
#7 MeSH descriptor: [Fracture Fixation, Internal] this term only (646)
#8 MeSH descriptor: [Fracture Fixation, Intramedullary] this term only (234)
#9 MeSH descriptor: [Bone Nails] this term only (321)
#10 #4 or #5 or #6 or #7 or #8 or #9 (25458)
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#11 (intramedullar* or IM or cephalocondylic or condylocephalic or Cephalomedullary):ti,ab,kw (Word variations have been searched)
(3196)
#12 #10 and #11 (584)
#13 ((ender or harris or gamma or interlocking or kuntscher* or targon or “proximal femoral” or holland or ACE) near/1 nail*):ti,ab,kw
(Word variations have been searched) (199)
#14 (PFN or IMHS):ti,ab,kw (Word variations have been searched) (31)
#15 #12 or #13 or #14 (730)
#16 #3 and #15 (276) [Trials]
MEDLINE (Ovid Online)
1 exp Hip Fractures/ (17920)
2 ((hip* or femur* or femoral* or trochant* or pertrochant* or intertrochant* or subtrochant* or extracapsular*) adj4 fracture*).tw.
(28221)
3 or/1-2 (32569)
4 (nail* or screw* or fix* or implant* or rod*1).tw. (610450)
5 Internal Fixators/ or Bone Screws/ or Fracture Fixation, Intramedullary/ or Fracture Fixation, Internal/ or Bone Nails/ (48592)
6 4 or 5 (625799)
7 (intramedullar* or IM or cephalocondylic or condylocephalic or Cephalomedullary).tw. (37594)
8 6 and 7 (8732)
9 ((ender or harris or gamma or interlocking or kuntscher* or targon or “proximal femoral” or holland or ACE) adj nail*).tw. (1513)
10 (PFN or IMHS).tw. (444)
11 8 or 9 or 10 (10003)
12 3 and 11 (2889)
13 Randomized controlled trial.pt. (395719)
14 Controlled clinical trial.pt. (90591)
15 randomized.ab. (311096)
16 placebo.ab. (166010)
17 Drug therapy.fs. (1786261)
18 randomly.ab. (219864)
19 trial.ab. (327892)
20 groups.ab. (1393917)
21 or/13-20 (3472807)
22 exp Animals/ not Humans/ (4093361)
23 21 not 22 (2978113)
24 12 and 23 (512)
25 (2007* or 2008* or 2009* or 2010* or 2011* or 2012* or 2013* or 2014*).ed. (7006243)
26 24 and 25 (255)
EMBASE (Ovid Online)
1 exp Hip Fracture/ (29018)
2 ((hip* or femur* or femoral* or trochant* or pertrochant* or intertrochant* or subtrochant* or extracapsular*) adj4 fracture*).tw.
(33832)
3 1 or 2 (43367)
4 (nail* or screw* or fix* or implant* or rod*1).tw. (687437)
5 Bone Nail/ or Bone Screw/ or Fixation Device/ or Internal Fixator/ or Fracture Fixation/ (42147)
6 4 or 5 (702371)
7 (intramedullar* or IM or cephalocondylic or condylocephalic or Cephalomedullary).tw. (48037)
8 6 and 7 (9802)9 ((ender or harris or gamma or interlocking or kuntscher* or targon or “proximal femoral” or holland or ACE) adj
nail*).tw. (1868)
10 (PFN or IMHS).tw. (538)
11 Ender Nail/ or Interlocking Nail/ or Intramedullary Nail/ (2394)
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12 8 or 9 or 10 or 11 (12073)
13 3 and 12 (3690)
14 Randomized controlled trial/ (362850)
15 Clinical trial/ (891046)
16 Controlled clinical trial/ (407136)
17 Randomization/ (64351)
18 Single blind procedure/ (18704)
19 Double blind procedure/ (119415)
20 Crossover procedure/ (39341)
21 Placebo/ (231943)
22 Prospective study/ (259171)
23 ((clinical or controlled or comparative or placebo or prospective* or randomi#ed) adj3 (trial or study)).tw. (742676)
24 (random* adj7 (allocat* or allot* or assign* or basis* or divid* or order*)).tw. (181677)
25 ((singl* or doubl* or trebl* or tripl*) adj7 (blind* or mask*)).tw. (161639)
26 (cross?over* or (cross adj1 over*)).tw. (69389)
27 ((allocat* or allot* or assign* or divid*) adj3 (condition* or experiment* or intervention* or treatment* or therap* or control* or
group*)).tw. (233163)
28 RCT.tw. (13327)
29 or/14-28 (1907125)
30 Case Study/ or Abstract Report/ or Letter/ (921006)
31 29 not 30 (1868931)
32 13 and 31 (634)
33 (2007* or 2008* or 2009* or 2010* or 2011* or 2012* or 2013* or 2014*).em. (8033361)
34 32 and 33 (301)
WHO International Clinical Trials Registry Platform
Search (11 January 2014) resulting in 76 trials) was: Nail AND fracture (in title) - ALL (recruitment status)
Appendix 2. Previous search strategies
The Cochrane Library (Wiley Interscience)
#1 MeSH descriptor Hip Fractures explode all trees
#2 ((hip* or femur* or femoral* or trochant* or pertrochant* or intertrochant* or subtrochant* or intracapsular* or extracapsular*)
NEAR fracture*):ti,ab,kw
#3 (#1 OR #2)
#4 4 (pin* or nail* or screw* or plate* or arthroplasty* or fix* or prosthes*):ti,ab,kw
#5 MeSH descriptor Internal Fixators, this term only
#6 MeSH descriptor Bone Screws, this term only
#7 MeSH descriptor Fracture Fixation, Internal explode all trees
#8 MeSH descriptor Bone Plates, this term only
#9 MeSH descriptor Bone Nails, this term only
#10 MeSH descriptor Arthroplasty explode all trees
#11 (#4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 (#3 AND #11)
MEDLINE (Ovid Online)
1. exp Hip Fractures/
2. hip$ or femur$ or femoral$ or trochant$ or pertrochant$ or intertrochant$ or subtrochant$ or intracapsular$ or extracapsular$)
adj4 fracture$).tw.
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3. or/1-2
4. (pin$1 or nail$ or screw$1 or plate$1 or arthroplast$ or fix$ or prosthes$).tw.
5. Internal Fixators/ or Bone Screws/ or Fracture Fixation, Internal/ or Bone Plates/ or Bone Nails/
6. Arthroplasty/ or Arthroplasty, Replacement, Hip/
7. or/4-6
8. and/3,7
EMBASE (Ovid Online)
1. exp Hip Fracture/
2. ((hip$ or femur$ or femoral$ or trochant$ or pertrochant$ or intertrochant$ or subtrochant$ or intracapsular$ or extracapsular$)
adj4 fracture$).tw.
3. or/1-2
4. (pin$1 or nail$ or screw$1 or plate$1 or arthroplast$ or fix$ or prosthes$).tw.
5. Bone Screws/ or Fracture Fixation/ or Bone Plate/ or Bone Nail/ or intramedullary nailing/
6. arthroplasty/ or hip arthroplasty/
7. or/4-6
8. and/3,7
9. exp Randomized Controlled trial/
10. exp Double Blind Procedure/
11. exp Single Blind Procedure/
12. exp Crossover Procedure/
13. Controlled Study/
14. or/9-13
15. ((clinical or controlled or comparative or placebo or prospective$ or randomi#ed) adj3 (trial or study)).tw.
16. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw.
17. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw.
18. (cross?over$ or (cross adj1 over$)).tw.
19. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or experiment$ or intervention$ or treatment$ or therap$ or control$ or
group$)).tw.
20. or/15-19
21. or/14,20
22. limit 21 to human
23. and/8,22
Appendix 3. Report of search results in previous version of the review (Parker 2006)
For the second update of this review, of four newly identified studies, three (Efstathopoulos 2007; Starr 2006; Vidyadhara 2007) were
included and one (Suckel 2006) was excluded. Overall, a total of 13 studies were considered, nine of which are included. Three others
are excluded for reasons given in ’Characteristics of excluded studies’. One study (Gahr 2003a) remains in ’Studies awaiting assessment’
pending the receipt of further information.
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Appendix 4. Outcome categories used for presenting the results
Where practical, we presented the results for each comparison under five categories. The relationship between the outcomes listed in
Types of outcome measures and these categories is shown below.
1. Final outcome measures
• Functional outcomes
• “Poor outcome”
• Mobility, use of walking aids, presence of a limp
• Hip, lower limb pain (chronic)
• Other: Functional impairment
2. Fracture fixation complications
• Serious adverse events and technical complications of fixation
• Less serious local complications
3. Post-operative complications and hospital stay
• Medical complications
• Economic outcomes (hospital stay)
4. Anatomical restoration
• Other: Anatomical restoration
5. Operative details
• Other: Operative details
Appendix 5. Previous Types of outcome measures (up to 2012)
In the first (2005) and second (2006) versions of the review, the types of outcome measures were presented as follows:
1. Operative details
• length of surgery (in minutes)
• operative blood loss (in millilitres)
• number of patients transfused
• radiographic screening time (in seconds or minutes)
2. Fracture fixation complications
• operative fracture of the femur (around or below the implant, but excluding comminution of the fracture site)
• later fracture of the femur (around or below the implant)
• cut-out of the implant from the femoral head
• non-union of the fracture
• breakage of the implant
• all technical complications of fixation (sum of above six outcomes with the addition of any other major complications of fracture
healing as specified in each study. Major complications were defined as those which generally required revision surgery or a change of
surgical procedure during the primary operation, such as using a longer nail. Excluded from this are minor operative complications
such as comminution of the fracture site during surgery)
• other operative or fracture healing complications as detailed in individual studies
• re-operation (within the follow-up period of the study)
• superficial wound infection
• deep wound infection (i.e. infection around the implant)
• wound haematoma/seroma
3. Post-operative complications and hospital stay
• pressure sores
• pneumonia
• thromboembolic complications (deep vein thrombosis or pulmonary embolism)
• any medical complication (as detailed in each individual study, excluding wound infections)
• length of hospital stay (in days)
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4. Anatomical restoration
• leg shortening (preferably > 2 cm)
• varus deformity of the femoral neck
• external rotation deformity (preferably > 20 degrees)
5. Final outcome measures
• mortality (within the follow-up period of the study)
• pain (persistent pain at the final follow-up assessment)
• mobility and use of walking aids
• failure to return to prefracture residential status
• functional activities of daily living
• composite function and hip scores
WH A T ’ S N E W
Last assessed as up-to-date: 6 January 2014.
Date Event Description
9 September 2014 New citation required and conclusions have changed The conclusions now apply to an increased number of
comparisons of different nails
Two new authors (JQ and EH) took on the main work
of the update; the previous two authors continued their
contribution
9 September 2014 New search has been performed For this versionof the review, published in Issue 9, 2014,
we made the following changes.
1. We updated the search to January 2014.
2. We included eight new trials (De Grave 2012;
Makridis 2010;Okcu 2013; Vaquero 2012;Wild 2010;
Xu 2010a; Zhang 2013; Zhu 2012). There were seven
new comparisons.
3. In accordance with Cochrane Collaboration policy,
we included new methodology, including the assess-
ment of risk of bias and quality of the evidence, the
latter using GRADE
H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 2, 2005
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Date Event Description
31 July 2008 New search has been performed For the second update, published in Issue 4, 2008, the following changes were
made:
(1) the search was updated to June 2007;
(2) three newly identified studies (Efstathopoulos 2007, Starr 2006, Vidadhura
2007) were included resulting in the addition of two new comparisons;
(3) one newly identified study (Suckel 2006) was excluded.
There were no changes made to the conclusions.
30 July 2008 Amended Converted to new review format.
17 May 2006 New search has been performed For the first update, published in Issue 3, 2006, the following changes were made:
(1) the search was updated to March 2006;
(2) two new studies (Marques 2005; Papasimos 2005) were included;
(3) additional data were included from Schipper 2004 after correspondence with
trialists;
(4) adjustments were made to text and tables to conform to revised methodology
and the Cochrane Style Guide.
There were no changes made to the conclusions.
C O N T R I B U T I O N S O F A U T H O R S
Martyn Parker (MJP) initiated the review and wrote the first draft of the protocol. Helen Handoll (HH) revised the protocol. Both
authors identified trials, selected trials for inclusion, performed data extraction and quality assessment of the included trials. MJP
compiled the first draft of the review and the two previous review updates: these were then critically revised and completed by HH.
Joseph Queally (JQ) initiated this review update and, after achieving agreement with HH and MJP on the revised methods and
restructuring, JQ and Ella Harris (EH), with intermittent input from HH, assessed all the studies and incorporated the new evidence
into the review. The review was then critically revised and completed by HH and MJP. JQ is the guarantor of the review.
D E C L A R A T I O N S O F I N T E R E S T
JQ: None known
EH: None known
HH: None known
MJP: Has received royalties from B.Braun Ltd related to the design and development of an implant used for the internal fixation of
intracapsular hip fractures. This implant and fracture type is not considered in this review.
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S O U R C E S O F S U P P O R T
Internal sources
• University of Teesside, Middlesbrough, UK.
• Peterborough and Stamford Hospitals NHS Foundation Trust, UK.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Differences in version published 2014
1. In line with Collaboration recommendations, the review now assesses risk of bias.
2. In Types of interventions, we clarified our criteria for selecting the control groups in the various comparisons.
3. The types of outcome measures were restructured into primary, secondary, other and economic outcomes (seeAppendix 5 for previous
list). Given the correspondence between the previous and revised outcome measures was presentational rather than content, we opted
to retain the five previous outcome categories (1. Operative details; 2. Fracture fixation complications; 3. Post-operative complications
and hospital stay; 4. Anatomical restoration; 5. Final outcome measures) but to adjust their order (5; 2; 3; 4; 1) and clarify their
relationship to the revised outcomes (see Appendix 4).
4. Assessment of quality of the evidence was done using GRADE.
Differences in version published 2006
1. The title of the review was changed in Issue 2, 2005 from that of the protocol (Cephalocondylic intramedullary nails for extracapsular
hip fractures in adults) to the present title. This reflected the expansion of the scope to include condylocephalic nails.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bone Nails; Fracture Fixation, Intramedullary [instrumentation; ∗methods]; Hip Fractures [∗surgery]; Randomized Controlled Trials
as Topic
MeSH check words
Aged; Female; Humans; Male
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